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ABSTRACT OF THE DISSERTATION
A MULTI-FACETED DIAGNOSTIC APPROACH TO LUNG INFECTIONS IN
PATIENTS WITH CYSTIC FIBROSIS
by
Melissa S. Doud
Florida International University, 2010
Miami, Florida
Professor Kalai Mathee, Major Professor
One in 3,000 people in the US are born with cystic fibrosis (CF), a genetic disorder
affecting the reproductive system, pancreas, and lungs. Lung disease caused by chronic
bacterial and fungal infections is the leading cause of morbidity and mortality in CF.
Identities of the microbes are traditionally determined by culturing followed by
phenotypic and biochemical assays. It was first thought that the bacterial infections were
caused by a select handful of bacteria such as S. aureus, H. influenzae, B. cenocepacia,
and P. aeruginosa. With the advent of PCR and molecular techniques, the polymicrobial
nature of the CF lung became evident. The CF lung contains numerous bacteria and the
communities are diverse and unique to each patient. The total complexity of the bacterial
infections is still being determined. In addition, only a few members of the fungal
communities have been identified. Much of the fungal community composition is still a
mystery. This dissertation addresses this gap in knowledge. A snap shot of CF sputa
bacterial community was obtained using the length heterogeneity-PCR community
profiling technique. The profiles show that south Florida CF patients have a unique,
diverse, and dynamic bacterial community which changes over time. The identities of
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the bacteria and fungi present were determined using the state-of-the-art 454 sequencing.
Sequencing results show that the CF lung microbiome contains commonly cultured
pathogenic bacteria, organisms considered a part of the healthy core biome, and novel
organisms. Understanding the dynamic changes of these identified microbes will
ultimately lead to better therapeutical interventions. Early detection is key in reducing
the lung damage caused by chronic infections. Thus, there is a need for accurate and
sensitive diagnostic tests. This issue was addressed by designing a bacterial diagnostic
tool targeted towards CF pathogens using SPR. By identifying the organisms associated
with the CF lung and understanding their community interactions, patients can receive
better treatment and live longer.
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Introduction
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1.1 Preface
Cystic fibrosis (CF) is a genetic disorder that affects the exocrine glands of the
human body (Davis, 1987). Sweat glands, lungs, and pancreas are the most affected but
problems can arise in other systems such as the reproductive system (Davis, 1987). The
mucus found in the lungs, pancreas, and reproductive system is thicker and stickier in
people who have CF and this leads to chronic lung infection, digestion problems and
infertility, respectively (Andersen, 1938; Johansen et al., 1968; Oppenheimer & Esterly,
1969; Oppenheimer et al., 1970). The leading cause of morbidity and mortality in CF
patients is due to lung deterioration as the result of the chronic infections (Buzzetti et
al., 2009; Patient-registry, 2008). Diagnosis and treatment of the pulmonary infections
is key to the overall health and age of survival for the CF individual. The following
introduction discusses the microbial community found in the lungs of CF patients and
the techniques that identify these microbes.

1.2

Cystic fibrosis
Cystic fibrosis (CF) is a fatal inherited disease primarily affecting Caucasians. In

the United States (US), 3500 children are born with the disease each year (Patientregistry, 2008). The gene responsible for CF encodes a protein called the CF
transmembrane conductance regulator (CFTR) (Kerem et al., 1989; Riordan et al.,
1989; Rommens et al., 1989). The CFTR is a secretory epithelial cyclic-AMP-activated
chloride channel; mutations in the cftr gene lead to decreased fluid secretion and
dehydration of epithelial surfaces (Figure 1.1) (Anderson et al., 1991). The change in
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mucus production and consistency affects various systems of the human body. The
thick mucus can plug the pancreatic ducts which lead to pancreatic enzyme
insufficiency and thus vitamin deficiency and malnutrition (Andersen, 1938; Johansen
et al., 1968; Oppenheimer & Esterly, 1969). The thick mucus also causes reproductive
complications (Kaplan et al., 1968; Kotloff et al., 1992; Oppenheimer & Esterly, 1969;
Oppenheimer & Esterly, 1970). Although the anatomy of the female reproductive tract
is normal, pregnancy can be difficult as a result of the presence of the viscous mucus
preventing the sperm from fertilizing the egg (Kopito et al., 1973; Oppenheimer et al.,
1970). Over 90 % of males are born with congenital bilateral absence of the vas
deferens, meaning that a man can produce sperm but due to the lack of vas deferens the
sperm cannot leave the testicles (Landing et al., 1969; Mercier et al., 1995;
Oppenheimer & Esterly, 1969).
The airways in a CF individual are also negatively affected by the defective
CFTR protein. Oversecretion of thick mucus in the airway leads to congestion of the
respiratory tract and increased susceptibility to chronic broncho-pulmonary infection,
which is the major cause of morbidity and mortality among patients with CF (Buzzetti et
al., 2009). To retard the rate of decreasing lung function, bacterial infections are treated
with antibiotics, however these must be tailored to the particular infection, which is
often polymicrobial. For example, anti-pseudomonal drugs are often ineffective against
Burkholderia cenocepacia infections due to the bacteria’s resistance to the drug
(McGowan Jr, 2006). Thus, it is important to correctly identify the infecting pathogens,
bacteria and fungi, in order to prescribe an appropriate treatment and prolong the life of
the individual.
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Figure 1.1: Cystic fibrosis transmembrane conductance regulator (CFTR)
channel. Schematic representation of proposed CFTR structure. CFTR is made
up of five domains: two nucleotide-binding domains that bind and hydrolyze
ATP and a regulatory domain comprised of two membrane-spanning domains
which form the chloride ion channel, http://www.cfgenetherapy.org.uk/).
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1.2.1 CF sputum bacterial flora. Initially because of culturing techniques, it
was thought that only a few bacterial species were present in the CF lungs.
Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa are the
primary pathogens cultured from CF patients (Whittier, 2001). Staphylococcus aureus,
the predominant pathogen in children, is succeeded by H. influenzae during early
childhood and P. aeruginosa becomes the predominant pathogen during adolescence,
reaching a prevalence rate of 80% in adults (Beringer & Appleman, 2000; Patientregistry, 2008) (Figure 1.2).

Figure 1.2: Respiratory infections at a given age. Patients throughout their life are
affected with numerous bacteria. Each line represents a specific bacterial infection over
the lifespan of the patient. The height of the line indicates the percentage of patients
that have a particular bacterial infection at that specific age (Patient-registry, 2008).
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However, there has been the emergence of other opportunistic pathogens such as
Burkholderia cenocepacia, Alcaligenes xylosoxidans, Ralstonia pickettii, Burkholderia
gladioli, Stenotrophomonas maltophilia, and Mycobacterium species (Pierre-Audigier et
al., 2005; Whittier, 2001). The occurrence of the more recent emerging organisms
increases with advancing age and severity of lung disease (Beringer & Appleman, 2000;
Lewin et al., 1990; Patient-registry, 2008; Pierre-Audigier et al., 2005).

The

identification of these emerging pathogens suggests the presence of a complex bacterial
community present in the CF lung. The true polymicrobial nature of the lung was
revealed with the development of DNA based diagnostic tools. These methods have
identified Streptococcus mitis, Streptococcus pneumoniae, Prevotella melaninogenica,
Veionella sp., Granulicatella para-adiacens and Exiguobacterium in CF samples (Bittar
et al., 2008; Harris et al., 2007). Potential novel pathogens Lysobacter, Coxiellaceae, and
Rickettsiales have also been found (Harris et al., 2007). The diversity of the CF lung
community continues to increase and change as more samples from CF lungs are
analyzed.

1.2.2 CF sputum fungal flora. Invasive mold infections are very common in
patients suffering from chronic bronchitis. Thus, it was not surprising when the fungal
infections in CF patients were recognized as early as 1967 by the presence of
precipitating antibody to Aspergillus fumigatus (Mearns et al., 1967). In fact, A.
fumigatus is one of the most common fungal pathogens found in the CF lung. In one
study, 65 patients underwent a lung transplant and it was noted that 52% of these
patients were determined to being infected with A. fumigatus before surgery
6

(Paradowski, 1997). Candida albicans is the other common fungal pathogens (Bakare
et al., 2003; Cimon et al., 2001). Recently, Candida dubliniensis, a close relative of C.
albicans, has been detected in these patients as well (Kim et al., 2003). Occasionally,
other fungi such as Scedosporium apiospermum, Scedosporium prolificans, Aspergillus
terreus, Acrophialophora fusispora, Exophiala dermatitidis and Penicillium emersonii
have been shown to infect CF patients (Bakare et al., 2003; Cimon et al., 1999; Cimon
et al., 2003; Cimon et al., 2005; Defontaine et al., 2002; Hennequin et al., 1997; Horré
et al., 2004).
Recent statistics have shown that there is an increase in the prevalence of fungi
being detected in the CF patient which may be a consequence from aggressive
antibacterial therapy (Nagano et al., 2007). Yet, the prevalence of fungi present in the
CF lung is still unknown. For instance, the prevalence of Aspergillus infection ranges
from nine to 57 % of CF individuals (Bakare et al., 2003). In addition, the fungal
community may be more diverse than culturing results have shown. Depending on the
organism present, fungal infections can lead to health problems ranging from allergic
bronchopulmonary aspergillosis (ABPA) to post-transplant fungaemia (Fahy et al.,
1991; Kubak, 2002; Mastella et al., 2000; Nagano et al., 2007) It is also possible for a
fungal infection to become chronic and lead to bronchitis (Nagano et al., 2007).
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1.3

Common assays used for clinical identification of bacteria and their

limitations
Cystic fibrosis patients that are experiencing an exacerbation typically produce a
sputum sample that can be analyzed for the presence of pathogenic bacteria and fungi.
Most often diagnostic clinics use culturing and commercial kits to identify common
pathogenic organisms that may be present in the sample (Figure 1.3). A few of these
assays and their limitations are discussed in further detail below.
1.3.1 Culturing and commercial phenotypic identification assays. Culturing
for microbial identification is commonly used in laboratories handling CF sputum. Using
various media, sputum is swabbed onto plates and then the organism is allowed to grow
for a period of time. Based on the phenotype of the organism and the media it is growing
on, an identification of the bacteria or fungi is made. Bacteria can be cultured using
various media including: Luria Bertani (LB), blood agar, chocolate agar, Pseudomonas
Isolation Agar (PIA), Burkholderia cenocepacia Selective Agar (BCSA) and MacConkey
agar (Murray & Baron, 2007). The phenotype of the bacteria can be examined using
microscopy.

In addition, a sample of the bacteria can undergo Gram Staining to

determine if the bacteria is Gram-positive or Gram-negative (Gram, 1884).

This

information in conjunction with phenotypic results is used to identify organisms present
in the sample.
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Figure 1.3: Methods of bacterial and fungal diagnosis. Flowchart demonstrating numerous ways organisms can be identified.

CHROMagar, a specialized media can identify some bacteria based on the colony
color; thus, circumventing any need for microscopy (Figure 1.4). CHROMagar plates
contain a specific substrate that is hydrolyzed by a specific organism which results in the
bacterial colony being colored or surrounded by a diffusible color (Merlino et al., 1996).
There are plates can identify various species of Salmonella, Staphylococcus aureus
including methicillin resistant strains, Group B Streptococcus, Enterococcus, various
strains of Escherchia coli, Listeria monocytogenes, and various species of Vibrio (Alonso
et al., 1996; Gaillot et al., 1999; Hegde et al., 2007; Merlino et al., 1996; Pape et al.,
2006; Su et al., 2005).

Figure 1.4: CHROMagar plates. Seven bacteria were grown on a plate. The color
of the colonies indicates the organism plated (www.chromagar.com).

Besides visual phenotypes, the biochemical tests are performed.

Currently,

multiple biochemical tests can be performed at the same time. For example, the API 20
NE system (BioMérieux, Marcy l'Etoile, France) is a strip that contain up to 20
biochemical tests.

There are 16 identification products with comprised of different
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biochemical tests that should identify up to 550 different species. These products identify
bacteria in two to 24 hours. Another advanced product that identifies bacteria is the
VITEK 2 by BioMérieux. The fully automated BioMérieux system uses different cards
containing biochemical assays. Fluorescence is used to detect the outcome of the assay
and then based on the results of the assays bacteria are identified. The VITEK2 ID-GNB
card can identify bacteria based on 41 biochemical tests and 20 preformed enzymes
(O'Hara & Miller, 2003).
Fungal identification tools are similar to the methods used in bacterial detection.
Culturing, phenotypic determination using microscopy and Gram staining can all be used
in the identification process. Fungi can be cultured on blood agar, chocolate agar, eosine
methylene blue agar, Sabouraud glucose agar, and potato dextrose agar (Murray &
Baron, 2007). Often the CF sputum sample contains Pseudomonas aeruginosa which is a
bacterium that can grow on the media listed above and thus impede the growth and
identification of the fungi. Therefore, antibiotics can be added to the medium to stop
bacterial contamination (Bakare et al., 2003). Culturing fungi can take as little as three
days but many species need weeks to grow. After the organism has been isolated,
microscopy is used to examine the fungi’s hyphae. The phenotype can be used to provide
an identification (Bakare et al., 2003).
Gram staining can also be used for yeast such as Candida (Gram negative) to
make the organism more readily observed microscopically (Subhash, 2004). Aspergillus
and other molds only retain a small amount of color and thus are poorly stained. Many
other fungi can be visualized and differentiated using other stains such as FontanaMasson stain, Grocott’s modification of Gomori’s methenamine silver method, Gridley’s
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stain, hematoxylin and eosin stains (Dixon & Polak-Wyss, 1991; Huppert et al., 1978;
Saeed & Hay, 1981; Schwarz, 1982; Wood & Russel-Bell, 1983).
Biochemical assays can also aid in identification. These methods may include
CHROMagar plates which contain a substrate that is hydrolyzed by a specific fungus.
The product from the reaction stains the fungus and based on the color the Candida
species can be identified (Figure 1.5) (Odds & Bernaerts, 1994).

For example,

CHROMagar Candida plates uses a chromogenic β-glucosaminidase substrate, which
when metabolized results in green colonies of C. albicans, steel blue colonies of C.
tropicalis, and fuzzy rose-colored colonies of C. krusei (Baumgartner et al., 1996; Cooke
et al., 2002) (CHROMagar, Paris, France). Currently, no other CHROMagar plates have
been developed for other species of fungi.

Figure 1.5: CHROMagar Candida plate. Plate shows the growth of four different
Candida species on CHROMagar Candida media (www.mycology.adelaide.edu.au).
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Multiple phenotypic commercial assays exist for fungal identification.

For

example, BioMérieux (Marcy l'Etoile, France) makes strips such as the API 20C AUX
that contain 18 biochemimal tests which aid in fungal identification (Gundes et al., 2001).
In this assay, a liquid suspension is made from a fungal isolate that has been growing for
48-72 hours. The suspension is placed onto the strip and based on the results of the
individual chemical tests, an identification is made (Gundes et al., 2001). The automatic
identification system VITEK 2 (BioMérieux) also works with fungi by using the ID-YST
card which consists of 47 biochemical tests and is capable of identifying 51 taxa in 15
hours (Graf et al., 2000).

1.3.2 Accuracy of commercial identification systems. Multiple studies have
been performed to determine the accuracy and specificity of the commercially available
identification system for both bacteria and fungi (Bosshard et al., 2006; Brisse et al.,
2002; O'Hara & Miller, 2003; van Pelt et al., 1999).

1.3.2.1 Bacterial identification.

Three studies have examined the

accuracy of the VITEK2 ID-GNB card (BioMérieux, Marcy l'Etoile, France). In one
study, the commercial system accurately identified 93.0 % of 414 clinically relevant
enteric bacteria strains (O'Hara & Miller, 2003). This study also correctly identified
95.1 % of the 103 glucose-fermenting and nonfermenting nonenteric strains (O'Hara &
Miller, 2003).
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Another study compared the bacterial identification systems, API 20 NE
(BioMérieux) and the VITEK2 ID-GNB card (BioMérieux), with sequencing data from
the same 107 isolates (Bosshard et al., 2006). The API system was only able to identify
54 % of the isolates to species level and 7 % to the genus level. Thirty-nine percent or
42 isolates were not identified at all and of 26 % (11 isolates) belonged to a species that
was not in the API database (Bosshard et al., 2006). The VITEK 2 system had similar
results where as 53 % of the isolates were identified to species level, one percent to
genus level, and 46 % (49 isolates) were unidentifiable. Of the 49 isolates, 39 belonged
to a species not represented in the VITEK 2 database (Bosshard et al., 2006). A third
study compared the VITEK with the BD Phoenix (BD Diagnostic System, Sparks, MD)
to determine the accuracy in identifying isolates of the B. cenocepacia complex, a
known CF pathogen (Brisse et al., 2002). The study determines an overall correct ID
rate of 50 % for both systems. The authors conclude by strongly recommending the use
of molecular techniques to identify members of the B. cenocepacia complex (Brisse et
al., 2002).

1.3.2.2 Fungal identification. Commercial fungal identification systems
have also been evaluated.

The API 20C AUX strip (BioMérieux, Marcy l'Etoile,

France) was determined to be 87 % accurate in a study that used 116 strains representing
11 species of Candida and one species of Trichosporon (Gundes et al., 2001). This
increased by 12 % when the strains not equivocally identified were analyzed with an
additional step. Only one strain was misidentified. In a separate study, the VITEK 2
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ID-YST card (BioMérieux) was tested with 241 strains representing 21 species (Graf et
al., 2000). Of these strains, 211 were identified to the species level. Eleven other
strains were identified conclusively after an additional assay was performed. Of the
remaining 19 strains, 10 strains were not conclusively identified even with additional
tests, four fungi were misidentified, and five were unidentifiable (Graf et al., 2000).
The most common Candida species isolated in clinic laboratories were correctly
identified 93.8 % of the time. With the addition of a second assay, 97.5 % of Candida
species were identified correctly. These two studies concluded that both BioMérieux
systems can identify high percentage of clinically relevant fungi that have been isolated
from a patient sample.

1.3.3 Misidentification through culturing. Commercial phenotypic tests are
indeed a rapid cost efficient way of identifying pathogens but there are potential issues
that lead to a misdiagnosis (Bosshard et al., 2006). These systems rely on a reference
database which can be limiting because the sample may contain organisms that are not
in the database (Bosshard et al., 2006; Ramani et al., 1998). Error may also occur
because of strain variation, that is, not all strains within a species possess the same
phenotypes (Brisse et al., 2002; Wigley & Burton, 1999).

Patients have been

diagnosed with Burkholderia cenocepacia on the basis of results obtained from
culturing techniques but with more stringent molecular techniques, it was shown to be
Burkholderia gladioli or Stenotrophomonas maltophilia (McDowell et al., 2001;
McMenamin et al., 2000).

Identification of common CF pathogen, Pseudomonas
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aeruginosa, can be difficult. The CF-derived isolates of this bacterium acquire many
mutations resulting in a huge phenotypic diversity from loss of pigment production,
mucoidy, and change in lipopolysaccharide (Spilker et al., 2004). Occasionally, P.
aeruginosa is identified as another bacterium.

In one study, 770 strains of B.

cenocepacia were reanalyzed using a polyphasic approach that included selective media
and biochemical tests. Only 682 strains were confirmed to be B. cenocepacia. The
remaining 88 samples were misidentified of which 11 of them were P. aeruginosa
(Shelly et al., 2000). The misidentified strains were inaccurately identified using a
variety of commercial assays including the VITEK and API 20NE (BioMérieux, Marcy
l'Etoile, France).
Multiple studies have shown that fungal misidentification is also a problem
(Balajee et al., 2006; Rowen et al., 1999).

For example, a common CF fungus,

Aspergillus fumigatus is identified based on macroscopic and microscopic features.
Through the use of molecular techniques, A. fumigatus identified isolates were shown to
be Aspergillus lentulus and Aspergillus udagawae (Balajee et al., 2006).

These

organisms vary greatly in their resistance to certain drugs and thus misidentification
may contribute to failure in treatment certain patients (Balajee et al., 2006). Strains of
Candida are often confused with one another because of similar phenotypes (Coleman
et al., 1997). Some strains also possess similar biochemical activities which can cause
inaccurate results when using commercial systems like the API 20C thus leading to
misidentification (Elie et al., 1998; Rowen et al., 1999).
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All of the above bacterial and fungal identification systems rely on culturing
which therein is a problem. It has been estimated that less than 1 % of eubacteria in the
environment can be cultured (Roszak & Colwell, 1987; Ward et al., 1990a; Ward et al.,
1990b).

Therefore, the bacteria present in a sample may not grow in a laboratory

setting and thus can never be identified using culture based phenotypic assays. Fungal
organisms can also be difficult to grow and some species can take up to 5 weeks to
culture (Elie et al., 1998; Murray & Baron, 2007). Misidentification problems can be
reduced or completely eliminated by using non-phenotypic methods like mass
spectrometry and genotype-based molecular identification methods (Elie et al., 1998;
Spilker et al., 2004).

1.4

Identification through mass spectrometry
There are many ways to identify bacteria and fungi that do not rely on phenotypic

assays. Some of these techniques originated from the chemistry field and were later
adapted to study microorganisms. One of the most widely studied techniques relies on
mass spectrometry.

1.4.1 Mass spectrometry (MS). Since the 1970’s mass spectrometry has been
used to identify bacteria (Abel et al., 1963; Fox, 2006). Mass spectrometry determines
the elemental composition of a sample by identifying the mass to charge ratio of the
compound (Aston, 1919; Dempster, 1918; Gross, 2004). The first mass spectrometry
based bacterial identification technique used MS coupled with gas chromatography (GC)
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to study the fatty acid composition of a bacterium (Abel et al., 1963; Fox, 2006). In this
technique, the polymers such as phospholipids are first broken into monomers by
hydrolysis or saponification. The monomers are then chemically converted through
derivatization by methylation in order to inhibit ionic or hydrogen-bonding interactions
which allow the compounds to be volatile and separated through the column in the gas
chromatograph. The isolated monomer which is in the gas phase then enters the mass
spectrometer and is ionized (Gross, 2004). The mass to charge ratio for the monomer is
calculated and with the generated retention time from the gas chromatograph, a fatty acid
mixture profile is determined for the bacteria being analyzed. The profile is characteristic
to each bacterium and thus provides identification of a sample (Fox, 2006).
In the 1980s and 1990s, MS technology evolved and soft ionization MS was
developed (Fenn et al., 1989; Fox, 2006; Karas & Hillenkamp, 1988). In soft ionization
MS, compounds do not have to be separated into individual components before
undergoing MS or if separation is needed then it is done using a liquid phase (Gross,
2004). Soft ionization MS has been coupled to numerous instruments and continues to be
used in bacterial identification (Fox, 2006). The roles and limitations of matrix-assisted
laser desorption/ionization – time of flight mass spectrometry (MALDI-TOF MS) and
electrospray ioinization (ESI-MS) in bacterial identification will be discussed in more
detail.

1.4.2 MALDI-TOF MS. In this technique, the sample being analyzed is spotted,
with a matrix, on a metal plate and allowed to air dry. The matrix is typically a solution
containing

3,5-dimethoxy-4-hydroxycinnamic
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acid

(sinapinic

acid),

α-cyano-4-

hydroxycinnamic acid (alpha-cyano or alpha-matrix) or 2,5-dihydroxybenzoic acid
(DHB) and water, ethanol, or acetonitrile (Gross, 2004).

Once the solvent has

evaporated, a crystallized matrix with the sample is left on the plate. The MALDI plate is
placed in the TOF MS. The matrix spot is struck with a laser beam which absorbs the
light and transfers some of the charge to the sample of interest. The ions from the sample
drift through a tube to the MS detector. The smaller the ion, the faster it will traverse the
tube and be detected. The TOF MS spectrum produced indicates the mass to charge ratio
for the sample and the time in which the ions took to reach to the detector (Gross, 2004).
The MALDI-TOF MS spectra has been used to look at the DNA, proteins,
bacterial toxins, bacteria DNA/RNA and bacterial metabolites (Jackson, 2001). Most
notably here is the use of proteins and whole cells to differentiate between bacteria
species. Bacteria were identified first by using MALDI-TOF MS to generate a total
protein profile from a total protein fraction from lysed bacteria (Cain et al., 1994;
Jackson, 2001). Another group, Holland et al. took bacteria colonies from an agar plate
and dried them on the MALDI plate with a solvent. The protein profile did not contain
all proteins that would be seen on the whole protein fraction spectra yet enough ions were
present to still ascertain and identification (Holland et al., 1996; Jackson, 2001).
Reproducibility of these spectra from whole cells, both from colonies and from liquid
culture, plagues this analysis (Jackson, 2001). However, the technique was refined and
eventually identification of whole cell bacteria became a more reliable tool.
To make MALDI-TOF MS more applicable as a tool for clinical diagnosis, a
database of protein profiles for individual bacteria was generated (Keys et al., 2004).
Over 3500 spectra with multiple spectra for a species were produced. The ability to
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identify an unknown profile using the database ranges from 33 to 100 % (Hsieh et al.,
2008; Keys et al., 2004). As a result of the strain variation in protein profiles, some
species were not correctly identified. This error decreased as more strains were added to
the database (Keys et al., 2004).
The database software may have also caused low identification rates (Hsieh et al.,
2008). This problem was addressed using bioinformatics programs like Support Vector
Machines and other algorithms (Hsieh et al., 2008).

By using clustering methods,

identification based on the protein profile of a bacterial colony greatly increased. In
addition, the programs were able to identify components of bacteria mixtures from six
human pathogenic bacteria (Staphylococcus aureus, Streptococcus serogroup B,
Escherichia coli, Klebsiella pneumoniae, Salmonella enterica serogroup B, and
Pseudomonas aeruginosa) (Figure 1.6) (Hsieh et al., 2008). The MALDI-TOF MS
spectra has been determined for many CF pathogens including members of the B.
cenocepacia complex (Degand et al., 2008; Keys et al., 2004).
The MALDI-TOF MS technique has also been used to identify fungi. In one
study, 92.5 % of 247 clinical fungal isolates were correctly identified using this technique
(Marklein et al., 2009).

The strains in this study included Candida, Cryptococcus,

Saccharomyces, Trichosporon, Geotrichum, Pichia, and Blastoschizomyces spp. Some
fungi were not identified because of the lack of a reference strain in the current database.
Updating the database ensured that the remaining fungi were identified based on the
protein profile (Marklein et al., 2009).
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Figure 1.6:

MALDI-TOF MS spectra for six different bacterial species.

The

representative MALDI-TOF MS spectra of each of the six bacterial species (Panels A–F)
representing Escherichia coli (Panel A, blue), Klebsiella pneumoniae (Panel B, yellow),
Salmonella enterica (Panel C, purple), Staphylococcus aureus (Panel D, red),
Pseudomonas aeruginosa (Panel E, light blue), and Streptococcus serogroup B (Panel F,
green), respectively are displayed. The enlarged region with the m/z ranging from 3800
to 5600 is shown. Species-specific m/z values across spectra are indicated by different
colors as noted above in arbitrary units. Image adapted from (Hsieh et al., 2008).
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Though MALDI-TOF MS can only use cultured organisms, it has its own merit in
that it is rapid and involves minimal sample preparation (Degand et al., 2008). In
addition, the technique may have the potential to be cost efficient when used in a clinical
setting (Carbonnelle et al., 2007; Tang & Stratton, 2006). Recently, a routine clinical
laboratory identified 1600 strains using MALDI-TOF MS (Seng et al., 2009).
Identification was attained in two to two and half hours. The cost of identification was
estimated to be between 22 and 32 % of the cost of traditional phenotypic assays (Seng et
al., 2009). Once the equipment is purchased, it is only a few cents to process a sample
because of the minimal consumables that are needed and the lack of a special operator
(Carbonnelle et al., 2007). These studies highlight the role MALDI-TOF MS may play
in future diagnostic laboratories.

1.4.3 Electrospray ionization (ESI). ESI-MS is another technique that can
identify bacteria but unlike MALDI-TOF MS, the sample being analyzed can be in liquid
form (Fenn et al., 1989; Vaidyanathan et al., 2002). In ESI-MS, the analyte that is either
liquid or dissolved in a liquid solvent is dispersed by an electrospray, an instrument that
uses electricity to disperse the liquid into fine aerosol.

The aerosol enters the vacuum

stage of the MS where it is further heated evaporating any residual solvent and the
remaining ions are detected by the MS which determines the mass to charge ratio
(Griffiths et al., 2001).

The technique has been used to characterize bacteria by

analyzing specific cell fractions of the bacteria or by studying phospholipids,
lipopolysaccharides, lipooligosaccharides, muramic acids, and proteins (Vaidyanathan et
al., 2002). In 1999, Goodacrea et al. was the first to use ESI-MS to study intact whole
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bacteria. In this study, three strains of Bacillus cereus and three strains of Escherichia
coli were subjected to ESI-MS and produced mass spectra (Figure 1.7, Panel A)
(Goodacre et al., 1999). Each spectra contained fragments that correlated to fragments
produced from bacterial phospholipids. In addition, spectra were also specific for the
organism analyzed (Goodacre et al., 1999).

In a related study, E. coli, Bacillus

sphaericus, Bacillus licheniformis, and Brevibacillus laterosporus were analyzed with
flow injection ESI-MS. Again, the mass spectra were produced for each bacterium and
the results were reproducible (Vaidyanathan et al., 2001).
In recent years, ESI-MS technology has been modified so that the analyte can be
in a solid form (Dole et al., 1968; Fenn et al., 1989). This technique, desorption ESI-MS
(DESI-MS), ionizes an analyte that is placed on a solid surface using an electrospray
(Figure 1.7, Panel B). The sample flows into the MS as it is ionized. Some analyte will
stay on the surface longer and thus the ions are more separated before entering the MS.
This method can also produce bacteria mass spectra and aid in bacterial identification and
detection (Mohammed et al., 2007). Both ESI-MS and DESI-MS have been used to
analyze bioactivity of fungi but at this time it appears that specific detection of fungi
using these techniques is limited (Pankiewicz et al., 2006).
Many instruments have been coupled to MS and used to study various biomarkers
of bacteria and fungi, enzyme pathways, and overall mass spectra of organisms. Mass
spectrometry techniques can be rapid, efficient, and reproducible but they are rarely used
in a clinical setting (Fox, 2006; Seng et al., 2009). These techniques may begin to cross
over to the clinical laboratory when there are cost-efficient instrumentation and reagents,
developed reference databases, and validated standard operation protocols (Nassif, 2009).
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Figure 1.7: Electrospray ionization.

Panel A shows the ESI spectra for Bacillus

sphaericus, Bacillus licheniformis, Brevibaacillus laterosporus, and two strains of
Escherichia coli (Goodacre et al., 1999). Panel B depicts the desorption electrospray
ionization method in which bacteria in an ambient environment can be identified using
mass spectrometry. Water is sprayed into an electric field making hydronium ions which
will transfer the extra proton to the bacterial sample causing the bacteria to be ionized.
The ions are then vacuumed into the mass spectrometer where the mass to charge (m/z)
ratio is determined for the ions (Song et al., 2007).
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1.5

Detection through antibody-antigen interactions
Detection of microorganisms through antibody-antigen interaction is a main stay

in most clinical microbiology laboratories. Bacteria and fungi detection systems have
been developed based on the natural human immune response to these organisms. The
next session gives a brief introduction to antibody response followed by two techniques,
enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) that
heavily depend on the host immune response.

1.5.1 The antibody response. Antibodies are glycoproteins that are produced in
response to the presence of foreign molecules (like bacteria and fungi) in the body
(Edelman et al., 1961; Edelman & Poulik, 1961; Edelman & Benacerraf, 1962; Nisonoff
et al., 1960; Porter, 1959). In general, antibodies are in the shape of a Y (Figure 1.8) and
are composed of two identical copies of a polypeptide chain (heavy chain) and two
identical copies of another polypeptide (light chain) (Berggard & Edelman, 1963;
Nisonoff et al., 1960). Humans have five classes of antibodies, IgG, IgM, IgA, IgE, and
IgD which vary in the number of Y units and the types of heavy-chain polypeptide they
contain (Ceppellini et al., 1964).

For example, IgG antibodies have one Y unit

(monomer) which has three protein domains; the Fc domain is the stalk of the Y and the
two Fab domains are the branches of the Y (Ceppellini et al., 1964). At the top of the
branch or the Fab domain is the antigen binding site (Figure 1.8). This site is composed
of the variable regions of the heavy and the light chains and will interact with the foreign
body (Ceppellini et al., 1964). The hinge region can vary in structure giving rise to
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Figure 1.8: IgG antibody. Two identical L chains are joined with two identical H
chains. Each light (L) chain is held to a heavy (H) chain via an interchain disulfide
bond. The variable regions of the four polypeptides lie at the ends of the arms of the Yshaped molecule. These regions are responsible for the antigen recognition function of
the antibody molecules. The hinge region varies based on the isotype of IgG present
(Garrett & Grisham, 2010).

subtypes or isotypes within IgG molecules (Figure 1.8). IgG has four isotypes and they
provide the majority of the antibody-based immunity against pathogens in the human
(Jefferis et al., 1985; Klein et al., 1977). Like IgG, IgD, and IgE exist as monomers. IgD
has one isotype and it functions as an antigen receptor on B cells (Pernis et al., 1966;

26

Takahashi et al., 1982). The only isotype of IgE is involved in the immune response to
allergies (Stanworth, 1969). The two isotypes of IgA exists as dimers and are found in
mucosal areas such as the respiratory tract to help prevent colonization by pathogens
(Heremans et al., 1959). The last antibody, IgM, is a pentamer (Tomasi, 1973). The only
isotype of IgM is expressed on the surface of B cells and is the primary antibody
produced at the first encounter to an antigen (Sanders et al., 1987).
All immunoglobulins have a site that interacts with antigens. Interactions can
only occur if the antigen is close enough to the antibody Fab domain. This domain of
110-130 amino acids gives specificity to antibody binding (Novotný et al., 1983). If the
proper antigen is present it will form an antibody-antigen complex held together by many
weak interactions including hydrogen bonds and van der Waals forces.

Once the

antibody has bound the antigen, other immune cells will help remove the antigen from
the human (Gowans, 1971; Nossal & Ada, 1971).

1.5.2 Enzyme-linked immunosorbant assay (ELISA). The presence of an
antigen such bacteria or fungi or an antibody in a human sample can be detected using the
same theory as the immune response mechanism described above. Antibody-antigen
interactions can be specific. By detecting this interaction, the causative agent of an
infection can be determined.

To detect an antigen using ELISA, the sample being

analyzed will first be fixed to a polystyrene microtiter plate. The antibody, for the
organism that is being detected, is linked to an enzyme and then added to the plate. If the
proper antigen is present, the enzyme-linked antibody will bind. Unbound antibodies are
washed away with a mild detergent. Then, an enzymatic substrate is added to the plate.
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Any enzyme present will react with the substrate producing a visible signal; thus
indicating the presence of a certain bacteria or fungi in the sample. This reaction can be
chromogenic or fluorogenic (Engvall & Perlmann, 1971; van Weemen & Schuurs, 1971;
Voller et al., 1978).
The ELISA technique can also be performed by immobilizing antibodies to the
plate.

A variation of this method is the sandwich ELISA (Figure 1.9) (Engvall &

Perlmann, 1972; Miles & Hales, 1968; Voller et al., 1978). In this assay, two antibodies

Figure 1.9:

Sandwich ELISA.

An antigen is detected using an assay in which

horseradish peroxidase (HRP) (linked to the antibody that binds the antigen) oxidizes
tetramethylbenzidine (TMB) to produce a blue color (www.newenglandbiolabs.de).
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are used. The first antibody called capture antibodies are attached to a plate. The sample
is added and if the specific antigen is present it will bind. After the remaining sample is
washed away, a primary antibody is added which will also bind to the antigen present.
Next, an enzyme-linked antibody is added which will bind to the primary antibody.
During the last step, an enzyme is added which is converted to a detectable form (color or
fluorescence). This signal tells the user if a bacteria or fungi are present in the sample
and the intensity of the signal can indicate the quantity (Voller et al., 1978).
Indirect ELISA is similar to the sandwich method except that first capture
antibody is serum that contains an unknown concentration of the antibody (Engvall &
Perlmann, 1972).

The secondary antibody affixed to an enzyme is added and the

sandwich ELISA method is followed (Engvall & Perlmann, 1972). A major disadvantage
of the indirect ELISA is that the method of antigen immobilization is non-specific. Any
amount of analyte present in the serum can stick to the plate. Thus indirect ELISA can
only give determine if an antigen is present but not the abundance (Engvall & Perlmann,
1972).
Competitive ELISA uses the theory of competitive binding. In this method,
unlabeled antibody is incubated with the antigen (Engvall & Perlmann, 1971). The
complexes that form are added to an antigen coated well. The plate is washed and
unbound antibody is removed. The antibody competes with the free antigen to bind to
the plate fixed antigen. Then, the secondary antibody with the attached fluorophore is
added and the signal is measured (Engvall & Perlmann, 1971). For competitive ELISA,
the higher the original antigen concentration, the weaker the eventual signal. This type of
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ELISA is well suited in situations in which the antigen is a low concentration or when
using crude or impure samples (Jordan, 2005).
Reverse ELISA uses a solid phase made up of an immunosorbent polystyrene rod
with 4-12 protruding fingerlike objects (ogives). The entire device is immersed in a test
tube containing the collected sample.

Then, the ogives are dipped into wells of a

standard microplate. These wells have been pre-filled with ELISA reagents. The ogives
are washed by a buffer in one well. The rods are then moved and the ogives are
immersed in the next well which contains enzyme labeled antibodies. After conjugation,
the ogives are incubated in a chromogenous sample. The develop color is read by
spectrophotometer (Sakaguchi et al., 1989). The ogives can be sensitized to the reagents
and thus be able to detect more than one antigen at a time (Emmerich et al., 2006). In
addition, sample sizes can be optimized to achieve high levels of antigen detection
(Emmerich et al., 2006)
The ELISA technique has been performed on numerous types of samples for
numerous organisms including P. aeruginosa and A. fumigates in CF sera (Brett et al.,
1988; Knutsen et al., 1994). An ELISA test has been developed to diagnose chronic P.
aeruginosa infections by fixing antigens from 17 serotypes of the bacteria to a plate
(Pedersen et al., 1987). The presence of serum IgG to the bacteria was then detected
indicating the patient had P. aeruginosa infection (Pedersen et al., 1987). Serum IgG
antibodies to Candida albicans and Aspergillus fumigatus have also been detected using
indirect ELISA (Przyklenk et al., 1987). The ELISA method is not used to detect
organisms directly from CF sputum but bacterial isolates and CF sera can be used with
ELISA detection systems.
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1.5.3 Surface plasmon resonance (SPR). Interactions between two surfaces,
such as antibodies and antigens, can also be identified using SPR. This technique relies
on the phenomenon of surface plasmons which are electron oscillations that exist at the
interface between any two materials (Figure 1.10) (Otto, 1968; Wood, 1902, 1912). The
interaction between two molecules can be measured by exciting the surface plasmons
with light and then measuring the degree of light refraction (Kretschmann & Raether,
1968; Otto, 1968). SPR was originally developed for chemical sensing. In 1983, SPR
began to be utilized for biosensing (Kretschmann & Raether, 1968).
One specific type of SPR biosensors is an immunosensor which detects
interactions between antibodies fixed on a gold sensor and antigens (Geddes et al., 1994;
Mayo & Hallock, 1989). The interactions cause charge-density oscillations that occur at
the interface of the two media; a SPR sensor measures the angle, wavelength, and the
intensity of each oscillation. These factors vary when the oscillations at the interface
between the two media change. For example, an antibody attached to the gold surface
will affect the oscillations (Dudak & Boyaci, 2009; Geddes et al., 1994). Most often the
angular modulation (the change in degree of light refraction from the gold sensor) is
measured. This measurement change when antigens bind to the antibody that is fixed to
the gold (Dudak & Boyaci, 2009).
Immunosensors have been used to identify E. coli O157:H7 (Fratamico et al., 1998;
Meeusen et al., 2005; Oh et al., 2003; Su & Li, 2005; Subramanian et al., 2006a; Taylor
et al., 2005), Vibrio cholera (Jyoung et al., 2006), Salmonella enteritis (Bokken et al.,
2003), Salmonella typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al.,
2004b), Listeria monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et
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al., 2005), Yersinia enterocolitica (Oh et al., 2005), Campylobacter jejuni (Taylor et al.,
2006), and Staphylococcus aureus (Subramanian et al., 2006b).
The sensitivity is not as good as many other detection systems that are marketed;
depending on the specific design of the SPR sensor, the detecting limits were between
102 to 107 cfu/ml (Dudak & Boyaci, 2009). The sensitivity of the assay can be changed
by modifying the mechanism in which the antibodies bind to the gold and the antigens
bind to the gold as well as specific instrument parameters (Dudak & Boyaci, 2009).
Surface plasmon resonance has been used to detect some isolated CF pathogens such as
S. aureus but has not been used to detect bacteria directly from sputum or bronchiolavage
fluid (Subramanian et al., 2006b).

1.6

Molecular analysis of isolates
Technologies based on DNA are increasingly used as diagnostic tools. Most

often bacteria and fungi are identified using ribosomal RNA. Specifically, molecular
markers such as 16S ribosomal RNA (16S rRNA) and fungal internal transcribed spacer
regions (ITS) contain information that can lead to the identification of pure isolates of
many types of bacteria and fungi, respectively.

1.6.1 Molecular markers. Not all regions of DNA can be used to identify an
organism. The regions that are used for speciation can be referred to as molecular
markers and these regions share a few characteristics. First, markers are molecular
chronometers meaning the region contains a DNA sequences that changes randomly in
time but overall have a constant rate of evolution. This clocklike behavior can be seen in
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genes that have a high degree of functionally constancy (Woese, 1987). Molecular
chronometers should also have a large phylogenetic range and therefore be present in
most to all organisms (Olsen & Woese, 1993). Lastly, the molecular marker needs to
have a large size with regions that are evolutionarily independent (Woese, 1987). One
family of genes fills all of these requirements to become the “ultimate molecular
chronometers”, the rRNA genes (Olsen & Woese, 1993).

The rRNAs have a constant

function, are found in all organisms, and the sequences change at different positions and
at different rates (Olsen & Woese, 1993).

1.6.2 Ribosomal RNA (rRNA). Ribosomal RNA is directly associated with
ribosomes (ribonucleoproteins) that play a role in protein synthesis (Lewin, 2002;
Nomura & Erdmann, 1970; Nomura et al., 1977). The basic form of the ribosome is
conserved throughout organisms although changes in overall proportions and size of
RNA and protein can be seen (Nomura & Erdmann, 1970; Nomura et al., 1977). All
ribosomes in a cell are identical and in prokaryotes they consist of a small (30S) subunit
that is composed of 16S rRNA and 21 proteins and the large (50S) subunit (Figure 1.11).
The larger unit contains 23S rRNA, 5S rRNA, and 31 proteins (Lewin, 2002; Nomura &
Erdmann, 1970; Nomura et al., 1977). In eukaryotes, ribosomes consist of a small (40S)
subunit that is composed of 18S rRNA. The large subunit (60S) consists of the 5S, 5.8S,
and the 28S subunits (Hillis & Dixon, 1991).
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Figure 1.11: Ribosome subunits. The purple 30S subunit joins the gray 50S subunit to
form the 70S ribosome (Yarris, 2003).
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1.6.3

16S ribosomal RNA (rRNA).

The 16S ribosomal subunit is most

commonly used in studies of prokaryotic phylogeny (Klappenbach et al., 2001). This
gene is composed of alternating evolutionary conserved and variable regions (Figure 1.12
and 1.13) (van de Peer et al., 1996). The conserved regions are involved in functions that
are shared across the species, as such any mutation in this region would affect its ability
to translate (Klappenbach et al., 2001).

Figure 1.12: 16S rRNA secondary structure map. Purple indicates absolutely conserved
regions, blue represents regions with a high amount of conservation. Red areas are the
most variable (van de Peer et al., 1996).
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Figure 1.13: Schematic representation of the variable and conserved regions of the 16S
rRNA genes, using Escherichia coli genome as a reference. The diagram illustrates the
approximate positions of some of the variable regions of the gene via base number. The
variable regions are interspersed with conserved regions. LH-PCR primer sequences are
included (Doud et al., 2009).
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1.6.4 Fungal internal transcribed spacer (ITS) regions. Similarly, molecular
diagnosis of the 18S rRNA (the fungal equivalent of 16S rRNA) can be used to identify
fungi (Atkins & Clark, 2004; Melchers et al., 1994). However, very often closely
related species in a genus are not easily differentiated. To resolve closely related
species, the ITS regions between the 18S and the 5.8S rRNA genes and between the
5.8S and 28S rRNA genes, referred to as ITS1 and ITS2, respectively, can be used
(Figure 1.14) (Leaw et al., 2006). The contiguous ITS regions have also been
successfully used to differentiate between the Aspergillus species, such as Aspergillus
flavus, Aspergillus fumigatus, and Aspergillus terreus, (Henry et al., 2000) and other
medically important yeasts (Chen et al., 2000; Chen et al., 2001).

Figure 1.14: Fungal rRNA genes. ITS1 region is located between the 18S and 5.8S
rRNA genes and can be amplified using the ITSF1 and the ITS2R primers. The ITS2
region is between the 5.8S and the 28S rRNA genes and can be amplified using the
ITSF3 and ITSR4 primers. All primers bind to conserved regions within the rRNA
genes and the reverse primers can be labeled with fluorophores for downstream
applications.
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1.6.5 Polymerase chain reaction (PCR). The PCR technique is often used to
isolate and amplify the bacterial and fungal molecular markers for use in downstream
applications (Erlich, 1991; Mullis et al., 1986). This method heralded a new era for the
detection and identification of various microorganisms in any sample. Thus, many
techniques that study microorganisms are molecular-based using both universal and
species-specific primers to select molecular markers (Liesack & Stackebrandt, 1992).
Polymerase chain reaction can be used to identify the presence of one specific organism
using one pair of specific primers. There have been numerous PCR assays developed to
identify the common CF pathogens P. aeruginosa (da Silva Filho et al., 1999), H.
influenzae (Falla et al., 1994), Staphylococcus aureus (Stepán et al., 2001), and
Aspergillus fumigatus (Reddy et al., 1993).

1.6.6 Multiplex PCR. By combining pairs of primers and optimizing the PCR
reaction, multiple organisms can be detected in the same reaction. Multiple PCR assays
have been developed for many different combinations of CF pathogen including but not
limited to: P. aeruginosa, Burkholderia cenocepacia, and Stenotrophomonas maltophilia
(da Silva Filho et al., 2004); Streptococcus pneumoniae, H. influenzae, Mycoplasma
pneumonia, and Chlamydophila pneumonia (Stralin et al., 2005); and Aspergillus
fumigatus, Aspergillus flavus, Aspergillus niger, and Aspergillus terreus (Logotheti et al.,
2009). By using multiplex PCR, multiple organisms can be identified in a small time
frame (Henegariu et al., 1997). Establishing a multiplex PCR assay can be difficult due
to uneven or lack of amplification for certain targets and difficulties reproducing the
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results. Thus, optimization of PCR protocols and carefully planned PCR primers are
crucial in the successfulness of a multiplex reaction (Henegariu et al., 1997).

1.7

Molecular tools for community studies
The aforementioned techniques more readily identify an organism if it is has been

isolated from a sample through culturing. Though some techniques such as multiplex
PCR can identify multiple organisms in a sample, the entire diversity of microbial
communities in complex samples such as water, soil, and CF sputa cannot be determined.
Community profiling techniques such as terminal restriction fragment length
polymorphism – polymerase chain reaction (T-RFLP) and amplicon length heterogeneity
– PCR (LH-PCR) are molecular tools that identify organisms in mixed samples without
the need to culture or isolate from the sample.
Community profiling techniques use variation within the molecular marker as
described earlier to determine the composition of the community within a sample. For
bacteria, the lengths and sequences of one or more of the nine variable regions of 16S
rRNA can lead to the identification of bacteria present in a complex community.
Similarly, the 18S or the ITS regions can be used to identify members in a fungal
community.

The two techniques, T-RFLP and LH-PCR generate PCR products of

different lengths which can provide a community profile and can putatively identify
individual organisms at the strain, species or genus level (Klappenbach et al., 2001).
(Klappenbach et al., 2001; Suzuki et al., 1998).

In addition, the sequence of the

fragments can be determined using high throughput sequencing which enables rapid
sequencing of the amplicons (bacterial and fungal, with the use of appropriate primers)
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which would lead to the rapid understanding of the community structure of any complex
niche.

1.7.1 Terminal restriction fragment analysis (T-RFLP) analysis. This PCR
based technique relies on the inherent variation of the sequence of a molecular marker
(Dunbar et al., 2001) and is the most widely used method in identifying phylogenetic
specificity in bacterial communities (Hiraishi et al., 2000). The amplicons are generated
using one primer that is fluorescently end-labeled, followed by

restriction enzyme

digestion, and detection of the terminal restriction fragment by an automated DNA
sequencer or capillary electrophoresis (Figure 1.15, Panel A) (Hiraishi et al., 2000). The
resulting output consists of a microbial profile where each detected length is that of
specific fragments from the digested PCR product. Each length represents one or more
bacteria that have the same terminal restriction fragment length (Figure 1.15, Panel B).
The profiles can be used for community differentiation, identification of specific
organisms in populations, and comparison of the relative phylotype richness and
community structure (Dunbar et al., 2001).
This method has been successful in differentiation of bacterial and fungal
communities present in many environments including marine samples, soil samples, and
sputum samples from CF patients (Dickie & FitzJohn, 2007; Hiraishi et al., 2000; Mills
et al., 2003; Rogers et al., 2003). Rogers et al. analyzed T-RFLP amplicons of CF
patient sputa and bronchoscopy samples using a computer program called MapSort
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A

B

Figure 1.15: Terminal restriction fragment length polymorphism (T-RFLP). Panel A
illustrates the T-RFLP process starting with PCR, followed by restriction digest and
ending with product separation (http://nodens.ceab.csic.es/t-rfpred/). Panel B is a TRFLP of a mixed DNA sample. Each peak represents at least one bacteria (Gonzalez et
al., 2000).
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(Wisconsin Package version 10.3; Accelrys) that has a database which contains restriction
patterns and lengths of fragments generated for known 16S rRNA bacterial sequences
(Rogers et al., 2003). The analysis inferred the presence of P. aeruginosa, Burkholderia
cenocepacia, Staphylococcus aureus, and H. influenzae in the CF samples (Rogers et al.,
2003). T-RFLP analysis of the fungal community in the CF lung does not appear to have
been performed yet.
The T-RFLP method is fast and data can be easily replicated for statistical
analysis. The major disadvantage of T-RFLP is that many bacteria produce similar
fragment sizes and thus not all peaks in the profiles are species-specific. Some peaks
may even represent more than one genus (Dunbar et al., 2001; Rogers et al., 2003).
There are also inherent problems using restriction enzymes, such as incomplete digestion,
which can produce DNA fragments that do not correlate to the correct bacterium (Mills et
al., 2003). Therefore to achieve better identification of the organism, further analysis like
sequencing of the 16S rRNA gene must be performed.

1.7.2

Amplicon length heterogeneity (LH).

The LH technique analyzes

microbial populations based on the lengths of generated PCR products produced from the
hypervariable regions of the 16S rRNA or the fungal ITS regions (Bernhard et al., 2005;
Martin & Rygiewicz, 2005; Moreno et al., 2006; Ritchie et al., 2000; Suzuki et al., 1997;
Yang et al., 2006). Profiles from each region can be produced and used to understand the
community. These profiles represent the minimum diversity of bacteria present within the
eubacterial or fungal community.

The profiles contain peaks at specific amplicon

lengths, which is representative of the number of nucleotides in the hypervariable region
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between the conserved regions. The peak heights are representative of the relative
abundance of amplicons for that particular length present in the community.
The organisms present in a community are determined by using a database which
contains the expected amplicon sizes for bacteria and fungi for given a certain set of
primers (Doud et al., 2009). The fragment lengths in the sample profile are compared
against the database to identity the putative organisms. A profile resulting from this
analysis infers the presence of certain organisms and the definitive absence of others. In
cases where the amplicon length is not species-specific, it is often genus-specific (Doud
et al., 2009).
The LH profiles can also be used to compare community profiles from multiple
samples.

Previous research using LH profiles has shown that the compositions of

bacterial communities are highly specific to the environment in which they are found
(Mills et al., 2003; Moreno et al., 2006).

Changes in the community’s niche can

drastically influence bacteria and thus add specificity to the profile of a bacterial
community showing that the overall bacterial community has many unique features from
sample to sample (Mills et al., 2003; Moreno et al., 2006).
The main advantages of LH-PCR are that it rapidly surveys relative gene
frequencies within complex mixtures of DNA, is reproducible, requires small sample
sizes, and can be performed simultaneously with many samples (Suzuki et al., 1998).
The LH profiles provide information about the members of the entire bacterial/fungal
community (not just specific isolates) and their relative abundance. This data allows one
to make taxonomic inferences and sample comparisons (Suzuki et al., 1998). A major
disadvantage of this technique is that one amplicon in the profile can represent more than
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one bacterium or fungus (Manter & Vivanco, 2007). Therefore, identification at the
species level cannot be guaranteed. This is also true with many length-based molecular
techniques such as T-RFLP. However, the fragments are discrete ‘units’ of information
that can be used for comparative analyses (Dunbar et al., 2001). Analysis of different
combinations of the 16S rRNA variable regions and ITS regions can increase the power
of microbial detection and sample discrimination and lead to more definitive
identification (Yang et al., 2006).
The LH-PCR method was first used in several ecological research projects to
compare microbial communities between samples and identify members within one
community (Mills et al., 2003; Mills et al., 2006; Moreno et al., 2006; Yang et al., 2006).
Multiples types of soil and water samples have been profiled using LH and various
regions of the 16S rRNA gene (Mills et al., 2003; Moreno et al., 2006; Ritchie et al.,
2000; Suzuki et al., 1998). LH has also been used to study bacterial communities present
in the CF lung. Fourteen CF sputum samples were analyzed using LH-PCR for the
presence of eubacteria (Rogers et al., 2003). The raw data generated from the Genetic
Analyzer was first processed with corresponding software such as GeneimageIR v.3.56
(Scanalytics, Fairfax, Va.) (Rogers et al., 2003). To presumptively identify the bacteria
present in the CF samples, the fragment lengths were compared with a database of
theoretical fragment lengths constructed using GAP (Wisconsin Package version 10.3;
Accelrys, Inc., San Diego, CA) (Rogers et al., 2003). For example, P. aeruginosa was
presumptively identified in all 14 CF samples, five of which were confirmed by cloning
and sequencing (Rogers et al., 2003).
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To expand the use of LH-PCR in clinical settings, Bjerketorp et al. combined it
with a lab-on-chip (LOC) system, which is used for sizing and quantifying DNA, to
analyze samples containing mixtures of known human gut microbes (Bjerketorp et al.,
2008). An Agilent 2100 Bioanalyzer, a bench-top instrument that uses microfluidicsbased separation, was used to detect the LH fragments. This modified method allows
LH-PCR to be more affordable and faster and thus more convenient and suitable for
clinical and diagnostic situations (Bjerketorp et al., 2008). To test this system, samples
containing mixtures of human gut microbes and known human gut bacteria isolates were
analyzed using both LOC and a capillary electrophoresis based genetic analyzer. The
latter method had a higher resolution and was thus able to resolve more peaks or
fragments from one another. It is important to clearly separate PCR fragments as that LH
identification is based on the lengths of PCR products.

Single base pair length

differences are known to occur between species and even at the genus level. Though the
level of resolution for the LOC LH-PCR technique is limiting, the technique is rapid,
economical and easier to analyze than the traditional system. Future modifications may
improve the resolution making it more useful for clinical diagnosis (Bjerketorp et al.,
2008).
Amplicon length heterogeneity studies of fungal communities from CF lungs have
not been performed but the lengths of ITS 1, ITS 2 and ITS 1-4 have been determined via
sequencing for many fungi that are known to colonize the CF lung such as various
species of Candida and Aspergillus (Henry et al., 2000; Leaw et al., 2006).
Community profiling techniques such as T-RFLP and LH-PCR can be used to
study both bacterial and fungal communities. The profiles generated provide a snapshot
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of the microorganism community as a whole. The identity of community members may
be determined with the aid of reference database; but, due to shared amplicon lengths for
certain organisms, some community members will not be identified. Through the use of
sequencing, these organisms can be identified.

1.8

Sequencing
Many organisms may share the amplicon length for a certain molecular marker

but they rarely share the same sequence for the same given marker. Sequencing of the
entire or partial 16S rRNA gene or 18S gene and the associated ITS regions is imperative
in identifying a bacterium or fungus with near certainty.

1.8.1 Sanger sequencing. The most common method of sequencing is the Sanger
Method developed in 1977 (Sanger et al., 1977). This method uses a single strand of
DNA. The DNA is divided into four reactions, each reaction containing four standard
deoxynucleotides (dNTPs), one dideoxynucleotide (ddNTP), and a polymerase (Figure
1.16). The complementary strand of DNA is made with the dNTPs and when a ddNTP is
incorporated into the growing strand, the chain extension will terminate. These different
sized newly synthesized fragments are then separated by size and visualized (using
radioactivity) to determine the sequence of the DNA (Sanger et al., 1977).

This

technique can be modified so that all sequencing reactions occur in one tube through the
use of fluorescently labeled dideoxynucleotides. The fragments are separated by size and
sequence is determined by the fluorescence. Once the sequences are generated they are
compared to known 16S rRNA, 18S, or ITS sequences stored in the Ribosomal Database
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Project II (Maidak et al., 1999), Greengenes (DeSantis et al., 2006), and GenBank
(Benson et al., 2008) to identify organisms in any sample including the CF lung
(Bosshard et al., 2006; Harris et al., 2007).

Figure 1.16: Sanger sequencing. Single stranded DNA is amplified using fluorescently
labeled ddNTPs and unlabelled dNTPs. Incorporation of a ddNTP causes the chain
lengthening to stop, leaving the fragment fluorescently labeled, which are separated by
polyacrylamide gel electrophoresis (Kae, 2009).

47

Sanger sequencing is able to identify organisms if the correct marker is being
sequenced. For some bacteria, partial sequencing of the 16S rRNA gene would lead to
identification, for others the entire gene would need to be analyzed. The same could be
said for fungi; that is, only the entire 18S rRNA gene sequence can be used to distinguish
between some fungi. Some bacteria or fungi can only be identified using the more
Sequencing isolates can be performed in a timely manner and the data produced is quite
easy to analyze especially with the use of commercial sequencing kits (Vliegen et al.,
2006).
Sanger sequencing has been used to identify the organisms present in CF children
bronciolavage (BAL) samples (Harris et al., 2007). As that the total DNA extracted is a
mixture of DNA (fungal, bacterial, and human), the bacterial DNA was isolated using
RFLP-PCR and the resulting PCR products were separated using bacterial cloning
methods. The individual RFLP fragments were then sequenced and bacteria such as P.
aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia, and H. influenzae
were found to be present in the BAL sample (Harris et al., 2007). Novel pathogens from
the genus Lysobacter, Coxiellaceae, and Rickettsiales were also sequenced (Harris et al.,
2007).
Fungi have also been identified in CF samples through PCR and Sanger
sequencing (Bouchara et al., 2009). By sequencing the entire PCR product from the ITS
region, A. fumigatus and C. albicans were identified in CF samples (Bouchara et al.,
2009). It is more common to use specie specific PCR to detect fungi in CF samples
because few fungal isolates have been sequenced (Williamson et al., 2001).
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Sanger sequencing is capable of providing the identification of isolates, but the
high cost of reagents and labor may be too expensive for wide-spread clinical use (Patel,
2001). This method can also been used to identify members of a complex community,
but it requires additional protocols, reagents, and time. With traditional sequencing
methods, cloning must be performed to isolate individual 16S rRNA genes or fungal ITS
regions which were amplified by PCR. The PCR product from a complex community
will contain multiple copies of the same gene and further screening such as restriction
digest must be performed to ensure that the same PCR product is not repetitively
sequenced thereby wasting time, reagents, and money.

The cloning and screening

process also increases the likelihood that certain members of the community are never
sequenced and the community composition is not entirely determined. Though possible,
traditional sequencing is a time consuming, arduous method when addressing
microorganism community based questions.

1.8.2

Pyrosequencing.

New developments in sequencing technologies are

revolutionizing the way microbial communities are being studied (Mardis, 2008;
Schuster, 2008).

Pyrosequencing relies on a process referred to as sequencing-by-

synthesis, a technique that allows for real-time monitoring of DNA synthesis (Ahmadian
et al., 2006; Ronaghi et al., 1998). Pyrosequencing is based upon the principle that
pyrophosphate (PPi) is released when the DNA polymerase adds a nucleotide to the
growing complementary strand (Figure 1.17).

The PPi is converted to adenosine

triphosphate (ATP) that is used as a substrate in a chemical reaction that results in visible
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Figure 1.17: Pyrosequencing reaction.

Schematic representation of the automated

pyrosequencing (sequence-by-synthesis) method. The addition of a nucleotide to the
growing strand releases pyrophosphate (PPi) which is converted to ATP by ATP
sulfurylase. The ATP then catalyzes a luciferase mediated conversion of luciferin to
oxyluciferin that produces light and is measured by a camera (Gharizadeh et al., 2001).
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light emission. The detectable amount of light produced is relative to the amount of
synthesis (Ronaghi et al., 1998). The dNTPs are added sequentially and light is only
emitted if the dNTP added to the reaction is the next one to be incorporated to the
growing strand. Like the Sanger method, pyrosequencing can only sequence individual
PCR products and thus must be used in conjunction with cloning to study microbial
communities (Ronaghi et al., 1998).

The method can produce a large amount of

sequencing reads in a small amount of time. Thus, it is more efficient to sequence a large
clone library using pyrosequencing rather than the Sanger method.
Pyrosequencing techniques that allow faster sequencing at a lower cost, are
opening doors for many laboratories to use sequence data for microbial identification.
Pyrosequencing of the first and third variable region of the 16S rRNA gene has been used
to identify bacterial isolates of Helicobacter pylori from secretions, indwelling catheters
and prosthetic devices, urine, blood and faecal specimens (Jonasson et al., 2002). In
addition, Acinetobacter and Haemophilus isolates from gastric biopsies were sequenced
for the same regions (Monstein et al., 2001).

Most recently, clinical isolates of

mycobacteria was identified using the V1 region (Heller et al., 2008). A year later,
antibiotic resistance of mycobacteria could be determined by pyrosequencing the
resistance-determining regions of three genes and looking for specific mutations (Bravo
et al., 2009).
Importantly, pyrosequencing surpassed traditional methods of detection in a
clinical setting by identifying 90 % of the isolates at least at the genus level (Luna et al.,
2007). The remaining 10 % could not be identified due to the short sequencing reads, a
clear drawback of pyrosequencing (Luna et al., 2007).
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Pyrosequencing may help

bacterial identification in samples that do not lend themselves to polyphasic approaches,
such as phenotypic assays (Heller et al., 2008; Tuohy et al., 2005). This technique has
also been shown to clearly distinguish between multiple species of Mycobacterium.
Pyrosequencing can also identify fungi including different species and strains of
Candida, a known CF pathogen (Boyanton et al., 2008).
With the additional step of cloning, pyrosequencing can be used to identify
organisms in a complex sample. One study used cloning followed by pyrosequencing to
identify bacteria present in 13 adult CF sputa samples (Kolak et al., 2003). Sequences
were determined by the amplification of the V3 and V6 region of the 16S rRNA gene.
Known CF pathogens were sequenced and the results concurred with the culture
identifications (Kolak et al., 2003). Sanger sequencing and pyrosequencing were also
compared in a later study. Both techniques were used to analyze the same sputum sample
from a 13 month old CF girl (Armougom et al., 2009). Both techniques identified many
of the same bacteria but pyrosequencing showed greater species richness and a more
reliable estimate on bacteria abundance. The authors concluded that pyrosequencing is
reliable and with newer technologies, the short reads will no longer be an issue
(Armougom et al., 2009). The fungal community in CF samples has yet to be analyzed
with pyrosequencing.

1.8.3 454 sequencing. Deep sequencing technologies are capable of sequencing
a whole genome in a matter of days. There are multiple platforms that are capable of
performing high throughput, parallel sequencing of a single isolate or mixed samples.
Previously cloning was necessary to provide clean sequence reads from mixed DNA
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samples. To circumvent the need for cloning, Roche’s 454 sequencing, which performs
many pyrophosphate-sequencing reactions in parallel, was developed (Figure 1.18)
(Margulies et al., 2005). The 454 sequencing combines an emulsion-based method that
isolates and amplifies DNA fragments in vitro with an instrument that performs
pyrosequencing in picoliter-sized wells (Margulies et al., 2005). The reactions are
resolved on a Genome Sequencer FLX which reads 200-300 bases and in one run can
read up to 400,000 bases (Patrick, 2007). This method has been used to study the
microbial diversity of the deep sea (Sogin et al., 2006) and the metagenome found in
honey bees, which led to the discovery of a possible causative agent of colony collapse
disorder (Cox-Foster et al., 2007). Members of the human oral bacterial community have
been identified using 454 sequencing (Zaura et al., 2009). Fungal communities have also
been sequenced in soil and the human mouth (Ghannoum et al., 2010; Lauber et al.,
2009).

1.8.4 Illumina. Another platform that is capable of high throughput, parallel
sequencing is the Illumina Genome Analyzer (previously called Solexa).

Illumina

sequencing technology amplifies randomly fragmented genomic DNA that are attached to
a planar, optically transparent surface which creates an ultra-high density sequencing
flow cell with hundreds of millions of clusters, each containing ~1,000 copies of the same
template (Adam, 2001; Balasubramanian et al., 2002; Mardis, 2008). These templates are
sequenced using a robust four-color DNA sequencing by synthesis technology that
employs reversible terminators with removable fluorescent dyes (Figure 1.19) (Adam,
2001; Balasubramanian et al., 2002; Mardis, 2008).
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Figure 1.18:

Overview of 454 sequencing.

(a) Genomic DNA is isolated,

fragmented, ligated to adapters and separated into single strands (ss). (b) One
fragment per bead is placed in a PCR-reaction-mixture-in-oil emulsion and amplified.
c) Beads carrying ssDNA templates are deposited into wells. (d) Smaller beads
carrying immobilized enzymes required for pyrophosphate sequencing reaction are
deposited. (e) Scanning electron micrograph of a portion of a fiber-optic slide. (f) The
454 sequencing instrument consists of: a fluidic assembly (i), a flow cell (ii), a CCD
camera-based imaging assembly (iii), and a computer (iii) (Rothberg & Leamon,
2008).
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Figure 1.19. Illumina sequencing technology. Schematic diagram of technique
with a brief explanation (Hodges et al., 2007).
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Illumina sequencing has a high degree of accuracy due to the base-by-base
sequencing which enables sequencing through homopolymers and repetitive sequences
and eliminates sequence-context specific errors (Balasubramanian et al., 2002; Mardis,
2008). This platform has been used to sequence the human oral bacterial community,
where hundreds of millions of 50 to 100 bp reads were obtained revealing the abundance
of bacterial species present in the mouth (Lazarevic et al., 2009; Mardis, 2008). No
fungal communities have been sequence using this technology.

1.8.5

SOLiD. Another next generation sequencing platform is the Applied

Biosystem SOLiDTM (sequencing by oligonucleotide ligation and detection) system
(McKernan et al., 2009; Valouev et al., 2008). As with 454 sequencing, a DNA library is
made which then undergoes emulsion PCR. The products are render single stranded and
fixed on a bead and deposited into a well. A set of four fluorescently labeled di-base
probes are added to each well where they compete for ligation to the DNA being
sequenced (sequencing by oligonucleotide ligation). A DNA polymerase is not used for
sequencing but rather a DNA ligase that attaches the labeled di-base probe to the growing
strand (Figure 1.20). On the basis of the fluorescence produced by the molecule, the
identity of the nucleotide at each position can be determined (McKernan et al., 2009;
Valouev et al., 2008).

At this time SOLiDTM cannot be used for metagenomic

sequencing but technological advances may change this in the future.
Illumina and 454 sequencing are both capable of sequencing mixed DNA samples
and within days the microorganisms present in a sample can be determined. At this time
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the bacterial and fungal community found in the CF sputum has not been analyzed with
either methods.

Figure 1.20. SOLiDTM sequencing technology. Schematic diagram of sequencing by
ligation.

The single stranded template DNA is ligated to a bead via an adapter

sequence. The primer for sequencing hybridizes to the adapter on the templated beads.
A set of four fluorescently labeled di-base probes compete for ligation to the
sequencing primer. The probe with the complementary base will attach to the primer
using a DNA ligase. The fluorescent molecule will produce a detectable signal. The
fluor will be cleaved from the probe leaving a phosphate at the end of the growing
strand that will be used in the next cycle of ligation. Multiple cycles of ligation,
detection and cleavage are performed (Hodges et al., 2007). SOLiDTM sequencing
technology description and figure was obtained from the manufacturer (Applied
Biosystems, Foster City, CA).
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1.9

Metagenomic statistics and bioinformatics
Identifying members of a community through LH-PCR or 454 sequencing only

addresses one question, “Who belongs to the community?” The significance of these
identities is determined using multiple statistical tests and bioinformatic programs.
Statistical analysis using 454 data is a field that is just beginning to be developed.
Analyzing the large amount of sequencing data obtained from 454 uses some
mathematical analyses and bioinformatic programs which are based on previous methods
that are used in LH, TRFLP, and other community profiling techniques, while other
analysis methods are created anew.

1.9.1 Statistical analysis based on ecological indices. The earlier approaches
used to study microbial diversity and community dynamics include computing measures
derived from ecological indices such as species richness and dominance or evenness
indices (Hill et al., 2003). Traditional indices include the richness (S), the Shannon
information index (H), and the evenness (E) derived from it, and are defined as follows in
Equations (1), (2) and (3), respectively:

S =# of peaks of in each sample,

(1)

,

(2)

where pi is the ratio of individual peak height to the sum total of the heights of all the
peaks in the LH profile, and
,

(3)
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where Hmax = ln(S).

Note the traditional diversity indices are based on the clear

definition of an ecological description of an individual species but these definitions have
been modified for presumptive identification of LH/T-RFLP profiles by replacing the
definition of an individual species with that of individual peaks in LH/T-RFLP profiles.
These calculations identify the richness (how many different types of organisms
are present in a community), the evenness (how these organisms are distributed
throughout the community), and the Shannon index (the diversity of the community
based on number of species and their abundance in the community). These indices
provide the basic framework to understanding a particular niche.

1.9.2

Statistical analysis based on abundance models.

Even with the

availability of the numerous diversity indices, analyzing microbial diversity and
communities merely using ecological indices has its shortcomings (Mills et al., 2006).
Although each index represents an attempt to distill diversity information into a single
quantity, each one ends up measuring specific aspects of diversity. Diversity indices vary
in their sensitivity to different abundance classes. Species abundance models are
considered to be more sophisticated tools to investigate diversity because they examine
the distribution of abundances in a population.
Statistical models used for species abundance of microbial communities include
log series distribution, log-normal distribution, broken stick model, and overlapping
niche model (Curtis et al., 2002; Hill et al., 2003). The most frequently used statistical
model for species abundance distributions is the log-normal distribution. In log-normal
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communities, the null model for the bacterial species abundance is a lognormal
distribution as follows:

where S(R) is the number of species that contain R individuals, ST is the total number of
species in the community, and σ2 is the variance of the distribution. The parameters ST
and σ2 can be estimated from a sample of measured species abundance data by using
statistical techniques such as the method of moments or least squares analysis (Curtis et
al., 2002). This distribution is seen when a species is persistent within a community
(Magurran & Henderson, 2003). The log series distribution comes into effect when a
species is not persistent in a community but only occasionally distributed (Magurran &
Henderson, 2003). Occasionally, a species can transition between the two types of
distribution (Magurran & Henderson, 2003).

The broken stick model describes the

relative abundance of species by random breaking of a theoretical line which represents
the resources of the environment. The length of each broken line or stick represents the
abundance for a particular species (McArthur, 1957). This definition can be rephrased to
mean that “a group of n species of equal competitive ability simultaneously occupying
the total niche and jostling each other to determine niche boundaries” (Tokeshi, 1993).
McArthur also proposed the overlapping niche which refers to species that share a part of
the same niche as another species (McArthur, 1957). Each of these statistical models can
be used to describe bacterial or fungal communities when species abundance is of
interest.
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1.9.3 Comparative metagenomics. Ecological indices and abundance models
can be informative when studying one population at a time or comparing between two
species.

Comparing communities as a whole can also provide clues as to how

communities change over time or how a community is affected by its environment or
outside factors.

For instance, by comparing all sequencing or LH data, it can be

determined if there are statistically differences between the bacterial or fungal
community from a healthy sputum sample versus a CF sample. In addition, the factors
that cause these distinctions can be identified.
Comparative metagenomics can be studied using statistics or bioinformatics.
Most statistical comparisons start with a distance matrix which determines the similarity
of one community to another community.

Jaccard’s coefficient, Hellinger distance,

Pearson chi-square test, Euclidean distance matrices, and Bray-Curtis/Sorenson
coefficient are often used to determine the relationship between two samples or two
populations (Beran, 1977; Bray & Curtis, 1957; De Leuuw & Heiser, 1982; Jaccard,
1901; Pearson, 1900). These equations use the presence/absence and/or abundance of all
the organisms in a sample to determine the relatedness between two samples (Beran,
1977; Bray & Curtis, 1957; De Leuuw & Heiser, 1982; Jaccard, 1901; Pearson, 1900).
The resulting distance/similarity matrices can then be further analyzed using multivariate
statistics.
Multivariate statistics can be used to identify what data links two samples (either
members in a sample or external environmental factors). These analyses can also be used
to determine if samples within a population are similar to one another (Rudi et al., 2007).
An example of multivariate statistical analysis is the clustering of microbial communities
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in soil using the unweighted pair-group method which uses the arithmetic averages
(UPGMA) algorithm on the data derived from the distance metric data (such as the
Jaccards or Hellinger or Pearson distances) (Blackwood et al., 2003; Dunbar et al., 2000;
Griffiths et al., 2000). Such methods have been used to support claims that certain
relationships between communities can be discerned, that the groupings are natural, and
that outliers can be identified (Clarke et al., 2006). Other statisitcs such as principle
component analysis, and multi-dimensional scaling will be discussed in detail in Chapters
2 and 3.
Phylogenetics can also be used to compare among samples and populations. The
evolution and/or relatedness of a community can be determined using the phylogenetic
tree that is present in the sample.

The bioinformatic program, UniFrac can use

phylogenetic trees to determine if the microbial community in a sample is similiar to
another sample factors (Lozupone & Knight, 2005; Lozupone et al., 2006; Lozupone et
al., 2007). If there are differences between the communities, then the program will
determine if a particular lineage of the tree is responsible for the difference. The UniFrac
program can also cluster communities based on environmental factors (Lozupone &
Knight, 2005; Lozupone et al., 2006; Lozupone et al., 2007). Megan 3 (metagenome
analysis software) is another bioinformatic program that can compare communities by
using the orginal sequencing data and identifying taxa (Huson et al., 2007). Both of these
programs can handle large amount of data which is key when analysis 454 sequencing
reads. The output for both programs can be used in colloboration with statitics to identify
correlations between communities.
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With rigorous statistical analysis and bioinformatics, it is possible to differentiate
between significant differences and random events. Thus, leading one to understand how
a microbial community is affected by its members and environment.

1.10

Hypothesis and aims
The CF lower respiratory tract contains a complex community of fungi and

bacteria which cause chronic lung infections. Because of the long term effects on the
lungs by microbial infection, a better understanding of the microbes present and the
factors that drive evolution of the microbial community will enable the development of
improved therapies.
This project proposes to characterize the bacterial and fungal communities found
in the CF lungs using the molecular techniques, amplicon length heterogeneity–
polymerase chain reaction (LH-PCR) and 454 sequencing. In addition, this study
proposes to develop a novel detection assay for CF pathogens. The hypothesis of this
project is that there is both bacteria and fungi present in the CF lung and the dynamics of
the community is dependent on the host and antimicrobial treatment. The hypothesis will
be tested by accomplishing the following three aims:

Aim I: Analyze the metagenomic DNA from the CF sputa samples using the V1 and
V1_V2 regions of the bacterial 16S rRNA gene using LH-PCR community profiling.
Community dynamics will be studied using these profiles. The working hypothesis is the
CF lung contains numerous bacteria and selective pressures from the host and antibiotic
therapy cause the community to change over time.
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Aim II: Analyze the metagenomic DNA from the CF sputa samples using the V1_V2
region of the bacteria 16S rRNA gene and the fungal ITS1 region using 454 sequencing.
The CF microbiomes will be compared with healthy oral rinse microbiomes. The
working hypothesis is the CF microbiome will contain organisms that are associated
with healthy individuals as well as pathogens unique to the CF lung infection.
Aim III: Detect bacteria from CF sputa samples using SPR technology. The working
hypothesis is CF pathogens can be detected based on antibody-antigen reactions
measured by SPR.
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Chapter 2

“Combination of 16S rRNA Variable Regions Provide a Detailed Analysis of
Bacterial Community Dynamics in the Lungs of Cystic Fibrosis Patients”

As published in Human Genomics
Volume 4, Issue 3 pgs 147-169, 2009
Copyright © Henry Stewart Publications

Melissa S. Doud, Michael Light, Gisela Gonzalez, Giri Narasimhan, and Kalai Mathee
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2.1 Abstract
Chronic bronchopulmonary bacterial infections remain the most common cause of
morbidity and mortality among patients with cystic fibrosis (CF). Recent community
sequencing work has now shown that the bacterial community in the CF lung is
polymicrobial. Identifying bacteria in the CF lung through sequencing can be costly and
is not practical for many laboratories. Molecular techniques such as terminal restriction
fragment length polymorphism or amplicon length heterogeneity - polymerase chain
reaction (LH-PCR) can provide many laboratories the ability to study CF bacterial
communities without costly sequencing. The aim of this study was to determine if the
use of LH-PCR with multiple hypervariable regions of 16S rRNA gene could be used to
identify organisms found in sputum DNA. This work also determined if LH-PCR could
be used to observe the dynamics of the lung infection over a period of time. Nineteen
samples were analyzed with the V1 and the V1_V2 region of the 16S rRNA gene. Based
on the amplicon size present in the V1_V2 region, P. aeruginosa was confirmed to be in
all 19 samples obtained from the patients. The V1 region provided a higher power of
discrimination between bacterial profiles of patients. Both regions were able to identify
trends in bacterial population over a period of time. LH profiles showed that the CF lung
community is dynamic and changes in the community may in part be driven by the
patient’s antibiotic treatment. LH-PCR is a tool that is well suited for studing bacterial
communities and their dynamics.
Key Words: LH-PCR, 16S rRNA, V1, V1_V2, cystic fibrosis, AmpliQué, Cystic fibrosis
microbiome, metagenome
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2.2 Introduction
Cystic fibrosis (CF) is an autorecessive disease affecting one in 3500 Caucasian
live births in the U.S (Patient-registry, 2008). CF results from a mutation in the gene that
encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein
(Riordan et al., 1989; Wainwright et al., 1985). A defect in the CFTR protein leads to a
malfunctioning

cyclic-AMP-activated

chloride

channel

in

secretory

epithelia

(Kunzelmann, 1999). This defect in the lung leads to the inability to secrete chloride and
to the excess re-absorption of sodium (Kunzelmann, 1999). Thus, there is decreased fluid
secretion and the mucus becomes immobilized and adheres to the epithelial cells.
Overproduction of mucus in the airway results in congestion of the respiratory tract and
increases susceptibility to bronchopulmonary infection. CF patients often suffer from
infections with Staphylococcus aureus, Haemophilus influenzae, Pseudomonas
aeruginosa, and Burkholderia cenocepacia (Lyczak et al., 2002).

These chronic

infections by highly adapted lung microbes cause inflammation and eventually lung
damage; therefore, lung disease is the major cause of morbidity and mortality among
these patients (Hull, 2003; Mathee et al., 1999).
It has also been estimated that less than 1% of eubacteria in the environment can
be cultured (Ward et al., 1990a; Ward et al., 1990b). Thus, these identification methods
will fail to detect all pathogens that might be causing the lung infection. Fortunately, with
the advent of molecular techniques, culturing for identification purposes can be
circumvented (van Belkum et al., 2000).

Recent molecular studies using terminal

restriction fragment length analysis and sequencing have shown that the lung community
is quite complex. Achromobacter (Alcaligenes) xylosoxidans, Rhodotorula mucilaginosa,
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Abiotrophia

spp.,

Bacteroides

gracilis,

Eubacterium

brachy,

Mycobacterium

mucilaginosus, Mycoplasma salivarium, Porphyromonas salivae, Ralstonia spp.,
Staphylococcus hominis, Streptococcus anginosus, Treponema vincentii, Veillonella spp.,
Burkholderia gladioli, Stenotrophomonas maltophilia and Pandoraea atypical have all
been demonstrated to be members of this polymicrobial infection(Bittar et al., 2008;
Burns et al., 1998; Coenye et al., 2001; Coenye et al., 2002; Coenye et al., 2003; Coenye
et al., 2005; Harris et al., 2007; Rogers et al., 2003).
Amplicon length heterogeneity – polymerase chain reaction (LH-PCR) is another
molecular method that has been used to study various diverse microbial communities
(Bernhard et al., 2005; Suzuki et al., 1998) including those of CF sputum (Rogers et al.,
2003).

LH-PCR utilizes the 16S rRNA molecular marker to analyze microbial

populations (Ritchie et al., 2000; Suzuki et al., 1998). The sequence and length of the
variable regions within the 16S rRNA gene are often used to determine phylogeny
(Coenye & Vandamme, 2003). It should be noted that some bacteria have multiple
copies of the 16S rRNA gene which can show intragenomic heterogeneity in sequence
and gene length (Coenye & Vandamme, 2003). This variation is unlikely to have an
effect on classification at the genus and species level and the marker is routinely used for
identification (Case et al., 2007).

Identification based on length variation in the

hypervariable regions of the gene is exploited by LH-PCR. In this technique, forward
and reverse primers bind to the conserved regions of the 16S rRNA gene and then
amplify the varying lengths seen in the hypervariable regions. LH-PCR has proven to be
a robust, time efficient and reproducible method (Mills et al., 2003; Moreno et al., 2006;
Suzuki et al., 1998). The main advantages of LH-PCR are that it surveys relative gene
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frequencies within complex mixtures of DNA, is reproducible, requires small sample
sizes, and can be performed with many samples simultaneously (Moreno et al., 2006;
Suzuki et al., 1998). Furthermore, some of the size classes emerging from LH-PCR
analyses can be related at the genus level to archived database sequences (Suzuki et al.,
1998). Overall, the attributes of LH-PCR make it useful for quick assessment of the
diversity of microbial communities for comparative purposes (Suzuki et al., 1998).
Prior studies have shown that LH-PCR and the hypervariable regions one and two
(V1_V2) of the 16S rRNA gene can be used to detect eubacteria in sputum from CF
patients (Miller, 2003; Rogers et al., 2003). The technique had limited efficacy when
determining overall diversity and attaining organism identification and it was concluded
that the small differences in amplicon lengths generated from the organisms was at fault
(Rogers et al., 2003). In this study, community profiles of CF sputa were obtained using
two regions of the 16S rRNA gene (hypervariable region 1 [V1] and [V1_V2]). Bacterial
identification based on amplicon length was attempted using a computer program,
AmpliQué, which determined the theoretical V1 and V1_V2 fragment lengths for known
organisms.

Community profiles and identification were analyzed using each region

separately and combined to determine if a combinatorial approach to LH-PCR (i) could
provide a more detailed analysis of the bacterial community in the CF lung and (ii) could
be used to observe the dynamics of this community over a period of time. This work has
shown that the V1 region provides a more detailed community profile which leads to a
higher power of discrimination between profiles than the V1_V2 region.

The LH

analyses provided snapshots of the CF bacterial communities. However, the analyses are
limited by their ability to identify community members with the V1 or V1_V2 regions
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separately or combined. In addition, through the comparisons of V1_V2 or V1 LH
profiles over time, it was established that the CF lung community is not only diverse but
also dynamic.

2.3 Material and methods
2.3.1 Sample collection. Nineteen sputum samples were obtained from CF
patients attending the University of Miami adult CF clinic (Miami, FL). Samples are
referred to by UM followed by a letter. The study was carried out in accordance with the
Declaration of Helsinki (2000) of the World Medical Association and was approved by
the appropriate institutional review board (FIU IRB approval # 033004-02). Appropriate
consent was obtained from human subjects. All 19 expectorated sputum samples were
frozen at -20 °C prior to DNA extraction. Sputum was liquefied using the method of
Reischl et al and the metagenomic DNA was extracted and cleaned using the GeneClean
Spin Kit (Qbiogene, Irvine, CA) as per manufacturer’s protocol (Reischl et al., 1994).
The eluted DNA was quantified and diluted to 10 ng/µL and refrigerated at 4°C until
further use.

2.3.2 Control bacteria isolates. Standard DNA manipulations were used to
extract chromosomal DNA from CF-related pathogens; P. aeruginosa strains PAO1 and
PA14 (burn wound isolates) and four additional P. aeruginosa strains isolated from CF
patients (Klockgether et al., 2007), B. cenocepacia (ATCC BAA-246; CF isolate),
Staphylococcus aureus (ATCC 12600; pleural fluid isolate), and Stenotrophomonas
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maltophilia (ATCC 17672; sputum isolate) were used as controls in the LH-PCR
experiments.

2.3.3 LH-PCR. The metagenomic DNA derived from the extracted sputum
samples were amplified in triplicate using eubacterial primers for the 16S rRNA gene.
The V1_V2 region of the 16S rRNA gene were amplified using 27F-6FAM forward
primer (5’– 6FAM – AGA GTT TGA TCM TGG – 3’) and the 355R reverse primer (5’ –
GCT GCC TCC CGT AGG AGT -3’) (Doud et al., 2009). The V1 region was amplified
using fluorescent primer P1F-6FAM (5’ – 6FAM – GCG GCG TGC CTA ATA CAT GC
– 3’) and reverse primer P2R (5’ - TTC CCC ACG CGT TAC TCA CC -3’) (Cocolin et
al., 2001; Doud et al., 2009) All forward primers are fluorescently labeled with 6FAMTM (Integrated DNA Technologies, Shokie, IL). The final V1_V2 PCR reaction
mixture was composed of: 1X PCR buffer (supplied with the enzyme by Applied
Biosystems, Foster City, CA), 2.5 mM MgCl2, 0.25 mM dNTPs, 0.5 µM forward and
reverse primers, 0.1% bovine serum albumin, 0.025 U of AmpliTaq Gold LD DNA
polymeraseTM (Applied Biosystems, Foster City, CA), and diethylpyrocarbonate (DEPC)
water to make up the final volume of 20 μL. A half a nanogram per microliter of DNA
template was added per reaction. The following parameters were used to amplify the
selected fragments on a MJ Research Peltier Thermal Cycler 200 (Waltham, MA): initial
denaturation at 95°C for 11 minutes, 25 cycles of denaturation at 95°C, annealing at 55°C
and extension at 72°C, each for 1 minute and a final elongation at 72°C for 10 minutes.
A negative control containing water was amplified for every PCR master mix to check
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for contamination.

Agarose gel electrophoresis was run to confirm the success of

amplification.

2.3.4 LH-PCR analysis. LH-PCR analysis was performed by the Forensic DNA
Profiling Facility (Florida International University, Miami, FL). The PCR products for
the three replicate reactions were detected using the ABI Prism 310 Genetic Analyzer
(Applied Biosystems, Foster City, CA). A formamide-size standard mix was prepared
using a 96:1 ratio of Hi-DiTM (highly deionized) formamide and GeneScanTM 500 ROXTM
internal standard (Applied Biosystems). Each PCR product was denatured by adding
0.50 µl to 9.5 µl of the formamide-size standard mix for 2 minutes at 95°C and snap
cooling for 5 minutes on ice. Each sample was run for 28 minutes on the ABI Prism 310.
Fragments were separated by capillary electrophoresis using polymer POP-4, matrix DS3O_6FAM_HEX_NED_ROX and filter D (Applied Biosystems).

2.3.5 Electropherogram analysis. The output was collected and analyzed using
GeneMapper® Software Version 3.7 (Applied Biosystems) and Microsoft Excel
(Microsoft, Redmond, WA). The ABI PrismTM Genotyper software analysis parameters
were set to the local Southern Size calling, no correction, and the minimum noise
threshold was set at 70 fluorescent units (Mills et al., 2003). For V1_V2, amplicons were
called if between 300 and 400 base pairs (bp). Amplicons for V1 region were between
60 and 120 bp.
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2.3.6

Statistical analysis.

Data were imported into MS Excel (Microsoft,

Redmond, WA), to determine mean relative ratios for each triplicate PCR reaction. The
normalized data for each sample were exported into PRIMER 5 statistical software for
further analyses (PRIMER E Ltd., Plymouth Marine Laboratory, United Kingdom). Bray
– Curtis similarity index and non metric multi-dimensional scaling (MDS) was used to
compare sample data between patients and patient profiles over time (Hartmann et al.,
2005; Rees et al., 2004).

2.3.7 Presumptive identity analysis. The GeneScanTM 500 ROXTM internal
standard was used to determine amplicon sizes in base pairs. Several approaches were
used to presumptively identify an organism in the CF community based upon the length
of the amplicon generated.

Chromosomal DNA from isolates of Burkholderia

cenocepacia, Staphlyococcus aureus, Stenotrophomonas maltophilia, and Pseudomonas
aeruginosa were used to determine the experimental amplicon length for the V1_V2 and
V1 regions. Next, in silico analysis was performed in which the expected amplicon length
was determined based on where the primers of interest would theoretically bind to the
published sequence. Lastly, the lengths of the expected amplicons for all bacteria were
determined using AmpliQué, a newly designed bioinformatics program (Gonzalez et al.,
2009). The Perl scripts are available at http://biorg.cs.fiu.edu/AmpliQue/. AmpliQué
uses the 16S rRNA sequences downloaded from the Ribosomal Database Project II
(Release 9.60). It takes a forward and a reverse primer (both of which may be potentially
degenerate) as input. The stringency of the primer binding can be set in the program to
control the exactness of the primer binding site within the 16S rRNA sequences. The
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stringency was first set to 100 % (E = 10) to identify the organisms that have exactly the
same conserved sequences as the primer and subsequently lowered to E = 5,000 which
allowed a larger database to be created as the conserved regions of the 16S rRNA gene
are not 100 % identical in sequence. The resulting output shows the identity of all the
16S rRNA sequences that will produce an amplicon with a particular pair of primers,
along with the length(s) of the amplicons. Thus, one can query the database using any
primer to determine the theoretical fragment lengths that would be generated from an
organism when analyzed.

In addition, a list of all bacteria that produce a specific

fragment length can be generated. One amplicon length may represent more than one
bacterium and thus only a presumptive identity of that amplicon can be achieved.

2.4 Results
2.4.1 PCR amplification of 16S rRNA genes for metagenome profiling.
Variable regions V1 and V1_V2 were successfully amplified using universal eubacterial
primers from the metagenomic DNA samples (See Methods). As expected, the amplicon
sizes from the 19 samples ranged from 335 to 365 bp for the V1_V2 region (Table 2.1
and Supplemental Figure 2.6). Sample UMC had the most complex V1_V2 profile with
eight amplicons (Figure 2.1A and Table 2.1). Samples UMF, UMG, UMH, UMJ, UMK,
UMP, and UMT had the least complex LH profiles with only one amplicon present at 342
bp (Figure 2.1B and Table 2.1).

The remaining 11 samples produced LH profiles

containing multiple amplicons (Table 2.1, Supplemental Figure 2.6). Amplicon 342 was
observed in all 19 samples (Table 2.1). Out of these 19 samples, 16 samples (84.2 %)
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Table 2.1: Amplicons seen in the V1 and V1_V2 regions for samples
Sample

V1_V2 (%)*

Total #
V1_V2

V1

Total #
V1

UMA

342, 349 (39.0), 350

3

60, 62, 63, 65, 68, 69, 70, 72, 73, 75, 76, 77, 78, 81, 82, 83, 86
(17.3), 90, 91, 92, 93, 94, 96, 98, 100, 101, 108

27

UMB

342 (61.7), 347, 365

3

62, 63, 72, 73, 75, 76, 77, 78, 81, 82, 88 (15.7), 91, 93, 94, 98, 100,
102, 103, 112

19

UMC

335, 342 (79.0), 347, 349, 350, 351, 352, 365

8

61, 62, 68, 69, 70, 72, 73, 75, 76, 77, 78, 81, 82, 84, 86, 88 (12.0),
90, 91, 92, 93, 94, 96, 98, 100, 102, 104

26

UMD

342 (93.7), 351, 352, 365

4

64 (14.4), 70, 73, 77, 82, 86, 88, 98, 103, 112

10

UME

342 (99.0), 348

2

60, 62, 64, 66, 67, 68, 69, 71, 72 (12.3), 73, 74, 75, 76, 77, 78, 80,
81, 86, 88, 91, 93, 94, 98, 100, 102, 103, 112, 113, 115, 120

30

UMF

342 (100)

1

60, 61, 62, 65, 68, 70, 72 (12.6%), 73, 75, 77, 78, 85, 91, 93, 94, 98,
103, 112, 113, 115

20

UMG

342 (100)

1

60, 61, 62, 68, 72 (3.6), 73, 75, 77, 78, 86, 91, 93, 98, 103, 112, 113,
115, 119, 120

19

UMH

342 (100)

1

60, 61, 62, 65, 68, 70, 73, 75, 76, 77 (3.9), 78, 80, 81, 84, 85, 86, 88,
90, 91, 93, 94, 96, 98, 101, 103, 111, 112, 113, 115

29

UMJ

342 (100)

1

60, 61, 62, 63, 65, 68, 70, 72, 73, 75, 77, 78, 80, 81, 84, 86, 88, 91,
92, 93, 94, 98, 102 (6.6), 112, 113, 115, 120

27

UMK

342 (100)

1

60, 61, 62, 65, 67, 68, 70, 72, 73, 75, 77, 78, 81, 85, 86, 90, 91, 93,
94, 98, 100, 101 (7.3), 103, 111, 112, 113, 120

27

UML

342, 350, 360 (55.7), 365

4

60, 61, 62, 63, 64, 65, 67, 68, 70, 71, 72, 73, 76, 78, 81, 85, 88, 91,
94 (31.3), 98, 100, 102, 103, 112, 113, 115, 119, 120

28

UMM

342 (98.7), 351, 365

3

61, 62, 65, 68, 70, 73, 75, 76, 77, 78, 81, 82, 84, 86, 88, 91, 94, 98,
101 (4.8), 103, 111, 113, 115, 119, 120

25

UMN

339, 342 (92.7), 347, 352

4

60, 61, 62, 65, 68, 70 (10.2), 73, 77, 78, 81, 85, 86, 88, 90, 91, 92,
94, 98, 100, 103, 108, 112, 113, 115

24

UMO

342 (74.0), 350, 352

3

60, 62, 65, 73, 77, 78, 80, 81, 85, 91, 98, 102 (3.1), 103, 108, 111,
112, 113, 115, 119, 120

20

UMP

342 (100)

1

60, 61, 62, 65, 77, 78, 81, 98, 102 (5.7), 112, 115, 120

12

UMQ

342 (41.3), 348, 350, 365

4

60, 61, 62, 63, 64, 65, 71, 72, 76, 78, 81, 84, 85, 87, 91, 94, 98, 102
(5.3), 103, 112, 115

21

UMR

342, 360 (63.7)

2

60, 62, 63, 65, 73, 77, 78, 80, 81, 82, 85, 94 (13.9), 98, 102, 108,
112, 115, 120

18

UMS

339, 342 (87.7), 347

3

60, 62, 63, 66, 72, 73, 74, 77, 78, 80, 81, 85, 88, 91, 94, 98, 102
(9.9), 103, 111, 112, 113, 115, 119, 120

24

UMT

342 (100)

1

60, 62, 63, 65, 71, 72, 73, 76, 78, 81, 85, 92, 94, 98, 102 (13.2), 111,
112, 115, 120

19

*Amplicons in bold are the most abundant amplicon in the profile for that particular
sample.

The number in parenthesis indicates the percentage abundance of the

dominant amplicon for that region.
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Figure 2.1: Hypervariable V1_V2 amplicon data graphs.

Panel A represents the

V1_V2 profile from patient UMC. Panel B depicts the profile obtained from patients
UMF, UMG, UMH, UMJ, UMK, UMP, and UMT using the V1_V2 region.
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had amplicon 342 as the dominant member of the profile. The most abundant amplicons
in UMA, UML, and UMR were 349, 360, and 360, respectively (Table 2.1).
As predicted, V1 profiles ranged from 60 to 120 bp in length (Table 2.1 and
Supplemental Figure 2.7). Unlike V1_V2 profiles, all 19 samples produced more diverse
profiles containing multiple amplicons in each profile (Table 2.1, Supplemental Figure
2.7). The most complex profile contained 30 amplicons for UME (Figure 2.2, Table 2.1).
The least diverse profile with 10 amplicons belonged to UMD (Table 2.1, Supplemental
Figure 2.7). All the samples contained a 98 bp amplicon, though it was not the most
abundant amplicon (Table 2.1). The 86 bp amplicon was present in 10 out of the 19
profiles and was the most dominant peak in UMA (17%) (Table 2.1).

The 84 bp

amplicon was found in five profiles. Seventeen out of 19 samples contained a 73 bp
amplicon.

2.4.2 Comparison of LH eubacterial profiles within CF center. The profiles
for each sample were compared to each other to determine if the bacterial communities
were similar between patients that were treated at the same CF center. The normalized
abundance data from the V1_V2 region was analyzed using the Bray-Curtis similarity
index. The similarity between samples was shown in a dendograph using group linkage
clustering. The UMF profile has 100 % similarity to UMG, UMH, UMJ, UMK, UMP,
and UMT as they all produced 100 % abundance for amplicon 342 (Table 2.1 and Figure
2.3A). The UMR profile had 36.0 % or less similarity with 13 of the samples, but had a
91.0 % similarity with UML (Figure 2.3A). The UMR and UML profiles had two
amplicons in common. The V1 region was able to discriminate between all samples; no
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two profiles were exactly the same (Table 2.1 and Figure 2.3B). The highest similarity
between two profiles was 79.2 % between UMF and UMG due to the presence of many
shared amplicons (Figure 2.3B). The most dissimilar profile was between UMD and
UMQ with 6.2 % similarity. Four out of the 10 amplicons were common between UMD
and UMQ (Table 2.1).

Figure 2.2: Hypervariable V1 amplicon data. Graph depicts the V1 profile from patient
UME, which was the most diverse profile found in this study.
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Figure 2.3: Similarity based clustering between LH profiles of patients. Panels A and B
are dendographs indicating the relatedness of LH profiles of patients generated from the
V1_V2 and V1 regions, respectively. Bray – Curtis similarity index and group linked
clustering were used to determine similarity of bacterial communities.
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The similarity of the patients’ bacterial population with both the V1_V2 and the
V1 data were also compared. The combination of regions decreased the degree of
similarity between V1_V2 profiles yet the LH profiles were most dissimilar with the V1
region analysis (data not shown).

2.4.3 Patient CF flora changes over time. The lung flora changes over time in
the CF lung. It is also known that the bacterial community composition in the lung at any
one given time is varied due to the compartmentalized structure of the organ (Harrison,
2007). When working with expectorated sputum, it was assumed that the bacterial
community within a given patient may vary from sample to sample. In order to study the
dynamics of lung flora over a period of time, sampling bias was addressed. That is, any
changes seen in community profiles over time may potentially be an artifact from the
sampling method. A control experiment was performed to understand the effect of
sampling.
Sputa samples from patient UML were analyzed over the course of two years
(Month 1 to Month 22). The samples were referred to as M0, M3, M16, M17, M22.1,
M22.2, M22.3, M22.4, and M22.5. Five samples were taken on the same day every three
hours for twelve hours (M22.1 - M22.5). The sampling scheme was designed to account
for the potential variability contributed by the lung structure. All samples were analyzed
using the V1 and V1_V2 regions. Bray-Curtis similarity index was used to determine the
variation between the community profiles of the patient samples. The relatedness of
bacterial communities was shown with dendographs created from the calculated
similarity (Figure 2.4). In addition, the relationship between profiles was graphically
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depicted using non-metric MDS which represents the samples as points in a lowdimensional space so that the relative distances of the symbols is correlated with the same
rank order determined by the Bray-Curtis similarity index (Figure 2.5). These analyses
visually showed that samples taken on the same day were more similar than LH profiles
from earlier time points (Figure 2.4 and 2.5). For the V1_V2 region, the samples in M22
ranged from 70.6 % to 93.4 % in similarity. The first three samples M1, M3, and M16
had less than 42.9 % similarity to any profile produced from the hourly samples. The LH
profile M17 and the five profiles in M22 are related with a range of 52.8 % to 78.3 %
similarity. M22.4 was more similar to M17 than the other same-day samples (Figure
2.4A).
The V1 profiles for these samples were also analyzed and compared. Overall, the
similarities between samplings were much lower when using the V1 versus the V1_V2
region (Figure 2.4B and 2.5B). The highest profile similarities were seen within M22
samples; as high as 96.0 % were seen between M22.3 and M22.5. M1 and M3 had a
similarity of 48.1 %; M16 and M17 were 47.1 % similar. Some of the samplings taken
months prior to the daily sampling in M22 were completely different (Figure 2.4B). The
MDS analysis clearly showed samples taken on the same day (M22) clustered (Figure
2.5B).
Combining LH data from both the V1 and the V1_V2 regions further indicated
the overall similarity of bacterial community within one day versus over a period of time
(Figure 2.4C and 2.5C). The additive effect of the regions created a tighter clustering of
the same-day samples and increased distances between samples taken in different months
(Figure 2.4C).
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Figure 2.4: Similarity based clustering between LH profiles over time in one patient.
Panels A and B are dendographs indicating the relatedness of LH profiles of patients
generated from the V1_V2 and V1 regions, respectively.

Panel C describes the

community similarity when both V1_V2 and V1 data are combined. Bray – Curtis
similarity index and group linked clustering was used to determine similarity of
bacterial communities.
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Figure 2.5: Similarity between LH profiles over time in one patient. Panels A and B
are MDS figures which represent the profiles generated from one patient over a period
of time using the V1_V2 and V1 regions, respectively. Panel C is the MDS figure
representing the combined V1_V2 and V1 data. Blue diamond, blue pentagon, red
heart, red diamond, orange cross, green triangle, black hexagon, aqua square, and
purple circle represent samples from Month 1, Month 3, Month 16, Month 17, Month
22.1- 22.5, respectively.
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2.4.4 Antibiotics drive CF community. After the initial time study with Patient
UML, two more patients were followed for a period of time to determine the effect of
antibiotics on the lung microbial flora. Azithromycin, bactrim, tobramycin and colistin
were administered at different time points for each patient. Azithromycin, which is most
often used to treat Gram-negative bacteria, is a macrolide antibiotic which interferes with
protein synthesis preventing growth of bacteria (Retsema et al., 1987). Bactrim is a
combination of sulfamethoxazole and trimethoprim and it interferes with DNA synthesis
in bacteria that cause respiratory infections, especially in Stenotrophomonas maltophilia
(Hughes & Russell, 1982; Muder et al., 1996). Tobraymcin, an aminoglycoside, prevents
translation in bacteria. The inhaled form of the drug targets P. aeruginosa in the lungs
(Ramsey et al., 1999). Colistin or polymyxin E is effective against most Gram negative
bacilli and is often used against multidrug resistant strains of P. aeruginosa (Beringer,
2001). The drug regime and sputa samples from two patients referred to as patient UMX
and patient UMY were analyzed every other month for five months. The three time
points are referred to as MO, M3, and M5. The amplicons of size 60 - 120 bp and 300 –
400 bp were obtained from the V1 and the V1_V2 region, respectively (Table 2.2).
Patient UMX was under triple combination therapy with azithromycin, bactrim,
and tobramycin at least two weeks prior and up to the sampling at month 0 (M0) and
month 3 (M3). Two weeks prior to month 5 (M5), the patient stopped taking tobramycin
but continued the treatment with azyithromycin and bactrim. The number of amplicons
for the V1_V2 and V1 LH profiles varied for the three time points (Table 2.2). The
dominant 342 bp amplicon was present in each time point (93.7 %, 100 % and 74 % at
M0, M3, and M5, respectively) for the V1_V2 region (Table 2.2).
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Table 2.2: Amplicon contributions for Patients UMX and UMY over a five-month time
period
Patient UMX
Amplicon
a
M0 (%)
(bp)*
Unique Amplicons
352

P (2.34)

351

P (1.67)

a

M3 (%)

Patient UMY
b

M5 (%)

Amplicon
(bp)

c

M0 (%)

M3 (%)

d

M5 (%)

P (1.00)

P (33.88)

P (0.81)

P (1.85)

d

P (13.00)

348

348

347

347

120

P (1.88)

P (5.88)

120

119

P (1.88)

P (3.53)

119

113

P (3.77)

P (2.35)

113

111

P (3.53)

111

108

P (18.82)

108

P (35.33)

100

100

P (4.66)

94

94

P (0.99)

87

87

P (2.47)

84

84

P (1.23)

76

76

74

74

P (0.81)

71

71

P (4.07)

70

P (4.36)

P (1.84)

P (1.63)

69

P (0.81)

67

67

P (0.81)

66

66

P (0.81)

65

65

63
Shared Amplicons
P (93.67)

365

P (2.00)

P (100)

112

P (16.50)

P (74.00)

P (3.25)

342

P (61.67)

365

P (3.00)

350

P (3.77)

P (2.35)

115

P (3.77)

P (4.71)

112

85

P (3.70)

63

P (13.00)

350
115

P (6.79)

70

69

342

P (4.94)

P (3.09)
P (99.00)

P (34.16)
P (2.20)
P (29.75)

P (10.31)

P (0.81)

P (2.47)

P (0.81)

P (3.09)

Patient UMX
Amplicon
a
M0 (%)
(bp)*
Shared Amplicons
103
P (4.85)
102
98
93
91
88
P (12.13)
86
85
82
P (14.07
81
80
78
77
P (8.73)
75
73
P (8.73)
72
68
64
P (21.35)
62
61
60

Patient UMY

b
a
M3 (%) M5 (%)

Amplico
d
d
c
M0 (%) M3 (%) M5 (%)
n (bp)

P (9.43) P (5.88)
P (10.59)
P (5.66) P (8.24)
P (3.77)
P (3.77) P (4.71)
P (1.88)

103
102
98
93
91
88
86
85
82
81
80
78
77
75
73
72
68
64
62
61
60

P (7.06)

P (1.18)
P (1.18)
P (3.77) P (1.18)
P (3.77) P (5.88)
P (1.88)
P (3.77) P (3.53)
P (20.75)
P (3.77)
P (3.77) P (4.71)
P (3.77)
P (15.09) P (4.71)

P (2.68)
P (8.62)
P (6.92)
P (0.99)
P (3.53)
P (19.92)

P (1.23)
P (3.25) P (29.63)
P (6.50) P (3.70)
P (0.81)
P (1.63) P (2.47)
P (1.63)
P (13.01)
P (6.79)

P (2.97)
P (2.12) P (3.25)
P (2.44)
P (1.69) P (3.25)
P (4.24) P (1.63)
P (2.26) P (2.44)
P (2.26) P (3.25)
P (1.27) P (30.08)
P (0.81)
P (0.81)
P (18.79) P (1.63)

P (3.70)
P (1.85)

P (11.73)

P (1.23)
P (2.47)
P (1.23)
P (12.20) P (3.70)

*V1_V2 amplicons range from 300 - 400 whereas V1 amplicons range from 60 -120 bp.
M0, M3 and M5 refers to collection of samples at time 0, 3 and 5 months
P indicates presence of amplicon with its percentage abundance in the individual profile
for that specific region
a

Patient UMX was treated with Azithromycin, Bactrim, & Tobramycin

b
c

Patient UMX was treated with Bactrim

Patient UMY was treated with Levaquin

d

Patient UMY was treated with Colistin
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The dominant amplicons in V1 for the three time points, M0, M3 and M5 were 64
(21.4 %), 72 (20.8 %) and 108 (18.8 %) bp, respectively. For the V1 profile, amplicons
73, 77, 103, and 112 bp were present at all time points. The amplicons 64, 70, 82, 88,
351 and 365 bp were present only during M0. The 352 bp amplicon was found during
M0 was absent in M3 and then present again at M5. Amplicons with 61, 68, 72, 75, 86,
and 93 bp were only present during M3. Amplicons with 60, 62, 78, 91, 98, 113, 115,
119, and 120 bp appeared at M3 and were also detected at M5. M5 unique amplicons
had 80, 81, 85, 102, 108, 111, and 350 bp.
Patient UMY was taking levaquin two weeks prior to the M0 sampling. At least
two weeks prior to the second sampling, M3, the therapy was changed to colistin. The
LH profiles (number and abundance) varied over time (Table 2.2). The 342 bp amplicon
in the V1_V2 region was the most abundant with 61.7 % at M0 and 99.0 % at M3.
However, this amplicon was drastically decreased at M5 (34.2 %) (Table 2.2). The V1
amplicons with 62, 72, 76, 78, 81, 91, 94, 98, 102, and 112 bp were found at all three
time points. The amplicons with 63, 103, and 365 bp were present in M0 and M5 but
absent in M3. Amplicons unique to M0 were 82, 100, and 347 bp. Amplicons present at
M0 and M3 but absent in M5 were 73, 75, 77, 88 and 93 bp. M3 and M5 shared
amplicons with 60, 64, 71, and 115 bp. The six unique amplicons present in M5 had 61,
65, 84, 85, 87, and 350 bp (Table 2.2).

2.4.5 Presumptive identity analysis. Based on amplicon lengths for both the
V1_V2 and V1 regions, separately or combined, a presumptive identity for an organism
can be determined. In attempt to achieve identification of an amplicon, chromosomal
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DNA from several CF related pathogens were amplified using V1_V2 primers and V1
primers. All strains of Pseudomonas aeruginosa used in this study amplified a 342 and a
83 bp amplicon for the V1_V2 and V1 regions, respectively.

Stenotrophomonas

maltophilia amplified a 350 and a 87 bp amplicon for the V1_V2 and V1 regions,
respectively.

A 353 bp amplicon was generated for Staphylococcus aureus for the

V1_V2 region. However, V1 primers amplified two peaks at 77 and 88 bp for S. aureus.
Burkholderia cenocepacia produced a 339 bp and a 85 bp amplicon for V1_V2 and V1,
respectively.
Many LH profiles did contain amplicons that correspond to these bacterial
isolates’ fragment sizes. Nineteen LH V1_V2 profiles may have contained the pathogen
P. aeruginosa but only one sample contained the corresponding V1 amplicon (83 bp)
(Table 2.1).

Five samples had the 350 bp amplicon which may be from

Stenotrophomonas maltophilia but only one sample had the corresponding V1 amplicon.
None of the samples had Staphylococcus aureus specific V1_V2 fragment of 353 bp.
However, the V1 specific fragments (77/88) were present in 16 samples; nine of these
samples contained both fragments. The 339 and 85 bp which may correspond to B.
cenocepacia were present in two and ten samples, respectively. Two samples contained
both amplicons.
The theoretical amplicon lengths for bacteria were determined manually using in
silico analysis and AmpliQué and then compared to the LH profiles of the strains. The
manual in silico analysis determined the V1_V2 fragment length for one specific strain of
a CF pathogen.

These results agreed with the experimental data.

The AmpliQué

program was developed to determine the V1_V2 fragment lengths for all bacterial strains
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which had a 16S rRNA sequence in RDPII. The data generated from the program did
agree with the experimental data for some strains yet showed different fragments for
other strains.

For example, in the database some strains of Stenotrophomonas

maltophilia produce the same 350 bp fragment as the LH result. In addition, many more
fragment lengths (304-344 and 346-351 bp) were identified for various strains of S.
maltophilia. Various isolates of P. aeruginosa produced theoretical fragments ranging
from 337-345 bp. Only two fragments, 347 and 348, were produced for this region based
on H. influenzae sequences. AmpliQué determined different isolates of Staphylococcus
aureus have a V1_V2 length of 340-344 and 346-351 bp. Based on B. cenocepacia
sequences, any of the fragments 327, 335, 337, 338, 340, 344, or 346 bp could be
generated using the V1_V2 primers. Most bacterial species produced multiple hits for
the V1_V2 region (data not shown).
AmpliQué was unable to determine the fragment sizes for many CF related
pathogens including P. aeruginosa. In silico analysis was able to determine the fragment
lengths of CF pathogens as that the site of primer binding could be detected manually.
Again, fragment lengths generated from sequences of individual strains varied from the
actual LH results for the specific control strain. Four different isolates of P. aeruginosa
produced an 86 bp fragment for the V1 region while experimentally the region was 83 bp
long. Some strains of Stenotrophomonas maltophilia produced the same 87 bp fragment
as the control strain while others were determined to have a fragment of 85 or 88 bp.
Staphylococcus aureus strains were 91 bp long in that region but the test strain did not
produce this fragment. B. cenocepacia was three bp longer (88 bp) than the LH isolate’s
profile (85 bp).
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2.5 Discussion
LH analysis of 16S rRNA genes has been used to detect both known and novel
organisms that may be present in many complex microbial communities including sputa
from CF patients (Miller, 2003; Mills et al., 2003; Rogers et al., 2003; Suzuki et al.,
1998). In these previous studies, only one region of the 16S rRNA was used to identify
bacteria present in the community at one time point (Miller, 2003; Rogers et al., 2003).
Identification based on one region is difficult and it is hypothesized that the use of
multiple regions might provide more information about the community. In this study, the
V1 and V1_V2 regions (separately and combined) were analyzed with LH-PCR to
determine the diversity and dynamics of the CF lung. Identification of the most abundant
amplicon lengths in the LH profiles was attempted through in silico analysis and
AmpliQué, a newly designed bioinformatics program.

Lastly, the dynamics of the

eubacterial community in the sputum over a period of time was further studied using data
generated from the LH profiles.

2.5.1 The V1 region of the 16S rRNA gene provides a more detailed look at
the complex bacterial community in the CF lung. The 16S rRNA gene contains nine
variable regions. In this study, the V1 region and the V1_V2 regions were used to
produce bacterial LH profiles of the CF sputa samples (Table 2.1). The V1_V2 profiles
were identical for seven patients and hence were unable to discriminate between patients.
The 342 bp amplicon produced a high relative fluorescence in the electropherograms
which may have caused the less dominant amplicons to be below the threshold limit and
inadvertently ignored (Table 2.1). PCR amplification bias may have also decreased the
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detection of other bacteria that were less abundant than the organism(s) represented by
the 342 bp amplicon.

Therefore, it appeared that seven CF samples had identical

bacterial communities. Statistically, the V1_V2 profiles cannot discriminate between
patients at the UM center (Figure 2.3A). The V1 LH profiles were more complex and
statically discriminated between samples to a higher degree than the V1_V2 region
(Figure 2.3). The V1 profiles which were unique to each patient contained multiple
amplicons per sample (Table 2.1).
The use of multiple regions to increase discrimination between samples was not
beneficial.

The identical communities shown in the V1_V2 profiles negated the

discriminatory power of the V1 region when analyzed in conjunction with each other.
The discriminatory strength of the V1 region as compared to the V1_V2 region was also
evident in a soil community LH study (Moreno et al., 2006). Prior LH analysis on CF
sputa used only the V1_V2 region and more information may have been gained by using
the V1 region (Rogers et al., 2003). Using the profiles from the two regions together did
not differentiate profiles to the same extent as the V1 region.

The combinatorial

approach may be of more use in amplicon identification or observing community
dynamics.

2.5.2 CF patients harbor diverse bacterial communities. The 19 sputum
samples obtained from South Florida patients produced unique profiles. No two LH
profiles for the V1 region were the same (Table 2.1 and Figure 2.3B). The V1_V2 region
profiles all contained the amplicon length of 342 bp, which presumptively could be
identified as Pseudomonas species, Burkholderia species (but not B. cenocepacia), or
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Ralstonia species. The 342 bp amplicon is indicative of P. aeruginosa since control CF
isolates produced the same fragment. In addition, the patients were clinically diagnosed
with P. aeruginosa. The high relative fluorescence of the 342 bp amplicon also indicated
a severe infection which would be in agreement with culturing results. The intense
fluorescence of the fragment in seven samples may have skewed the community profile
causing it to appear as if there was only one bacteria present. The V1 region for these
seven samples show some shared amplicons, but largely they had very diverse microbial
communities. Though some amplicons (presence not abundance) were common to
patients, no two overall profiles were identical to each other (Table 2.1 and Figure 2.3B).
It was thought that there are only a few pathogens commonly found in the lungs
of CF patients due to clinical diagnostic procedures (Govan & Nelson, 1993). Molecular
techniques have revealed that many more organisms plague the CF lung which is in
agreement with our findings (Harris et al., 2007; Rogers et al., 2003). Many of the
samples in this study produced LH profiles that contained numerous amplicons, some in
low abundance. These less dominant amplicons may represent bacteria that are not
routinely cultured and are potentially responsible for some of the differences seen in
disease manifestation between CF patients with the same genetic mutations. Recent
Sanger sequencing projects have identified uncultured bacteria in the CF lung (Bittar et
al., 2008; Harris et al., 2007) Deeper sequencing techniques such as 454 could be used to
identify other less abundant and potentially uncultured organisms (Margulies et al.,
2005). In order to understand the significance of these organisms within the CF lung,
proper statistical tools for comparative metagenomics need to be developed.
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2.5.3 Challenges of identifying organisms in complex communities. One of
the downsides to the LH technique is that the organism found in a sample cannot be
conclusively identified.

We hypothesized that organisms could be presumptively

identified based on the V1_V2 and V1 amplicon lengths that would be generated from
LH-PCR.

In this study, the fragment lengths for both regions were experimentally

determined for one strain of four known CF pathogens. In addition, in silico analysis and
AmpliQué were used to determine the expected amplicon length of a variable region for
any given organism. This information was correlated with the LH profile in an attempt to
identify bacteria present in the CF sputum. The bioinformatics approach highlighted the
presence of intraspecies length variation present in both regions. The high degree of
variation seen in different isolates drastically decreased the ability to identify a bacteria
based on the length of one hypervariable region. It was previously known that one
amplicon length could represent multiple species; thereby allowing only a presumptive
identification. Based on the absence of a peak, a specific genus or species could be ruled
out from being a member of the community. The AmpliQué output clearly demonstrates
that one V1_V2 fragment could represent a multitude of species or genera. The wide
range of fragment lengths generated for different isolates of the species may be accurate
or it may be due to problems related to the database used in the program. The database
contains sequences which are determined by various users. It is possible that some of the
length heterogeneity at the isolate level may arise from poor sequencing reads, incorrect
trimming of sequences, and old taxonomy references (some organism names have
changed). Database issues will change as more genome wide sequencing is performed.
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As it stands currently, identification is nearly impossible based solely on amplicon length
from the V1_V2 region.
The V1 region, which was more informative when looking at the community
profile as a whole, proved to be more problematic when analyzing individual peaks.
Chromosomal DNA of P. aeruginosa, Staphylococcus aureus, Stenotrophomonas
maltophilia, and B. cenocepacia were amplified using the V1 primers and the fragment
lengths were detected. In silico analysis was used to determine fragment lengths for the
CF associated lung pathogens including those listed above (though not always the same
isolate).

The initial analysis indicated the presence of length heterogeneity within

species. AmpliQué was used to determine the degree of strain variation present in the V1
region. The primer binding parameter was initially set to 100 % stringency which
resulted in a very small database of organisms and their corresponding fragment lengths.
Many CF pathogens including P. aeruginosa were not present at this high stringency. By
lowering the stringency, AmpliQué generated more results yet no information was given
for P. aeruginosa. The V1 region primers (P1F and P2R) experimentally amplified P.
aeruginosa PAO1.

To determine the putative primer binding site, the 16S rRNA

sequence for PAO1 was manually examined. Both the forward and reverse primer
sequences show some degeneracy. Lowering the stringency parameter was unable to
correct for this degeneracy. This issue can be resolved by determining the binding motif
of the primers using programs such as iterative enhancement of motifs (IEM) (Zeng et
al., 2007a) and then using that motif in AmpliQué. Although P1F is a common V1
primer used extensively in the lab, other less degenerate V1 forward primers such as 27F
(which was used to amplify V1_V2) could be used when attempting to identify
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organisms based on amplicon length. Selection of primers for LH-PCR is critical to
ensure that all bacteria are being amplified and to increase the success of identification
based on fragment length. The widely used primers, 27F and 355R, are based on E. coli
sequence and should be thought of as generalized primers and not universal primers
(Wang & Qian, 2009). Primers that have been developed with a bioinformatics approach
may prove to be more useful in future LH studies (Wang & Qian, 2009).
Due to the limitations of the V1 AmpliQué database, identification using two
regions simultaneously could not be performed. Therefore, identification based on two
regions has yet to be proven. Further modification of AmpliQué and/or the use of
different primers or variable regions may eventually lead to LH-PCR being used as an
identification technique. At this time, LH- PCR can still be useful when looking at a
bacterial community as a whole.

2.5.4 The eubacterial communities in CF lungs are dynamic. The LH-PCR
profiles provided a view of the CF bacterial community as a whole. It is known that in
soil and water samples, the members and their abundances change and these changes can
be driven by external factors (Fierer & Jackson, 2006; Shade et al., 2008). Thus, it is
hypothesized that the bacterial community within the CF lung also changes based on
external factors. To understand the changes in the community, LH-PCR was used to
profile three patients over a period of time. Samples from patient UML were used to
determine the bacterial community variation over a short period of time (3 hours) and
over a long period of time (two years). UMY and UMX were used to study how
antibiotics may affect the lung community.
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Sputum samples from patient UML were analyzed over the course of two years
(M0, M3, M16, M17, M22.1, M22.2, M22.3, M22.4, and M22.5). Five samples were
taken on the same day every three hours for twelve hours (M22.1 - M22.5). For both the
V1 and the V1_V2 LH profiles, the overall bacterial community was more similar within
the one day then across multiple time periods over two years (Figure 2.4 and 2.5). The
LH profiles from the samples taken in one day were not identical. These variations may
arise from transient bacteria that were present in the oral cavity at the time of sampling
such as Lactobacillus from yogurt. Analyzing the samples with both regions further
demonstrated that bacterial communities change over time. By combining regions, the
data indicated increased similarity of the samples taken in one day which was a result of
the more abundant organisms, not the less dominant amplicons in the profile that may
represent the transient bacteria in the oral community. The dissimilarity between the
samples taken months apart was increased due to the presence of the more dominant
possibly disease-causing organisms (Figure 2.4C and 2.5C). This LH analysis is the first
to show that colonization of the CF lung is dynamic and these changes can be tracked.
To date the dynamics of the bacterial community in the CF lung in response to
external drivers such as the presence of antibiotics has yet to be studied. Thus, a short
term study was performed in an attempt to understand how the overall community in the
lung changes when under attack by antibiotics. To begin, CF sputum samples from
Patient UMX and Patient UMY were analyzed every other month for five months.
During this time, patients were taking a combination of antibiotics.
During the five-month period, Patient UMX was taking azithromycin, bactrim and
tobramycin. Shortly before the third time point, the patient stopped taking tobramycin.
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The patient’s profiles contain a large number of V1 amplicons whose presence and
abundance change throughout the time course (Table 2.2). For V1_V2, Patient UMX’s
profiles consisted predominately of the 342 bp amplicon at all time points (Table 2.2).
This fragment was presumptively identified as P. aeruginosa which concurred with the
patient’s clinical diagnosis. Interestingly, UMX had been prescribed tobramycin (which
targets P. aeruginosa) for the majority of the sampling period, yet the 342 bp amplicon
was always present in large abundance (74 – 100 %). LH analysis with both the V1 and
V1_V2 regions indicate a dynamic environment within the lungs of UMX.

These

changes seen over the time period are likely to be an effect of the antibiotic regime.
Patient UMY’s profile was more dynamic than Patient UMX. Patient UMY’s
sputum showed a high level of abundance for the 342 bp amplicon between the first two
samplings followed by a drastic decrease in the abundance of the 342 bp amplicon in the
profile from the third sampling (Table 2.2). This change in profile may correspond to the
patient’s antibiotic regime; specifically, colistin replacing levaquin.

This may have

caused the pathogen associated with that amplicon to disappear. As the abundance of the
342 bp amplicon decreased, a 348 bp amplicon emerged. It is possible that as one
pathogen was cleared, it was replaced with another bacterium that fit that niche (Boni &
and Feldman, 2005). The decreasing 342 bp amplicon may represent P. aeruginosa,
which had been cultured from the patient. Levaquin and colistin are both used to target
against this pathogen. There are studies that have demonstrated levaquin being less
effective in treating P. aeruginosa than the first generation fluoroquinolones (Phillips et
al., 2000). Antibiotic resistant strains of P. aeruginosa are often treated with colistin
(Canton et al., 2005; Scheld, 2003) . It could be hypothesized that Patient UMY was
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infected with an antibiotic resistant strain of P. aeruginosa which may have been
susceptible to the stronger antibiotic. The patient’s lung infection was then dominated by
a bacterium represented by the 348 bp amplicon, which may belong to H. influenzae or
Stenotrophomonas maltophilia. Changes in the bacterial community were also seen in
the V1 profiles (Table 2.2). Due to the limitations of AmpliQué, it is not clear if similar
changes in abundance were seen in peaks that may represent P. aeruginosa.
The microbial community was more dynamic in UMY (a 60-year-old Caucasian
man) than UMX (a 23 year-old Hispanic woman). The number of unique amplicons in
UMX and UMY were eight and 14, respectively. UMX had five (73, 77, 103, 112, and
342 bp) and UMY had 11 (62, 72, 76, 78, 81, 91, 94, 98, 102, 112, and 342 bp)
amplicons that were present at all three time points. These constant amplicons may come
from chronic colonizers that no longer respond to the treatment regimen.

The

uniqueness, diversity and selective abundance of certain amplicons could be attributed to
the age, gender and ethnicity. The patients’ respective lung flora may have adapted to the
patient’s immune response and the presence of antibiotics differently. The variations in
profiles due to age and antibiotic treatment have been previously demonstrated (Beringer
& Appleman, 2000; Lyczak et al., 2002).
Clearly, LH can be used to analyze changes in a microbial community. Although
this study used a small sample size over a relatively short period of time, changes in the
presence and abundance of amplicons in the LH profiles could be seen. To accurately
identify the drivers of the community, a more comprehensive long term study needs to be
performed. Armed with the patient’s antibiotic information and long term sampling, it
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should be possible to determine the effectiveness of a drug against pathogens in the CF
lung. This could eventually lead to more effective treatments.
In conclusion, LH-PCR analysis detected the dynamic and complex flora that is
present in South Florida CF patients. Although LH-PCR could not be used to identify
bacteria in this study, it still proved to be a useful community profiling technique. LHPCR of the V1_V2 and to a greater extent the V1 region of the 16S rRNA gene can be
used to compare microbial communities between samples. Interpreting LH profiles may
provide insight into the evolution of a microbial community and identify the factors that
drive these changes. Technologies such as pyrosequencing will likely be used to identify
the members present in the bacterial community. However, LH-PCR is still an accessible
tool that can be implemented to study microbial communities.
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Supplemental Figure 2.6: Hypervariable region V1_V2 amplicon data graphs. Panels A – E represents patients UMA – UME.
Panels F – I refers to patients UML, UMM, UMN, UMO, respectively. Panels J, K, and L represents patients UMQ, UMR, and
UMS, respectively. Panel M represents profiles from patients UMF, UMG, UMH, UMJ, UMK, and UMT.
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Supplemental Figure 2.7: Hypervariable region V1 amplicon data graphs. A-H are the graphs for patients UMA-UMH,
respectively. I-S refers to patients UMJ-UMT, respectively.
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Chapter 3

“Cystic Fibrosis Lung Eubacteriome and
Mycobiome as Revealed by 454 Sequencing”
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3.1 ABSTRACT
Community profiling and Sanger sequencing projects have been used to study the
polymicrobial nature of the cystic fibrosis (CF) lung. These studies have shown that the
bacterial communities are diverse and unique to each patient. Additionally, species
specific PCR and culturing have demonstrated the presence of fungi in the CF lungs.
However, the diversity of the fungal community remains to be elucidated. In this study,
MultiTag PyrosequencingTM (454) was used to resolve the bacterial and fungal
community in sputa from 18 south Florida CF patients. Sequencing results corroborated
the polymicrobial nature of the lungs. CF sputa contained DNA from known pathogenic
genera,

Pseudomonas,

Burkholderia.

Staphylococcus,

Haemophilus,

Stenotrophomonas,

and

A large percentage of sequenced genera were associated with oral

microbiota which may play a role in the progression of lung disease. Potentially novel
bacteria, Chryseomonas and Flavimonas were also identified.

In addition, the CF

mycobiome dataset contained 33 genera. Many of the species were associated with the
environment. Though patients were not being treated for a fungal infection, DNA from
pathogenic species of Aspergillus, Exophilia, Cryptococcus, Wangiella, Candida, and
Pichia were sequenced from the sputa. The CF microbiomes were unique to each patient
and dissimilar to the microbiomes present healthy oral rinses.

Key words: cystic fibrosis, 454 sequencing, microbiome, mycobiome, eubacteriome,
bacterial community, fungal community, MultiTag Sequencing
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Abbreviations: CF, cystic fibrosis; BAL, bronchoalveolar lavage; MTPS, MultiTag
Pyrosequencing; MDS, non-metric multidimensional scaling; PCO, principle coordinate
analysis; T-RFLP, terminal restriction fragment length polymorphism

3.2 Introduction
The major cause of morbidity and mortality in CF patients is lung disease as a
result from chronic infections (Buzzetti et al., 2009; Patient-registry, 2008).

These

infections are most often caused by bacteria, many of which are resistant to antibiotics.
Pseudomonas aeruginosa, Burkholderia cenocepacia, Staphylococcus aureus, and
Haemophilus influenzae are routinely cultured from CF sputa (Patient-registry, 2008).
Recently, two Sanger sequencing projects have identified the presence of numerous
bacteria, many of which were rarely if at all cultured from CF sputa or bronchiolavage
samples (Bittar et al., 2008; Harris et al., 2007). Based on sequence analysis, known
pathogens, aerobic and anaerobic species were detected in the CF samples. Emerging
pathogens

such

as

Stenotrophomonas

maltophilia,

Serratia

marcescens,

and

Achromobacter xylosoxidans were also identified (Bittar et al., 2008; Harris et al., 2007).
In addition, organisms not readily associated with CF, such as Moxaxella cattharalis,
Granulicatella

elegans,

Inquilinus

limosus,

Granulicatella

adiacens,

Rothia

mucilaginosa, Dialister pneumosintes, Dolosigranulum pigrum, Lysobacter, and
Coxiellaceae were identified from either bronchoalveolar or sputum samples from CF
patients (Bittar et al., 2008; Harris et al., 2007; Rogers et al., 2003). Oral bacteria,
Prevotella, Veillonella, Porphyomonas, and Streptococcus were present in numerous
samples (Bittar et al., 2008; Harris et al., 2007). Another method, 454 sequencing, (ultra-
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deep, high throughput, parallel-sequencing), was used to analyze the lung bacterial
community in one adolescent CF girl (Armougom et al., 2009). In this study, 1,000 bp of
the 16S rRNA gene present in the metagenomic DNA was amplified. The PCR products
were analyzed using 454 sequencing (Armougom et al., 2009). The most commonly
identified organisms were M. catarrhalis, D. pigrum, G. adiacens, H. influenzae and
Streptococcus mitis. Sequencing techniques have identified numerous bacteria in the CF
lung eubacteriome that have previously gone undetected with culturing methods
CF individuals can also suffer from fungal infections. Candida albicans and
Aspergillus fumigatus are the most commonly diagnosed fungal pathogens (Bakare et al.,
2003; Cimon et al., 2001; Mearns et al., 1967). Other fungi such as Scedosporium
apiospermum, Scedosporium prolificans, Aspergillus terreus, Acrophialophora fusispora,
Exophiala dermatitidis and Penicillium emersonii have been shown to infect CF patients
(Bakare et al., 2003; Cimon et al., 1999; Cimon et al., 2003; Cimon et al., 2005;
Defontaine et al., 2002; Hennequin et al., 1997; Horré et al., 2004). Recent statistics
have shown an increase in the prevalence of fungi in the lung which may have resulted as
a consequence of aggressive antibacterial therapy (Nagano et al., 2007).
The prevalence of fungal infections in the CF population varies from one study to
another. Using culturing and microscopy analysis, A. fumigatus and C. albicans were
detected in 45.7 % and 75. 5%, respectively of the 369 samples obtained from 94 CF
patients over a period of time. In another study, 24.5 % of 201 patients were culture
positive for A. fumigatus (Burns et al., 1998). Detection of fungal infections is crucial as
the infection can lead to complications such as allergic bronchopulmonary aspergillosis
(ABPA) and post-transplant fungaemia (Fahy et al., 1991; Kubak, 2002; Mastella et al.,
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2000; Nagano et al., 2007; Stevens et al., 2003) It is also possible for a fungal infection
to become chronic which leads to bronchitis (Nagano et al., 2007).
The total composition of the fungal community (mycobiome) within the CF lung
has not been well explored and many of the fungi were identified using culturing and
microscopy. Some fungi, such as Scediosporim and Pseudallescheria are difficult to
identify with these methods (Horré et al., 2009; Williamson et al., 2001). In those cases,
molecular analysis using fungal ribosomal rRNA genes and the associated internal spacer
regions (ITS) are employed (Bouchara et al., 2009; Hinrikson et al., 2005; Kumeda &
Asao, 1996; Schmidt & Rath, 2003; Williamson et al., 2001; Zeng et al., 2007b). Most
PCR-based assays only identify one organism. An oligonucleotide array can identify 20
fungi simultaneously in CF samples but the panel may not include all fungi present in the
mycobiome (Bouchara et al., 2009). Therefore, the CF lung mycobiome may be better
characterized with sequencing technique, such as 454 sequencing.
The 454 sequencing technique has been used to used to analyze the fungal
mycobiome in the healthy human mouth (Ghannoum et al., 2010). The technique has
also identified members of the bacterial communities present in the healthy oral cavity,
gut, and vagina (Aas et al., 2005; Keijser et al., 2008; Spear et al., 2008; Turnbaugh et
al., 2009; Zaura et al., 2009). The method has also been used to characterize the lung
eubacteriome from one CF individual (Armougom et al., 2009). The 454 sequencing
technique has been shown to provide a more accurate estimation of diversity and a more
reliable estimate of the relative abundance of bacterial species (Armougom et al., 2009;
Quince et al., 2009; Sogin et al., 2006).
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Sanger sequencing projects have shown the CF lung eubacteriome to be large and
phylogenetically diverse.

Eubacteriomes are unique to each individual and the

differences in microbiota may be influenced by host’s factors such as gender, ethnicity,
and cftr mutation.

Therefore, it can be hypothesized south Florida CF patients

eubacteriomes will differ and may harbor novel bacteria.

It is also likely the lung

mycobiome is more diverse than previously determined by culturing and species-specific
PCR. This study proposes to resolve the eubacteriome and mycobiome associated with
CF sputum from 19 south Florida CF patients by using MultiTag PyrosequencingTM.
This analysis will provide a more accurate estimation of diversity for the CF lung
microbiome. In addition, the CF sputa microbiomes will be compared with healthy oral
rinse microbiomes.
3.3 Materials and methods
3.3.1

Ethics statement.

Written informed consent was obtained from all

participants in this study. Recruitment of study participants was performed according to
protocol (number 040407-01) approved by the Human Subjects Institutional Review
Board (IRB) of Florida International University, Miami, Fl.

3.3.2 Study participants. Sputum samples were obtained from 19 adult CF
individuals. The individuals were patients at the University of Miami adult cystic fibrosis
care center. Summary demographic information of the study participants was provided in
Table 3.1. All CF patients were of the Caucasian race as defined by the United States
Census Bureau.

Ethnicities, Hispanic and not Hispanic, were included in the

115

demographics (Table 3.1). Inclusion criteria were >18 years of age, diagnosed to have
CF, and proficient in English.
exacerbations.

Samples were taken during routine visits or during

All participants gave an expectorated sputum sample which was

immediately kept frozen until analysis.

Table 3.1: Patient demographics. Patient number, gender and ethnicity of the study
subjects are listed.
Patient

Gender

CF1
CF2
CF3
CF4
CF5
CF6
CF7
CF8
CF9
CF10
CF11
CF12
CF13
CF14
CF15
CF16
CF17
CF18
CF19

Male
Female
Male
Male
Female
Male
Female
Male
Female
Female
Female
Male
Male
Male
Female
Male
Male
Female
Male

*

Ethnicity*
NH
NH
H
H
NH
NH
H
H
NH
H
NH
NH
NH
NH
NH
NH
H
H
H

NH refers to non-Hispanic
H refers to Hispanic
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3.3.3 DNA extraction. The sputum samples were liquefied using a freeze/boil
method (Reischl et al., 1994). Each sample was separated into three aliquots which were
used for metagenomic DNA extraction. The DNA was extracted and cleaned using the
FastDNA® Spin Kit (Qbiogene, Irvine, CA) according to the manufacture’s protocol.
Briefly, liquefied sputa were homogenized and cells were mechanically lysed using the
FastPrep® instrument (Qbiogene) and the lysing matrix. The DNA was cleaned using the
GeneClean® procedure included in the kit. The DNA obtained from the three aliquots
was combined to ensure that the total DNA present in each sputum sample would be
analyzed. The eluted DNA was quantified and diluted to 100 ng/µL and refrigerated at
4°C until further use.

3.3.4 Metagenome analysis. The eubacteriome and mycobiome analysis of the
sputum samples were performed using the MultiTag PyrosequencingTM (MTPS)
technique (Gillevet, 2006). Bacteria were identified by sequencing the hypervariable
region 1 and 2 (V1_V2) of the 16S rRNA gene using the forward primer 27F (5’- AGA
GTT TGA TCM TGG CTC AG-3’) and the reverse primer 355R (5’- GCT GCC TCC
CGT AGG AGT-3’) (Figure 1.13) (Doud et al., 2009; Suzuki et al., 1998). Fungi were
identified by sequencing the ITS 1 region using the forward ITS1 primer (5’-TCC GTA
GGT GAA CCT GCG G-3’) and the reverse primer ITS2 (5’-GCT GCG TTC TTC ATC
GAT GC-3’) (Figure 1.14) (White et al., 1990).
MTPS technique is a variation of 454 pyrosequencing in which a molecular
barcode is incorporated into the fusion primer (Gillevet, 2006). In general, the fusion
primers, referred to as Adapter A/B consist of a 20 base sequencing primer, a four base
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sequence key (used to calibrate base calling during pyrosequencing), and a PCR primer.
In MTPS, Adapter A also contains a 7 base “barcode”. This barcode is used to sort the
sequencing reads for downstream analyses. For this experiment, a set of 42 emulsion
PCR fusion primers were designed to amplify the microbial DNA. The fungal Adapter A
and B were designed to have the ITS1 and ITS2 sequences, respectively. Similarly, the
bacterial Adapter A and B contained the 27F and 355R primer, respectively. Therefore,
each DNA sample was amplified with sets of uniquely barcoded fungal and bacterial
forward and reverse primers. All sequences were read from the A adapter side (forward
PCR primer) using the GS-FLX pyrosequencer (454 Life Sciences-Roche, Branford, CT).
The incorporated nucleotides were detected by the generation of a bioluminescent signal
that is dependent on a luciferase mediated reaction. The intensity of the signal was
proportional to the number of incorporated nucleotides. The signals were detected and
analyzed by the instrument in real time and a pyrogram composed of a series of peaks
reflecting the DNA sequence was generated.

3.3.5

Data analysis.

A custom PERL script was developed to sort the

sequencing reads into bacterial and fungal bins per each patient.

The Ribosomal

Database Project II (Release 9) Bayesian classifier was used to obtain a classification for
each sequence (Maidak et al., 1999).

The annotations for each sequence were

downloaded, and the PERL script sorted the output into taxa per sample. Using the
PERL script, the fungal ITS sequencing data was automatically compared against
GenBank (Benson et al., 2008) and identity of the sequence was determined at a 98 %
cutoff. The classifications per sequence were again sorted into taxa per sample. The
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final output of the PERL script for both the bacterial and fungal data was a table (one
table per community) showing the taxon in each sample and its associated abundance
determined as number of taxon sequence reads divided by total number of sequenced
read per sample
The bacterial data were imported into Primer 5 (Primer-E, Ltd, Ivybridge, United
Kingdom) and square root transformed to reduce the influence of the more common
organisms (Grant & Ogilvie, 2003; Mills et al., 2003). To determine similarity between
bacterial communities, a similarity matrix was calculated using the Bray-Curtis similarity
index (Bray & Curtis, 1957; Doud et al., 2009; Mills et al., 2006; Moreno et al., 2006;
Rees et al., 2004). Principal coordinate analysis (PCO) was performed on the Bray
Curtis distance matrix generated from the CF communities using Multivariate Statistical
Package, MVSP (Kovach, Wales, UK; (Ghannoum et al., 2010). Graphically, the PCO
analysis plots each community as a rotation of data points in multidimensional space so
that the axis with the greatest variance is the first principle component axis (Ghannoum et
al., 2010). This analysis will group or separate the samples in the dataset revealing which
samples are more similar in the dataset. PCO analyses were used to identify similarities
between bacterial communities, bacterial community and age/gender, and between CF
sputa and healthy oral rinse eubacteriomes.
Similarities between fungal communities and host’s age/gender were determined
using the same method. Healthy fungal communities from oral rinses was also compared
to the CF sputa mycobiomes (Ghannoum et al., 2010). Presence/absence of taxa were
used to construct a Sørenson similarity matrix between the two communities (Sorensen,
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1948). Unweight pair group average clustering was performed on the matrix and results
were plotted on a dendograph.

3.4 Results
3.4.1 Participant demographics. The CF samples were obtained from 11 males
and eight females. Of these individuals, 11 were Caucasian of non-Hispanic origin and
eight were Caucasian of Hispanic origin (Table 3.1).

3.4.2 Identification of bacterial taxa in CF samples. Of the 19 samples, 18
samples produced on average 2,809 MTPS reads. Only 11 reads were obtain from
CF_11. Thus, the sample from a female of non-Hispanic origin was removed from all
bacterial analyses.

Using a cutoff≥of1% of abundance, a total of 34

identified from the remaining 18 CF samples (Figure 3.1 and Table 3.2).

taxa were
Sputum

samples contained between four and 16 different taxa with the average of 9.6 ± 3.3
genera. Sixteen samples contained sequences belonging to Pseudomonas (absent from
CF4 and CF16) and Streptococcus (absent from CF2 and CF18). Chryseomonas was
present in 15 samples (absent from CF2, CF4, and CF16). Fourteen samples contained
sequences from Micrococcineae (absent from CF10, CF13, CF18, and CF19) and
Prevotella (absent from CF1, CF4, CF7, and CF17).

Ten taxa (Burkholderia,

Coriobacteriaceae 2, Elkenella, Haella, Moryella, Propionbacterineae, Schlegelella,
Spingobacterium, and Stenotrophomonas) were not present in multiple samples. The
most abundant taxon in 14 samples was Chryseomonas. CF18 was more abundant with
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Figure 3.1: Bacteria taxon present≥1% abundance in CF sputum samples. Each
color represents a different genus. The height of the color represents the abundance of
the reads for that genus in comparison to the total number of sequencing reads for the
sample.
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Table 3.2: Frequency distribution (%) of bacteria present with at least 1 % abundance in the CF sputa eubacteriome
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Organism
Achromobacter
Actinomycineae
Burkholderia
Campylobacter
Capnocytophaga
Carnobacteriaceae
Chryseomonas
Coriobacterineae
Eikenella
Flavimonas
Fusobacterium
Gemella
Haemophilus
Hallella
Lactobacillus
Leptotrichia
M egasphaera
M icrococcineae
M oryella
Neisseria
Oribacterium
Porphyromonas
Prevotella
Propionibacterineae
Proteus
Pseudomonas
Schlegelella
Shigella
Shuttleworthia
Sphingobacterium
Staphylococcus
Stenotrophomonas
Streptococcus
Veillonella
Count*

CF1 CF2 CF3 CF4 CF5 CF6
10.42 4.24
6.05
4.90
1.98 1.13

CF7

CF8

CF9

CF10 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19
5.41
3.48
2.70 2.16 4.31

23.47
1.03
4.60
15.73

67.03

2.13
1.75 1.51
23.00 25.91 58.39 52.11 14.29 42.93 27.45 19.74

1.22
1.09
2.25
6.45 48.68

5.03
1.65

1.44
32.53 44.08 38.76

1.76
1.72
23.18

1.39
2.69

1.18

3.07

1.35
1.13

1.16

3.55 30.31

1.40

1.02
1.30

4.12

1.52
2.15

1.13

1.72

1.37

15.17
5.02 24.37 14.55
2.44
2.23

1.59

1.45

3.59

2.85

1.85

19.67

1.14

1.42

1.43

9.09
1.12

1.91
2.18
9.62

3.84
1.32

1.74
7.34

1.91

16.62

1.79

15.76
2.38
1.85

9.34

2.38

6.32

3.83 21.02

1.74 22.05

2.44

8.20
1.45

5.91 13.67

6.18
2.90

3.34
6.61 18.35

1.45

2.24
3.82 12.00

47.58
4.04

12.33 15.50 15.63 17.95

3.74 29.09

1.14
1.53
2.51

4.37
1.19

6.88

2.30
2.74
1.97
1.12

1.29
3.57

1.46
1.06

7.23

6.53
2.09

32.79
18.23 45.07 12.51
7.37

1.46

1.16
1.74

2.04

2.12
35.38

14.63 30.72

4.09

7.55
6.62
6

34.09
2.66
10
11

4.53 14.16
6

10

9.50
7

# is the total samples that contained that specific taxon
* is the total number of taxa present per sample

9.22 10.02
8

9

4.93
11

4.88 14.82 30.71 23.34
4.08 7.63 1.91
6
11
10
16

6.08 26.63
2.21 7.80
12
15

4.12
7

4

6.47
7.68
14

#
4
7
1
2
2
7
15
1
1
8
5
8
6
1
1
7
2
14
1
6
2
4
14
1
3
16
1
2
2
1
4
1
16
7

hits belonging to the Pseudomonas genus. Micrococcineae, Proteus and Prevotella were
the most sequenced organism in CF2, CF4 and CF15, respectively (Table 3.2).

3.4.3 Relationship between gender, ethnicity and the eubacteriome. A PCO
analysis was performed on the Bray-Curtis similarity matrix constructed from the CF
eubacteriomes to determine if there was an association between the communities and the
patient gender and/or ethnicity (Figure 3.2). No clustering was present on the PCO plot
regardless of bacterial community profile, patient gender, or ethnicity.

3.4.4 Healthy oral eubacteriome. Oral rinse samples were obtained from 25
healthy individuals (data obtained from collaborator). The bacterial community for each
sample was determined using MTPS. The data was processed in the same manner as the
CF data. Only taxa with greater than 1 % abundance were included in the analysis (Table
3.3). The 25 samples had between eight and 18 bacterial taxa with the average of 12.84 ±
2.37 taxa.

Prevotella, Streptococcus, and Veillonella were present in all samples.

Micrococcineae was present in all except for H9. Twenty-three taxa were not present in
multiple samples i.e. each taxon was only sequence from one sample, and not necessarily
the same sample.

The most abundant organism in 12 samples was Streptococcus.

Neisseria and Prevotella were most abundant in six (H8, H11, H12, H21, H23, and H25)
and five (H2, H3, H6, H18, H24) samples, respectively. Porphyromonas, Lepotrichia,
and Haemophilus and were found to be most abundant in one sample (H9, H10, and H13,
respectively).
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Figure 3.2: Relationship between the host and the eubacteriome. Principal coordinate
analysis (PCO) was used to represent the relationship between the bacterial
communities as represented by the Bray-Curtis similarity matrix. Lilac squares are
samples from females. Males are represented by green squares. Numbers in black
indicate samples from non-Hispanic subjects while red text represents Hispanic
samples.
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Table 3.3: Frequency distribution (%) of bacteria present with at least 1 % abundance in the healthy mouth eubacteriome
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Organis m
Achromoba cter
Acti noba ci l l us
Acti nomyci nea e
Aggrega ti ba cter
Al k a l i fl exus
Aqui ta l ea
Ba cteroi des
Bergeyel l a
Bul l ei di a
Burk hol deri a
Ca mpyl oba cter
Ca pnocytopha ga
Ca rnoba cteri a cea e 2
Cori oba cteri nea e
Coryneba cteri nea e
Del fti a
Ei k enel l a
El i za bethk i ngi a
Empedoba cter
Enhydroba cter
Fi l i fa ctor
Fusoba cteri um
Gemel l a
Ha emophi l us
Ha l l el l a
Ki ngel l a
Kordi a
Leptotri chi a
M ega spha era
M i crococci nea e
M ycopl a sma
Nei sseri a
Ori ba cteri um
Pa steurel l a
Pel omona s
Phocoenoba cter
Porphyromona s
Prevotel l a
Propi oni ba cteri nea e
Protei ni phi l um
Ra l stoni a
Schl egel el l a
Seba l del l a
Sel enomona s
Snea thi a
Sphi ngomona s
Streptococcus
Ta nnerel l a
Treponema
Vei l l onel l a
Count*

H1

H2

H3

H4

H5

H6

H7

H8

H9

H10

H11

H12

H13

H14

H15

3.61
1.86

2.09

2.71

H16

H17

4.77
2.87

2.45

5.67

1.53

2.16

1.13

H18

H19

1.03
4.15

H20

H21

H22
21.01

H23

1.61
1.75

1.88

H24

H25

1.89
3.71

1.38

1.17
1.26
1.91

1.33

1.32

1.93

1.39

1.89

1.59

3.71

3.58
1.58
1.18
1.55

1.69

2.01

1.69

1.26

2.06
2.97

1.39
1.67

3.19

1.53

2.30

1.28

1.64

2.27

1.02
2.18
3.67

2.32

2.12
1.14

1.06

1.18
1.65

2.14
2.02
3.22
1.83
1.30
2.79

6.23

4.50

8.15 12.98

6.76
5.06 2.06
9.75 11.13

7.38
9.15

3.26
1.88
5.24

4.58
6.11

4.22
7.76
1.77

5.14

9.21

1.27

4.74

5.89

2.62
6.54 12.44 24.40 16.64
1.51

1.75 2.39
4.91 5.30 1.45
7.87 17.16 12.58

5.67
6.60

2.90

3.42
2.67
7.37 10.18

5.49
8.42

4.54
2.10

3.22
1.90
8.50

3.18

4.34
1.81
8.14 14.26
1.02

1.48
1.06

1.05

1.90

8.26

1.22
10.42

2.46
1.21
3.20 10.15

15.02 11.91
1.03 1.25

1.79

1.03

1.17

1.15

4.63 11.52

3.02

1.18
3.55

1.41

1.52
1.01

2.98 7.09 1.13 1.54 11.32 6.82
2.40 7.68 7.14 10.61 13.44 9.27 4.81
1.39
1.96
2.12 22.90 21.81 17.36
27.81 11.34 10.40 20.21 24.53 11.31 1.45 11.81 13.94
1.04
2.17 1.15
2.06 1.63
1.75

1.24 4.22 16.94
10.01 14.52 19.99

1.15 11.86 3.95
9.55 4.85 19.09 14.98

5.34 22.49
6.11 15.22

1.17 1.11
6.38 2.23 3.02 3.24 1.16
6.34 16.54 16.78 13.80 16.17

5.76

1.32

1.22
6.20

1.01 13.53 11.80
3.27

2.71

2.97

22.03 24.53 33.07

2.69

6.22 21.78

3.37

4.28 7.89
2.16 11.06 22.33

1.36
2.32
15.13
1.69

2.98
4.96

3.18
3.85

8.23
8.05

1.26 7.32
1.76 13.58 26.42
9.83

1.14

8.44
9.86
1.36

1.01
1.72

18.63

6.50
13

3.16

9.93 15.02 28.48 23.53 14.61 38.51 19.79
4.04
8.98 12.57
15
12

4.54
10

3.48
13

4.10
12

7.46
12

7.20
12

1.73

1.54
5.37
1.05
1.09

3.52

6.37 10.47
1.32
2.41
2.00 7.70
16
18

8.77
1.19

# is the total samples that contained that specific taxon
* is the total number of taxa present per sample

3.32
12

1.23

2.84

4.35

1.34
6.75 16.10 21.41 38.00 30.29 30.56 15.63 28.14 28.46 23.06 26.39 17.68 25.17 14.56

8.72
14

3.47 12.10
11
12

7.11
8

1.51
15

9.92 10.16
13
12

1.87
12

1.22
15

5.30
8

3.19
16

8.16 12.08
14
11

5.21
15

#

1
5
11
3
1
1
8
1
1
1
6
4
13
1
1
1
1
1
1
1
1
21
11
24
2
1
6
14
1
24
2
22
9
1
1
2
21
25
1
3
1
8
1
1
1
1
25
2
2
25

3.4.5

Comparison of CF and healthy eubacteriomes.

Twelve taxa were

present in CF samples but not in healthy samples (Table 3.4). Common CF pathogens
Pseudomonas, Staphylococcus, and Stenotrophomonas were only sequenced in the CF
samples. In addition, Chryseomonas, Eikenella, Flavimonas, Lactobacillus, Moryella,
Proteus, Shigella, Shuttleworthia, and Sphingobacterium were exclusively present in CF
samples.

Twenty-seven taxa were unique to healthy oral samples (Table 3.4).

A

similarity index of the two dataset was calculated using the Bray-Curtis similarity index
on the square root transformed abundance data. The similarity matrix was used in the
PCO analysis. The PCO graph showed the data points (blue triangles) representing the
healthy oral rinse microbiomes clustered closer to each other than the CF microbiomes
(red circles) (Figure 3.3).
Table 3.4: Bacteria sequenced in CF sputa and/or mouth rinse from healthy individuals
Only in CF
Only in Healthy
Present in Both
Chryseomonas
Actinobacillus
Kordia
Achromobacter
Neisseria
Eikenella
Aggregatibacter Mycoplasma
Actinomycineae
Oribacterium
Flavimonas
Alkaliflexus
Pasteurella
Burkholderia
Porphyromonas
Lactobacillus
Aquitalea
Pelomonas
Campylobacter
Prevotella
Moryella
Bacteroides
Phocoenobacter Capnocytophaga
Propionibacterineae
Proteus
Bergeyella
Proteiniphilum Carnobacteriaceae 2 Schlegelella
Pseudomonas
Bulleidia
Ralstonia
Coriobacterineae
Streptococcus
Shigella
Corynebacterineae Sebaldella
Fusobacterium
Veillonella
Shuttleworthia
Delftia
Selenomonas
Gemella
Sphingobacterium Elizabethkingia Sneathia
Haemophilus
Staphylococcus Empedobacter
Sphingomonas Hallella
Stenotrophomonas Enhydrobacter
Tannerella
Leptotrichia
Filifactor
Treponema
Megasphaera
Kingella
Micrococcineae
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Figure 3.3: PCO analysis of healthy mouth rinse and CF eubacteriomes. Bray-Curtis
similarity matrix and PCO was used to compare the sequenced eubacteriomes from
healthy mouth rinse samples (blue triangles) and CF sputa (red circles).
3.4.6 Identification of fungal taxa in CF samples. Of the 19 samples, 18
samples produced between 5,467 and 45,178 reads with the average read count of 21,976.
Only 3453 reads were obtained from CF_10, a female Hispanic patient. The number of
sequencing reads is low in comparison to the rest of the samples and thus CF_10 was
removed from all fungal analyses. Using a cutoff of ≥ 1% of abundance, 33 taxa were
identified from the remaining 18 CF samples (Figure 3.4 and Table 3.5).

Sputum

samples contained between 13 and 30 different taxa with an average of 26 ± 3 (Table
3.5). Sample CF1 was the most diverse community with 30 taxa. Twenty-nine and 28
taxa were present CF16 and CF5, respectively. Twenty-seven taxa were sequenced in
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CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF11 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19

Amanita
Bulleromyces
Cladophialophora
Debaryomyces
Exophiala
Glomus
Metschnikowia
Olpidium
Phialophora
Rhizoctonia
Saccharomyces

Aspergillus
Candida
Cladosporium
Dipodascus
Fonsecaea
Hortaea
Mucor
Paracentrotus
Pichia
Rhodosporidium
Schizosaccharomyces

Blastocladiella
Capronia
Cryptococcus
Eutypella
Geotrichum
Hypocrea
Myrothecium
Penicillium
Rhinocladiella
Rhodotorula
Tricholoma

Figure 3.4: Fungi genera present in≥1% abundance in CF sputum samples. Each
color represents a different genus. The height of the color represents the abundance of
the reads for that genus in comparison to the total number of reads for the sample.
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Table 3.5: Frequency distribution (%) of fungi present with at least 1 % abundance in the CF sputa mycobiome
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Organism
CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF11 CF12 CF13 CF14 CF15
Amanita
Aspergillus
2.10 2.93 2.67 3.13 2.60 2.89 1.78 2.29 2.76 2.59 2.46 2.80 2.92 2.51
Blastocladiella
1.05 1.44 1.33 1.59 1.31 1.44
1.18 1.38 1.28 1.31 1.29 1.46 1.28
Bulleromyces
1.07 1.48 1.35 1.60 1.32 1.46
1.23 1.39 1.30 1.33 1.31 1.47 1.30
Candida
5.42 4.99
3.31 4.84
4.47
1.78
5.26
Capronia
5.68 6.07 5.82 6.44 5.59 5.94 4.24 5.26 6.03 5.25 5.58 5.41 5.97 5.21
Cladophialophora
3.52 3.08 3.09 3.22 2.95 3.01 2.34 2.78 3.23 2.62 2.90 2.78 3.00 2.60
Cladosporium
6.85
1.80
1.43
2.31
2.39
Cryptococcus
1.07 1.49 1.36 1.61 1.32 1.46
1.21 1.39 1.30 1.33 1.31 1.48 1.29
Debaryomyces
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.30 1.34 1.31 1.48 1.30
Dipodascus
1.07 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.30 1.33 1.31 1.49 1.30
Eutypella
1.03
Exophiala
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Fonsecaea
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Geotrichum
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Glomus
1.08 1.50 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Hortaea
2.76
Hypocrea
2.17
1.42
4.49 2.27
2.22 1.64 1.98
2.30
M etschnikowia
1.04 1.44 1.32 1.55 1.29 1.44
1.15 1.36 1.29 1.31 1.28 1.46 1.25
M ucor
1.04 1.44 1.32 1.55 1.29 1.44
1.15 1.37 1.28 1.31 1.29 1.46 1.27
M yrothecium
12.11 1.01 4.75 0.00 7.94 2.37 24.79 12.62 2.68 12.23 8.95 10.89 1.54 12.70
Olpidium
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Penicillium
2.13 2.98 2.71 3.21 2.64 2.92 1.89 5.28 2.78 2.61 2.73 2.62 3.06 2.75
Phialophora
4.31 3.17 3.56 3.35 4.01 3.36 6.31 4.71 3.26 4.82 4.27 4.59 3.24 4.83
Pichia
15.61 21.49 19.81 23.21 19.35 21.46 13.73 17.12 20.46 19.28 19.71 19.25 21.88 18.83
Rhinocladiella
2.15 2.99 2.72 3.22 2.65 2.93 1.90 2.46 2.79 2.62 2.68 2.62 2.97 2.60
Rhizoctonia
14.82 19.53 17.80 21.03 17.65 19.27 13.20 16.33 18.44 18.45 18.11 17.90 19.48 17.97
Rhodosporidium
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Rhodotorula
1.08 1.49 1.36 1.61 1.32 1.46
1.23 1.40 1.31 1.34 1.31 1.49 1.30
Saccharomyces
Schizosaccharomyces 4.32 4.48 4.51 4.83 4.68 4.61 5.09 4.83 4.43 5.05 4.85 4.92 4.59 5.04
Tricholoma
2.15 2.99 2.72 3.22 2.65 2.93 1.90 2.46 2.79 2.64 2.68 2.62 2.97 2.60
Wangiella
1.38
Count*
30
26
27
24
28
26
13
26
27
26
27
26
26
26

# is the total samples that contained that specific taxon
* is the total number of taxa present per sample

CF16 CF17 CF18 CF19 #
1.06
1
2.16 2.58 2.32 1.69 18
1.06 1.29 1.19 1.30 17
1.12 1.32 1.21 1.32 17
1.39
8
5.18 5.48 5.20 5.52 18
2.91 2.83 2.73 2.86 18
1.07 6
1.12 1.31 1.21 1.32 17
1.12 1.32 1.21 1.32 17
1.12 1.32 1.21 1.32 17
1
1.13 1.32 1.23 1.33 17
1.13 1.32 1.23 1.33 17
1.13 1.32 1.23 1.33 17
1.13 1.32 1.23 1.33 17
1.32
2
2.09 1.81 1.98
11
1.06 1.27 1.18 1.29 17
1.06 1.28 1.18 1.29 17
11.32 10.00 11.62 3.10 17
1.13 1.32 1.23 1.33 17
2.23 2.63 5.03 13.46 18
4.35 4.43 4.40 3.20 18
15.99 19.10 17.61 19.42 18
2.27 2.64 2.46 2.66 18
14.67 18.05 16.52 17.33 18
1.13 1.32 1.23 1.33 17
1.13 1.32 1.23 1.33 17
8.29
1
6.51 4.86 4.78 4.27 18
2.27 2.64 2.46 2.66 18
1
29
27
26
26

four samples (CF3, CF9, CF12, and CF17).

Twenty-six taxa were present in nine

samples (CF2, CF6, CF8, CF11, CF13, CF14, CF15, CF18, and CF19). Twenty-four and
13 taxa were identified from samples CF4 and CF7, respectively.
Ten genera were present in all 18 samples (Aspergillus, Capronia, Penicillum,
Phialophora,

Pichia,

Rhinocladiella,

Rhizoctonia,

Schizosaccharomyces,

Tricholoma).

Fiveteen genera were also common in 17 samples (Blastocladiella,

and

Bulleromyces, Cryptococcus, Debaryomyces, Dipodascus, Exophiala, Fonsecaea,
Geotrichum, Glomus, Metschnikowia, Mucor, Myrothecium, Rhodosporidium, and
Rhodotorula. Sequences for Amanita and Saccharomyces were sequenced in sample
CF16. Eutypella and Wangiella were present in CF1. The species for each genera are
listed in Supplemental Table 3.8.
In regards to abundance, the most sequenced genus in 17 samples was Pichia with
sequences from P. anomala, P. membranaefaciens, and Pichia sp.
exception with a 24.8 % abundance for the genus Myrothecium.

CF7 was the

The second most

abundant genera in all 17 samples was Rhizoctonia (Table 3.5).

3.4.7 Relationship between gender and ethnicity and the mycobiome. A
Bray-Curtis similarity matrix was constructed from the fungal abundance table. The
results were plotted using PCO to identify relationships between the communities and the
gender and/or ethnicity of the subjects (Figure 3.5). No clustering of community based
on gender and/or ethnicity was seen.
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Figure 3.5:

Relationship between the host and the fungal community.

Principal

coordinate analysis was used to represent the relationship between the fungal
communities as represented by the Bray-Curtis similarity matrix.

Lilac squares are

samples from females. Males are represented by green squares. Numbers in black
indicate samples from non-Hispanic subjects while red text represent Hispanic samples.
3.4.8 Healthy oral mycobiome. Fungal DNA was sequenced from 20 oral rinse
samples from healthy individuals. The data were analyzed separately from CF sequences
and have been published (Ghannoum et al., 2010).

With author’s permission, the

summary of results and tables showing the genera and species (≥1% of the community)
identified in the oral rinse samples have been included (Table 3.6 and Supplemental
Table 3.9). All samples contained organisms identified as non-culturable; this group was
included in all diversity accounts.

Between three (H14) and 16 (H2) genera were

131

sequenced from the healthy dataset with the average diversity of 10.85 ± 3.07. Fifteen
genera were present in two samples (H10 and H16). Thirteen genera were sequenced
from H1, H8, and H19.

Twelve genera were identified in three samples (H6, H7,

andH18). Eleven genera were sequenced H13 and H17. Three samples had ten genera
(H5, H9, and H11) while H3 was the only samples with nine fungal taxa. Eight genera
were present four samples (H4, H12, H15, and H18) (Ghannoum et al., 2010).
Excluding the non-culturable group, the most commonly sequenced genus was
Candida (15/20) followed by Cladosporium (13/20), Auereobasidium (10/20) and the
family Saccharomycetales (10/20) (Table 3.6). Thirty-nine fungal taxa were not present
in more than one sample (Ghannoum et al., 2010). The unculturable group was the most
abundant in 12 samples. Cladosporim was the most abundant sequence in H11, H13, and
H15. Schizosaccharomyces, Aspergillus, Saccharomyces, Nigrospora, and Ophiostoma
were the most abundant taxon in H1, H8, H9, H12, and H20, respectively (Table 3.6).
The species present for each genera were listed in Supplemental Table 3.9.

3.4.9 Comparison of CF and healthy mycobiomes.

To compare the

communities, a Sørenson similarity matrix was calculated based on the presence/absence
of organisms sequenced in the two communities (Sorensen, 1948). The matrix was used
for unweight pair group average clustering. The results, represented on a dendograph,
showed no healthy mycobiomes clustered with the CF mycobiomes (Figure 3.6). There
were 22 genera that were sequenced in CF sample and not found in the healthy samples
(Table 3.7). In addition, there were 63 genera unique to the healthy samples. Eleven
genera but only one organism, C. albicans, were present in both datasets.
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Table 3.6: Frequency distribution (%) of fungi present with at least 1 % abundance in
the healthy oral mycobiome
Organism

H1

Al ternari a

H2

H3

H4

H5

1.03

1.57

H6

H7

H8

H9

H10

H11

H12

H13

H14

3.10

2.72

3.32

H17

H18

2.82

H19

H20

3.00

Aspergi l l us

8.50

Atractyl odes

6.03

3.90

1
2

2.26

8.79 34.75

12.07

2.77

4.03

3.02

5.96

4.52

7
2

7.23
6.49

Aureobasi di um

4.70

2.35

1.94

11.29

11.76

6.91

1

7.99

Bagni si el l a

1

2.47

Campyl obacter
5.47 12.05 11.24

0.00 11.81 14.39

1.05

2.27 14.64

14.98

2.97

2.41

1.18

2.58

2.69

2.47

7.39

5.41

3.30 56.18

3.49 31.83

42.02

3.95 14.08 15.70

13

2.42

1

1.20

Cl avi ceps

15
1

1.24

Chaetomi um
1.55

10
1

5.04

Avena

1.44

#
8

1.94

5.04

Ascomycete

Cl adospori um

H16

1

1.84

Amani ta

Candi da

H15

1.17

Acremoni um

Cl avi spora

2.46

1

Conopl ea

3.40

1
1

2.42

Corynespora

1.06

Cryptococcus

3.79

2.45

Cystofi l obasi di um
10.72

Dothi deomycete

1.45
3.01

Dothi oraceae

1
3

1.94

5.34

4.20

1.61

1.73

2.77

1.29

10.97

4.74

1

1.44

5

17.80

1

1.85

1

8.83

Fl ammul i na
4.08

Fusari um

2.18
1.66

Gi bberel l a

5.26

6

3.91

17.90

4

1.82

7.15

2.00

1.65

2.20

3.70

1

1.15

Gi gaspora
5.40

13.14

2.02

5
1

5.04

Gui gnardi a
1.03

Hormonema

2

1.18

1.03

Hypocreal es

1

1.65

1

2.87
4.45

Lecani a
1.10

Lewi a

1

3.54

1

1.03
1.24

Ni grospora

2

48.37

3.45

2

7.65
41.33

Ophi ostoma
1.08
2.81

3

1.92

1

3.71

Pezi za

1

1.51

Phaeosphaeri a
2.55

Phoma

2

1.72
1.10

Pi chi a
Pl eosporaceae

8.39

2

1.15

1

4.03

1

1.44

Puerari a

1

2.11

Pyrenophora

1

6.10

Rhi zopogon

10.02

Saccharomyces

5.64 13.65

Saccharomycetal es

49.05
1.11 12.36

5.99

2.47
8.04

1.18
1.85 18.09

1.41

14.75

Schi zophyl l um

3.39 29.39
2.22

1.84

Sordari omycete

1.70

1
2

1.32
6.18

Stachybotrys

1.34

3

1.20

1

6.45

Stemphyl i um

1

2.47

Subul i spora
1.24

Teratosphaeri a

1.87

17.14

1.12 17.66

16.81

1.09 10.87

9

5.37

1

2.05

Torul aspora

1

1.87

Tremel l al es
Tri chaptum

2.34

Tri chocomaceae

2.61

1
2.80

3

2.27
1.10

Tri chosporon
Verti ci l l i um

4.12

2

1.37

1
1

7.31

Wal l emi a
7.71

Xyl ari al es

3.96
9

8

10

12

12

13

1

0.00

16.37 34.44 34.98 52.08 57.11 53.02 29.47 25.61 20.80 44.69
16

2

31.27

Zygosaccharomyces
13

3
2

1.10

Sebaci na

6
10

7.26

2.57

Schi zosaccharomyces 20.10

Non-culturable

2

1.13

Pongo

Count*

2

1.61
12.82

1
1

2.09

Orpi nomyces
Paeci l omyces

1
2

2.36

Nectri a

Peni ci l l i um

2

5.16

Issatchenki a

M acrophomi na

9
2

1.01

1.30

Fi l obasi di al es

Ochroconi s

2.34

1.26

Epi coccum

Lasi odi pl odi a

1

4.11

1.73

Emeri cel l a

Gl omus

4

3.66
1.06

Davi di el l a

Euroti um

5.55

10

# is the total samples that contained that specific taxon
* is the total number of taxa present per sample
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15

1.94
10

8.32 19.92 62.26
8

11

3

6.72 31.85 39.03 34.34 53.39
8

15

11

12

13

6.09
8

20

Table 3.7: Fungi sequenced in CF sputa and/or mouth rinse from healthy individuals
Only in CF
Blastocladiella
Bulleromyces
Capronia
Cladophialophora
Debaryomyces
Dipodascus
Eutypella
Exophiala
Fonsecaea
Geotrichum
Hortaea
Metschnikowia
Mucor
Myrothecium
Olphidium
Phialophora
Rhinocladiella
Rhizoctonia
Rhodosporidium
Rhodotorula
Tricholoma
Wangiella

Only in Healthy
Acremonium
Nectria
Alternaria
Nigrospora
Ascomycete
Ochroconis
Atractylodes
Ophiostoma
Aureobasidium
Orpinomyces
Avena
Paecilomyces
Bagnisiella
Peziza
Camplobacter
Phaeosphaeria
Chaetomium
Phoma
Claviceps
Pleosporaceae
Clavispora
Pongo
Conoplea
Pueraria
Corynespora
Pyrenophora
Cystofilobasidium Rhizopogon
Davidiella
Saccharomycetales
Dothideomycete
Schizophyllum
Dothioraceae
Sebacina
Emericella
Sordariomycete
Epicoccum
Stachybotrys
Eurotium
Stemphylium
Filobasidiales
Subulispora
Flammulina
Teratosphaeria
Fusarium
Torulaspora
Gibberella
Tremellales
Gigaspora
Trichaptum
Guignardia
Trichocomaceae
Hormonema
Trichosporon
Issatchenkia
Verticillium
Lasiodiplodia
Wallemia
Lecania
Xylariales
Lewia
Zygosaccharomyces
Macrophomina
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Present in Both
Amanita
Aspergillus
Candida
Cladosporium
Cryptococcus
Glomus
Hypocreales
Penicillium
Pichia
Saccharomyces
Schizosaccharomyces

Figure 3.6: Relationship between CF sputa and healthy oral rinse mycobiomes. A
Sørenson similiarity matrix based on presence/absence of fungi was used with
unweighted pair group average clustering to determine the similarity between CF and
healthy oral fungal communities.

The length of the branch connecting two samples

indicates the dissimilarity between the samples.
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3.5 Discussion
The leading cause of morbidity and mortality in CF is lung disease is a result of
chronic infections. Through the use of molecular techniques, the CF lung was shown to
contain numerous bacteria. Sanger sequencing projects have identified both known and
novel pathogens revealing a complex bacterial community (Bittar et al., 2008; Harris et
al., 2007). Though fungal infections occur in the CF lung, the composition of the
community has not been determined. This study further characterizes the eubacteriome
and mycobiome by identifying organisms using MTPS which has been shown to provide
a more accurate estimation of diversity. In addition, the CF microbiomes from 18 sputa
samples were compared to the communities in healthy oral samples.

3.5.1

MTPS shows greater diversity in the CF bacterial community as

compared to clonal sequencing. The sputa samples were sequenced for bacteria using
the first two hypervariable regions of the 16S rRNA gene. After the data was processed,
every sample was revealed to contain anywhere from four to 16 genera with an average
of 9.6 ± 3.3 genera.

The diversity per patient was greater than the previous

cloning/sequencing study by Bittar et al. (one to 14 with an average 7.2 ± 3.9 species)
(Bittar et al., 2008). The sequences in this study were identified to the genus level or
higher. It is likely that multiple species were present for some genera which would
further increase the diversity of organisms in the lung. As with other 454 sequencing
studies, the estimation of diversity within the CF sputa community was higher than other
sequencing and community profiling methods have shown (Armougom et al., 2009;
Quince et al., 2009; Sogin et al., 2006).
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The number of genera associated with CF dataset was similar to the earlier clonal
sequencing studies. In total, sequences were identified from 34 genera. In comparison,
the Sanger sequencing study using sputa by Bittar et al. identified 53 species from 32
genera (Bittar et al., 2008). The other study by Harris et al. sequenced DNA belonging to
65 species from 35 defined genera and one unidentified organism (Harris et al., 2007).
All three studies highlighted the bacterial diversity within the CF lung.

3.5.2

Common and emerging pathogenic bacteria are present in CF lungs.

CF samples are routinely culture positive for Burkholderia, Haemophilus, Pseudomonas,
and Staphylococcus. Therefore, it was not surprising to identify these pathogens from the
samples (Figure 3.1 and Table 3.2). Of these organisms, Pseudomonas was present in 16
of the 18 samples. This was expected as P. aeruginosa is quite common in adult patients
(Patient-registry, 2008).

Haemophilus and Staphylococcus were present in some

samples. This agrees with epidemiology reports which show that less than 10 % and less
than 40 % of patients at the age of 35 have culturable Haemophilus and S. aureus
infections, respectively (Patient-registry, 2008).

Though Burholderia cenocepacia is

associated with CF, it was surprising to identify Burkholderia sequences in one sample at
a 23.4 % abundance. This individual has never been culture positive for any members of
the Burkholderia cenocepacia complex. Burkholderia infections are extremely difficult
to treat and are considered a poor indication of the prognosis for the patient (Jones et al.,
2004). The identity of the species should be determined using other techniques to ensure
the patient is undergoing proper treatment.
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There are other pathogens that are cultured less frequently from CF sputa (De
Baets et al., 2007; Demko et al., 1998; Goss et al., 2004; Lambiase et al., 2009; Mentasti
et al., 2008; Ojeda-Vargas et al., 1990; Reina et al., 1992; Spicuzza et al., 2009). The
less

prevalent

pathogens

Achromobacter,

Stenotrophomonas,

Proteus,

and

Sphingobacterium were also sequenced from the samples. Of these genera, Proteus was
the only organism to dominate a community (CF4). Pseudomonas was not present in the
sample which may suggest they share similar resources and Proteus outcompeted
Pseudomonas for the niche (Figure 3.1 and Table 3.2).

3.5.3 Oral microbiota may play a role in disease progression. Some sequences
obtained belong to genera that are known to be found in the oral cavity. In this dataset,
Actinomycineae,
Neisseria,

Capnocytophaga,

Porphyromonas,

Lactobacillus,

Prevotella,

Prevotella

Leptotrichia,
dentalis

Fusobacterium,

(formally

Hallela),

Streptococcus, Shuttleworthia, and Veillonella were all identified (Figure 3.1 and Table
3.2). These organisms have been routinely cultured and sequenced in oral samples
(Downes et al., 2002; Jousimies-Somer & Summanen, 2002; Lazarevic et al., 2009;
Williems & Collins, 1995). The oropharyngeal bacteria have also been sequenced in
other CF studies (Bittar et al., 2008; Rogers et al., 2006).
It is difficult to define the role of the organisms in the CF lung without identifying
the species. Each sequenced genus contains species that are part of the normal oral
microbiota and organisms which cause infections in other areas of the body. For example
Neisseria contains two pathogenic species which cause gonorrhea and meningitis
(Liljemark & Gibbons, 1971). It is doubtful the organism is associated with lung disease
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and the DNA from the oral strains were most likely present in the sputa. Leptotrichia is
another genus that contains both nonpathogenic species such as L. buccalis which is part
of the healthy microbiota yet other species have been associated with bacteremia,
neutropenia, and endocarditis (Bhally et al., 2005; Eribe & Olsen, 2008). Some oral
genera such as, Capnocytophaga, Porphyromonas, and Lactobacillus have species that
are known to be pathogenic in the human oral cavity but an association with the lung has
not been established (Bunyaratavej, 2003; Cannon et al., 2005; Geisler et al., 2001).
Studies are beginning to make connections between oral flora and lung health.
Certain oral bacteria are present more often in those suffering from asthma and chronic
obstruction pulmonary disease (Arbes et al., 2006; Deo et al., 2009). It is has been
proposed that pneumonia or ventilator-associated pneumonia is partly attributed to oral
bacteria and proper oral hygiene in nonambulatory patients will reduce the risk of
infection (Bahrani-Mougeot et al., 2007; Paju & Scannapieco, 2007; Scannapieco, 2006).
In addition, Capnocytophaga gingivalis, an oral microbe, was isolated from
bronchoalveolar lavage (BAL) fluid of a patient with pneumonia (Geisler et al., 2001).
Thus, it is possible for oral bacteria to reside in the lungs.
Recently, oral microbes belonging to Streptococcus, Actinomyces, Veillonella,
and Prevotella have been shown to colonize the oral cavity and the lungs (Hilty et al.,
2010; Lazarevic et al., 2009; Mabeza & Macfarlane, 2003; Shah et al., 2008; Sibley et
al., 2008). Prevotella and Veillonella have recently been isolated from the lower lungs of
healthy individuals disproving the opinion that the lower lung is sterile (Hilty et al.,
2010). Oral microbiota has also been attributed to lung infections. Veillonella has been
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associated with chronic anaerobic pneumonitis in a non-CF individual (Shah et al., 2008).
Actinomyces also causes pulmonary actinomycosis (Mabeza & Macfarlane, 2003).
It could be hypothesized that certain species within a genus are a part of the
normal lung microbiota while others are pathogens. In addition, it is also likely an
organism can become pathogenic if certain conditions are present. This has recently
shown true for Streptococcus milleri. The oral microbe has been cultured from the CF
lung and shown to be pathogenic when present in high amounts (Sibley et al., 2008). It is
also possible the organism contributes to the disease through interactions with known
pathogens. For example, a strain of oral Streptococcus can induce a positive regulation
of virulence factors in P. aeruginosa (Duan et al., 2003). Virulence factors are known to
help P. aeruginosa establish an acute infection in the CF lung (Goodman et al., 2004).
Understanding the role of oropharyngeal bacteria in lung progression may lead to novel
treatment methods.

3.5.4

Rarely cultured bacteria are readily identified using molecular

methods. There were a number of sequence reads corresponding to organisms that are
rarely cultured but identified in molecular studies. In this study, two samples contained
Campylobacter sequences at low abundances (1.03 and 1.22 %) (Figure 3.1 and Table
3.2). Though this genus is not associated with lung infections, it has been previously
identified in a CF sample based on a band in a T-RFLP profile (Rogers et al., 2003).
However, the organism was never sequenced from the sample (Rogers et al., 2003). It
has been sequenced from healthy oral samples (Keijser et al., 2008).
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Eikenella, identified in this study in one sample, is a commensal bacterium in the
mouth and upper respiratory system (Figure 3.1 and Table 3.2). It can cause lung
infections; although, to date it has not been associated with CF patients (Hoyler &
Antony, 2000).
Gemella, another anaerobic bacterium, was present in eight samples (Figure 3.1
and Table 3.2). Certain species are opportunistic pathogens and have been associated
with endocarditis and isolated from lung abscesses (da Costa et al., 1996; La Scola &
Raoult, 1998; Valipour et al., 2005).

This organism has been sequenced from CF

samples and cultured from BAL samples (Bittar et al., 2008; Harris et al., 2007; Tunney
et al., 2008). High concentration of Gemella in the CF lung can lead to exacerbations
(Michael Surette; personal communication)
Eikenella and Gemella may be more prevalent in oral and lung communities than
previously thought. Routine culturing methods for CF samples do not usually include the
anaerobic growth conditions that are required to culture these organisms. A recent study
has shown that with proper culturing techniques numerous anaerobic bacteria in high
numbers can be isolated from the CF lung (Tunney et al., 2008). The significance of
many anaerobes in the lung is unknown. However, as that Gemella can lead to illness,
other anaerobes may also contribute to lung disease.

3.5.5 Unusual organisms present in CF sputa. The most abundant genus in 14
samples was Chryseomonas which is closely related to Pseudomonas (Figure 3.1 and
Table 3.2). Some species such as C. luteola have been reclassified as belonging to the
Pseudomonas genus due to the high degree of similarity between their 16S rRNA gene
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sequence (Anzai et al., 1997). In addition, Ribosomal Database Project II (RDP; Release
10) no longer includes the genus Chryseomonas and species were placed under
Pseudomonas. There is 100 % homology of the full length 16S rRNA gene between P.
aeruginosa, P. flavescens, P. mendocina and Chryseomonas/Pseudomonas luteola. The
MTPS reads were analyzed with RDP II (Release 8) which may have had Chryseomonas
separated from Pseudomonas. Reanalysis with the newer release version is necessary to
determine if the sequences belong to Pseudomonas or a closely related group. If the
sequences are indeed P. luteola then it may be the first report of this bacterium in the CF
lung. The organism is known to cause infections in the eye, brain, and around implanted
devices such as prosthetic valves leading to bacteremia (Casalta et al., 2005; Gaschet et
al., 2009; Uy et al., 2007). Like P. aeruginosa, P. luteola expresses a beta-lactamase
making it more resistant to antibiotics (Doublet et al., 2010). Its ability to colonize
humans and its resistant to antibiotics increases the need to confirm the presence of P.
luteola.
Flavimonas sequences were present in eight samples with a high abundance of
23.1 % in CF2 (Figure 3.1 and Table 3.2). However, the other seven samples were
between one and two percent abundance. This genus was reclassified as Pseudomonas in
RDP II (Release 10) (Anzai et al., 1997). Formerly Flavimonas oryzihabitans, P.
orzihabitans is a rare pathogen but has been implicated in catheter associated infections
(Marin et al., 2000). There is a high homology between the 16S rRNA sequence from
strains of P. orzihabitans and various strains of P. aeruginosa, yet the V1_V2 region of
the gene is not the same between all species which indicates a Flavimonas species was
present. Species-specific PCR could be used to confirm the presence of P. orzihabitans.
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Some sequences were present in very low abundance. Oribacterium was present
in two samples with less than 2 % abundance (Figure 3.1 and Table 3.2). This genus,
discovered in 2004 from sinus pus obtained from a young boy, has not been cultured
from any other source (Carlier et al., 2004). However, it was sequenced from healthy
oral samples (Keijser et al., 2008)
Moryella, present in one sample (2.44 %), contains one species indoligenes which
has only been isolated from three human abscesses (Figure 3.1 and Table 3.2) (Carlier et
al., 2007). This organism has not been well characterized and its relationship to human
lungs and oral cavity is unknown.
Megasphaera sequences were present in two samples in low abundances (Figure
3.1 and Table 3.2). The bacterium is normally associated with the rumens of animals.
Phylogentic analysis of 16S rRNA sequences from uncultured bacteria have shown
Megasphaera-like organisms present in the vaginal and oral cavity (subgingival plaque
and endodontic infections) samples (Marchandin et al., 2003; Spear et al., 2008; ZozayaHinchliffe et al., 2008). In this study, the bacteria are most likely associated with the oral
cavity.
Two other taxa, Schlegellella and Shigella, were identified. Schlegellella spp.
were present in one sample at 7.37 %. This genus contains aquatic bacteria some of
which are associated with hot springs (Chou et al., 2006; Elbanna et al., 2003). Two
samples also had low abundances for Shigella which causes dysentery (Yang et al.,
2005).
Oribacterium, Moryella, Megasphaera, Schlegellella and Shigella sequences were
present in few samples and at low abundances. Their role in the CF lung may be quite
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minor. It is possible that Oribacterium and Megasphaera are from the oral cavity as they
have been sequenced from oral samples or are potentially colonizing the upper
respiratory system. Sequences from Moryella may be a rare member of the eubacteriome
and attempts should be made to isolate the organisms from sputa. Schlegellella and
Shigella sequences are perplexing to find in the CF sputa and could possibly be attributed
to sequencing error. Chryseomonas and Flavimonas are potentially novel bacteria in the
CF lung. These organisms were present in most samples at large abundances indicating
that the organisms were metabolically active. Due to the high 16S rRNA homology, it
should be confirmed that these organisms are not in fact P. aeruginosa.

3.5.6

Identifications above genus level are difficult to interpret. Not all

sequences obtained could be identified to the genus level. Five taxa, Actinomycineae,
Carnobacteriaceae, Coriobacterineae, Micrococcineae, and Propionibacterineae were
identified at high taxonomic levels that contain many environmentally divergent
organisms. It is difficult to conjecture the significance of the taxon in the CF samples.
Actinomycineae sequences may potentially be from common oral bacteria.
Carnobacteriaceae

sequences

may

indicate

the

presence

of

Carnobacterium,

Dolosigranulum, and Granulicatella, organisms sequenced in other CF samples (Bittar et
al., 2008; Harris et al., 2007; Rogers et al., 2009). The suborder Coriobacterineae
contains many organisms that have been isolated from the human oral cavity (Lazarevic
et al., 2009). Micrococcineae is a suborder of Gram-positive organisms mostly found in
soil (Hennessee & Li, 2010). Propionibacterineae is a suborder that contains a diverse
group of bacteria living in dairy products to intestinal tracts of animals (Goldschmidt et
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al., 2009) (Figure 3.1 and Table 3.2). Sequencing the samples again with a different
region of the 16S rRNA gene may provide better resolution of the community for these
genera.

3.5.7

Gender and ethnicity of the host may not affect the bacterial

community. Previous studies and this work has shown that the bacterial communities
are not the same in CF individuals but rather unique (Bittar et al., 2008; Harris et al.,
2007; Rogers et al., 2003; Rogers et al., 2009). It is not known why some CF patients
have diverse communities while others may be dominated by one organism, such as P.
aeruginosa. This study attempted to determine if there was a correlation between the
gender and ethnicity of the host and the bacterial community. Using PCO and the BrayCurtis similarity matrix, it was determined that there was no correlation between the
bacterial community (as a whole) and the host’s gender and ethnicity (separately or
combined) (Figure 3.2). Though this study did not find a link between these factors and
the community, it does not necessarily indicate that gender and ethnicity do not play a
role in the community. A larger sample size is needed to increase the power of statistics.
In addition, other races such as African-American should be added to the analysis.

3.5.8 Healthy and CF bacterial communities are statistically different despite
shared bacteria. The Bray- Curtis similarity matrix calculated from the abundance of
the identified taxa in each CF sputum sample and the healthy oral rinse were used to
determine the similarity between the CF and healthy samples. The PCO analysis of the
CF sputa communities and the healthy oral rinse communities clearly indicates that the
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overall eubacteriomes between the two datasets were different (Figure 3.3). The CF
samples were not as tightly clustered indicating the dissimilarity between CF samples.
The healthy samples were clustered together and away from the CF samples.

The

separation of the two datasets show that the overall bacterial community in CF sputa is
different from the community present in healthy oral rinses, yet there are organisms
common to both groups. Within the communities, 27 taxa were only present in healthy
samples, 12 groups were associated with CF, and 22 taxa were present in both groups
(Table 3.4).

3.5.8.1 CF pathogens mostly absent in healthy eubacteriomes. Twelve
taxa were unique to the CF dataset. It was not surprising to find Proteus, Pseudomonas,
Staphylococcus, and Stenotrophomonas sequences in the CF dataset (Table 3.4). Each
genera contains pathogenic species that have been cultured from the lung (Patientregistry, 2008; Whittier, 2001). Sphingobacterium, an uncommon CF pathogen, was also
unique to the CF samples (Reina et al., 1992). Chryseomonas and Flavimonas, both of
which have been reclassified as Pseudomonas, were not found in the healthy samples
(Anzai et al., 1997).

This further supports the hypothesis that these two taxa are

potentially pathogens.
Shigella which is known to cause dysentery was present in two CF samples (Yang
et al., 2005). It is likely the bacteria were transient members of the oral community or
identified incorrectly due to sequencing error. Lactobacillus, Shuttleworthia, and
Eikenella were not found in any healthy samples which is surprising as they are known to
be associated with the oral cavity (van houte et al., 1972). These groups may have not
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competed well with the rest of the communities in the healthy samples. Moryella was not
present in the healthy oral rinses. This anaerobe may potentially be a rare bacterium in
the lung.

3.5.8.2 CF and healthy samples share bacteria. Twenty-two taxa were
present in both datasets (Table 3.4). Achromobacter, Burkholderia, and Haemophilus are
pathogens routinely cultured from CF patients. Achromobacter sequences were present
in one healthy individual (H22, 21.0 %) (Table 3.3). This organism can cause infections
in non-CF patients and it is possible the healthy individual was actually suffering from an
infection. Burkholderia in a healthy individual (H22, 1.18 %) was unexpected. The
Haemophilus sequences, present in all samples but H3, were most likely from species
that live in the oral cavity (Keijser et al., 2008; Kraut et al., 1972; Sixou et al., 1991). It
is possible the six CF samples with Haemophilus DNA were not from H. influenzae but
rather from the oral species.
The

largest

subset

of

shared

taxa

which

included

Actinomycineae,

Campylobacter, Capnocytophaga, Gemella, Hallella, Fusobacterium, Lepotrichia,
Megasphaera, Neisseria, Porphyomonas, Prevotella, Streptococcus, and Veillonella are
known colonizers of the mouth (Table 3.4). Species identification is needed to establish
if the bacteria is unique to the normal oral sample or shared between the datasets.
Oribacterium was present in both datasets (Table 3.4). The organism is not well
studied but it has been previously cultured from sinus pus and sequenced from healthy
saliva (Carlier et al., 2004; Keijser et al., 2008). Due to its low abundance in samples, it
is doubtful the organism is a major player in the mouth or lung communities.
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Schlegelella sequences were present and this group of bacteria is most often associated
with aquatic environments (Chou et al., 2006). It is likely the organism is not a resident
of the mouth. The taxonomic identification of Carnobacteriaceae 2, Coriobacterineae,
Micrococcineae, and Propionibacterineae sequences are too broad to conjecture a
hypothesis as to their role in the mouth.

3.5.8.3 Bacterial diversity decreased in CF samples. Twenty-seven taxa
were identified in the healthy samples and not in the CF eubacteriomes (Table 3.4). The
diversity of the healthy eubacteriome was much greater than in the sputa. It is not known
if these taxa are a part of the core oral eubacteriome. The significance of the organsisms
may be revealed when the oral core biome is determined. Perhaps in the future, the
composition of the oral community could be used as an indicator of health.

3.5.9 Fungi are prevalent in CF sputa. Through the use of culturing and
species specific PCR, multiple species of Aspergillus and Candida are known to culture
the CF lung (Bakare et al., 2003).

There have also been reports of Scedosporium

apiospermum, Exophilia sp., and Wangiella dermatitidis infections (Defontaine et al.,
2002; Dixon & Polak-Wyss, 1991; Horré et al., 2004). Yet, the mycobiome in the CF
lung has not been characterized. This is the first study identifying fungi in CF sputa.
From the 18 samples, 33 genera were identified (Figure 3.4 and Table 3.5).
Sputum samples contained between 13 and 30 different taxa with an average of 26 ± 3
(Table 3.5). All but one sample (CF7) had more than 24 genera present. These results
highlight a complex mycobiome despite clinical results which report no fungal infections
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in all patients. The majority of the taxa were present in low abundances which may
indicate low levels of growth at the time of sampling. Shifts in the microbiome may
promote growth of fungi which can lead to CF exhaberations. Therefore, it is important
to identify and understand the role of the mycobiome in the CF lung.

3.5.10

Pathogenic fungi undetected by clinicians.

Though the average

diversity of mycobiome appears as large as the eubacteriome, there were few fungi
previously associated with the CF lung present.

Candida albicans sequences were

present in eight samples (1.39 – 5.42 % abundance) (Supplemental Table 3.8). This
species is often ruled as a commensal organism in the mouth. However, antibiotic
treatment can shift the microbiome and cause rampant growth of Candida which leads to
candidiasis. If this was the case in the CF patients, the Candida sequences would most
likely be more abundant.
In addition, Aspergillus terreus (18/18), Aspergillus ustus (18/18), Cryptococcus
neoformans (17/18), Exophilia (17/18) and Wangiella dermatitidis (1/18) sequences were
present in the samples (Supplemental Table 3.8). Though the abundances were low (<
2%), their presence is still cause for concern. These organisms are pathogenic and known
to colonize CF patients.
Pichia (P. anomala, P. membranaefaciens, and Pichia spp) sequences were the
most abundant in all samples except for CF7 (15 - 22 %). Many strains of Pichia are
environmental and clinician would consider it a contaminate if cultured. This reaction is
beginning to change as P. anomala, P. membranefaciens and P. ohmeria have been
shown to be causative agents of opportunistic mycoses. Though other pathogenic species
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were sequenced, the higher abundance of Pichia sequences indicated that this is the
dominant colonizer in the mycobiome.
3.5.11 Environmental fungi abundant in CF sputa. Of the 33 genera present,
the species from 24 genera are most likely environmental contaminates and unassociated
with human mycobiomes (Supplemental Table 3.8). Most of the species sequenced from
the following genera are not associated with humans or known to be human pathogens:
Amanita, Blastocladiella, Bulleromyces, Capronia, Cladosporium, Debaryomyces,
Eutypella,

Glomus,

Geotrichum,

Hortaea,

Hypocrea,

Metschnikowia,

Mucor,

Myrothecium, Olphidium, Penicillium, Phialophora, Rhinocladiella, Rhizoctonia,
Rhodosporidium, Rhodotorula, Saccharomyces, Schizosaccharomyces, and Tricholoma.
These fungi are either mushrooms, household mold, or associated with water, soil, and
plants.
Environmental fungi can cause chromoblastomycosis, which is a fungal infection
of the skin and subcutaneous tissue.

The mycobiome contained four organisms,

Cladophialophora arxii, Cladophialophora devriesii, Phialophora verrucosa, and
Fonsecae pedrosoi which can occasionally cause chromoblastomycosis.
In total, 27 genera identified from the sputa are most likely derived from
consumed food and air. The sequences were present in low abundances which supports
the conjecture that these fungi are transient members of the CF mycobiome.

3.5.12 Gender and ethnicity may not effect fungal community composition.
This study attempted to determine if there was a correlation between the gender and
ethnicity of the host and the fungal community (Figure 3.5).
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Using PCO, it was

determined that there was no correlation between the fungal community (as a whole) and
the host’s gender and ethnicity (separately or combined). As discussed with the bacterial
community, these results do not necessarily indicate that gender and ethnicity do not play
a role in the community. A larger sample size and other races should be added to the
analysis.

3.5.13 Healthy oral cavity contains a diverse mycobiome. Using MTPS,
Ghannoum et al. identified 74 culturable and 11 non-culturable fungal genera
representing a total of 101 species for all 20 participants (Table 3.6 and Supplemental
Table 3.9) (Ghannoum et al., 2010).

Over 60 genera are commonly found in the

environment and not associated with human infections. The reoccurrence of the genera
in multiple patients led the authors to state that the organisms were most likely in the oral
cavity as a result from eating and breathing.
The largest percentage of fungi identified in the mouth rinse samples was
identified as non-culturable fungi. Four pathogenic fungi were present in at least 20 % of
the subjects. Of these pathogens, Candida was present in 75 % of the samples. The
prevalence was much higher than other studies and the authors attributed it to better
technology. Aspergillus, Fusarium, and Cryptococcus sequences were surprising as that
they have never been shown to colonize the mouth. The authors conjectured that the
organisms’ pathogenic behaviors were controlled by other fungi in the mycobiome. The
study determined the mycobiome in the healthy mouth is diverse but the clinical
relevance of the fungi are unknown (Ghannoum et al., 2010).

151

3.5.14 CF sputa and oral rinses contain unique mycobiomes. Caution must be
taken when comparing the CF and healthy mycobiome data sets. The sequences from the
two datasets were not analyzed together as one dataset. The separate analyses may have
led to different identifications for the sequences. In addition, the CF analysis did not
include uncultured fungi, rather if a sequenced was identified as uncultured the next
closest aligned sequence from a cultured organism was used for the analysis.

The

absence of this category in the CF samples skews any abundance-based statistical
analysis. Therefore, the two communities were compared with Sørenson similarity index
based on presence/absence of the genera (Sorensen, 1948). The results were shown on a
dendograph (Figure 3.6). Healthy mycobiomes were more similar to one another than
with the CF communities. This clustering pattern of the samples was attributed to 63
genera only present in healthy samples and 22 genera unique to the CF dataset (Table
3.7). At the species level, C. albicans, an opportunistic pathogen, was the only shared
organism between the two datasets.

3.5.14.1 Pathogenic fungi were present in healthy and CF subjects.
Aspergillus, Candida, Cryptococcus, and Pichia sequences were associated with healthy
and CF individuals.

Of the four species of Candida, C. albicans sequences were

identified in the sputa samples. In addition, Candida was much more prevalent in the
healthy samples. The oral samples contained six Aspergillus species, two Cryptococcus
species and one Pichia species, none of which were present in the CF individuals
(Supplemental Table 3.8 and 3.9). It was unexpected to identify pathogenic fungi in the
healthy mouth. As mentioned by Ghannoum et al., these fungi may be controlled by
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other members of the community preventing them from behaving as pathogens in the
healthy individual.

3.5.14.2 Environmental fungi abundant in both CF sputa and healthy
oral samples but no species are in common. Twenty genera of environmentally
associated fungi were present in the CF samples. In addition, most if not all of the fungi
unique to the mouth mycobiomes were from the environment. No species were present
in both datasets. It is not surprising to find such a small overlap in genera between the
two groups. The participants were from south Florida or Cleveland, Ohio; two entirely
different geographically locations. The individuals were exposed to different fungi and
that is reflected in their mycobiomes. Moreover, subjects from the same environment do
not share all the same fungi. These differences could be attributed to where a person
works or what they eat.

3.5.15 Conclusion. This study addressed the eubacteriome and mycobiome of
the CF lung. Through 454 sequencing, the polymicrobial nature of the CF lung was
explored.

Pathogenic bacteria and microbes associated with the oral cavity were

abundant. Previous studies have shown that sputum is not contaminated by oral bacteria
(Rogers et al., 2006). Therefore, oral bacteria may play a role in the progression of lung
disease. Although the lung and mouth are different environments, the comparison is still
noteworthy, demonstrating the overlap of oral bacteria present in the mouth and the
sputa. The results illustrate the need to understand the role of oral bacteria in the airways.
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South Florida patients also have an extensive fungal community in their sputa.
Although most of the fungi present were attributed to environmental sources, pathogenic
species were present in patients negative for fungal infections.
This sequencing study clearly demonstrates the complexity of the CF
microbiome.

Future work should examine the significance of the members in the

community.
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Supplemental Table 3.8: Frequency distribution (%) of fungal species present with at
least 1 % abundance in the CF sputa mycobiome
Sam ples

CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF11 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19
1.1

Amani ta phal l oi des
Aspergi l l us terreus

1.0

1.4

1.3

1.5

1.3

1.4

1.1

1.4

1.3

1.1

1.3

1.5

1.2

1.1

#
1

1.3

1.1

16

Aspergi l l us ustus

1.1

1.5

1.3

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Bl astocl adi el l a emersoni i

1.0

1.4

1.3

1.6

1.3

1.4

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Bul l eromyces al bus

1.1

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

3.3

4.8

Candi da al bi cans

1.5

1.3

5.4

5.0

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

4.5

1.8

5.2

1.4

8
0

Candi da dubl i ni ensi s
Caproni a acuti seta

1.1

Caproni a coronata

1.4

Caproni a epi myces

1.1

1

Caproni a pi l osel l a

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Caproni a pul cherri ma

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Cl adophi al ophora arxi i

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Cl adophi al ophora devri esi i

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Cl adophi al ophora sp.

1.4

1

Cl adospori um cl adospori oi des

1.3

1

Cl adospori um macrocarpum

1.3

Cl adospori um sp.

2.8

Cl adospori um tenui ssi mum

1.4

Cryptococcus neoformans

1.1

1
1.0

2
1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Debaryomyces hanseni i

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Di podascus al bi dus

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Eutypel l a vi ti s

1.0

Exophi al a sp.

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1

Fonsecaea pedrosoi

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Geotri chum candi dum

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Gl omus mosseae

1.1

Hortaea wernecki i

2.8

Hypocrea koni ngi i

1.1

2.2

1.1

1.1

Hypocrea rufa

1.1

2.2

1.1

1.1

M etschni kowi a bi cuspi data

1.0

1.4

1.3

1.5

1.3

1.4

1.4

1.3

1.6

1.3

1.4

1.3

2

1.2

1.0

6

1.2

1.0

0

Hypocrea muroi ana

M ucor racemosus

1.0

M yrotheci um atrovi ri de

1.1

M yrotheci um ci nctum

2.3

1.5

6

1.1

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.1

1.4

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.2

1.0

2.3

2.0

1.3

1.3

2.2

1.1

1.1

0.8

4.6

2.3

2.3

1.7

2.0

0.3

1.8

1.1

8

2.1

12

M yrotheci um i nundatum

1.1

2.2

1.1

1.1

1.1

1.0

1.1

7

M yrotheci um l eucotri chum

1.1

2.3

1.2

1.1

1.2

1.0

1.1

7

M yrotheci um rori dum

4.3

2.8

9.0

4.5

4.4

3.2

3.9

4.6

4.1

3.6

3.9

M yrotheci um verrucari a

2.2

1.4

4.5

2.3

2.2

1.6

2.0

2.3

2.1

1.8

2.2

Ol pi di um brassi cae

1.1

1.3

1.3

1.3

1.3

1.1

1.3

1.2

1.7
1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.5

1.1

13

1.3

17

11

Paracentrotus l i vi dus

1.1

1.5

1.3

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Peni ci l l i um argi l l aceum

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Peni ci l l i um frei i

1.1

1.5

1.3

1.6

1.3

1.5

Phi al ophora sp.

3.2

1.7

2.2

1.7

2.7

1.9

5.4

1.3

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.3

1.8

17

3.5

1.9

3.5

2.9

3.3

1.8

3.5

3.2

3.1

3.2

1.9

18

Phi al ophora verrucosa

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Pi chi a anomal a

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Pi chi a membranaefaci ens

6.2

8.6

7.9

9.3

7.7

8.6

5.5

6.8

8.2

7.7

7.9

7.7

8.7

7.5

6.4

7.6

7.0

7.8

18

Pi chi a sp.

8.3 11.4 10.5 12.3 10.3 11.4

7.3

9.1 10.9

10.3

10.5

10.2

11.7

10.0

8.5

10.2

9.4

10.3

18

Rhi nocl adi el l a atrovi rens

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Rhi nocl adi el l a phaeophora

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

14.8 19.5 17.8 21.0 17.6 19.3 13.2 16.3 18.4

18.5

18.1

17.9

19.5

18.0

14.7

18.1

16.5

17.3

18

Rhodospori di um torul oi des

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

Rhodotorul a gl uti ni s

1.1

1.5

1.4

1.6

1.3

1.5

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.1

0.3

8

Rhi zoctoni a sp.

8.2

Saccharomyces cerevi si ae
Schi zosaccharomyces fi mi col a

1.1

Schi zosaccharomyces pombe

2.2

3.0

2.7

3.2

2.6

2.9

Schi zosaccharomyces scl eroti orum

1.1

1.5

1.4

1.6

1.3

1.5

2.2

3.0

2.7

3.2

2.6

2.9

37

38

36

40

37

Tri chol oma matsutake
Wangi el l a dermati ti di s
Count*

2.2
1.9

1.1

1.1

1.1

1

1.0

2.5

2.8

2.6

2.7

2.6

3.0

2.6

2.3

2.6

2.5

2.7

18

1.2

1.4

1.3

1.3

1.3

1.5

1.3

1.1

1.3

1.2

1.3

17

1.9

2.5

2.8

2.6

2.7

2.6

3.0

2.6

2.3

2.6

2.5

2.7

18

15

45

38

45

41

39

38

45

48

40

43

37

1.38
54

1

# is the total samples that contained that specific taxon
* is the total number of taxa present per sample
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Supplemental Table 3.9: Frequency distribution (%) of fungal species present with at
least 1 % abundance in the healthy oral rinses mycobiome
Organism
Alternaria sp.
Alternaria tenuissima
Alternaria triticina
Amanita bisporigera
Ascomycete sp.
Aspergillus amstelodami
Aspergillus caesiellus
Aspergillus flavus
Aspergillus oryzae
Aspergillus penicillioides
Aspergillus ruber
Aspergillus sp.
Atractylodes macrocephala
Aureobasidium pullulans
Avena fatua
Bagnisiella examinans
Campylobacter concisus
Candida albicans
Candida khmerensis
Candida metapsilosis
Candida parapsilosis
Candida sp.
Candida tropicalis
Chaetomium globosum
Cladosporium cladosporioides
Cladosporium herbarum
Cladosporium sp.
Cladosporium sphaerospermum
Cladosporium tenuissimum
Claviceps purpurea
Clavispora lusitaniae
Conoplea fusca
Corynespora cassiicola
Cryptococcus cellulolyticus
Cryptococcus diffluens
Cryptococcus sp.
Cystofilobasidium lari-marini
Davidiella tassiana
Dothideomycete sp.
Dothioraceae sp.
Emericella rugulosa
Eurotium amstelodami
Eurotium sp.
Filobasidiales sp.
Flammulina velutipes
Fusarium culmorum
Fusarium oxysporum
Fusarium poae
Fusarium sp.
Gibberella sp.
Gigaspora margarita
Glomus fulvum
Glomus mosseae
Glomus sp.
Guignardia mangiferae
Guignardia sp.
Hormonema sp.
Hypocreales sp.
Issatchenkia orientalis

H1 H2
2.0

H3

H4

H5

H6

H7

H8

H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20
1.1

1.0
1.9
5.0
3.0

2.3

2.2

2.4
9.5
3.0
1.0

1.1
3.3
6.0

1.0
2.3
3.0 29.0
7.2
2.3

2.6
6.3

4.6

2.0
1.9

10.9

11.8
5.0

2.8

4.0
6.0

4.5

6.4

8.0
2.5
9.0 10.4

7.8 10.7
1.3

2.4

3.2

14.2

14.1

2.0

2.4
2.7

1.0
1.0

4.7

2.5

1.2

1.6
4.5

1.3 46.8
1.8
1.3

1.2
2.8 26.1

32.8

5.7

8.4

2.3 11.5 11.8
1.1

1.1

8.3
1.1

1.3

2.4

3.6

1.6
1.0

2.8

1.2
1.1
2.5
3.4
2.2
3.8
3.3
1.8
3.6
1.1
10.7

1.5
3.0

1.1
9.6

4.1

1.7
1.2

1.9

1.3

4.0

5.3

4.2

1.3

1.4
15.5

1.1
8.8
1.9

4.3
3.1

4.0

1.1
1.1

2.1
1.7

1.6

3.8

16.9

1.2
1.8
5.4

13.1

2.0
7.1
3.4
1.7
1.0

1.0

1.2
5.2

1.6
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2.3

#
1
2
1
1
2
2
1
1
1
1
2
6
2
10
1
1
1
8
1
1
3
1
2
1
10
2
9
1
1
1
1
1
1
1
1
1
1
1
3
9
2
2
5
0
1
2
1
1
3
4
1
1
3
1
1
1
2
2
1

Organism
H1 H2
Lasiodiplodia theobromae
2.8
Lecania gerlachei
Lewia infectoria
M acrophomina phaseolina
3.5
Nectria cinnabarina
Nigrospora oryzae
Ochroconis gamsii
3.2
Ophiostoma floccosum
Ophiostoma pulvinisporum
Orpinomyces sp.
Paecilomyces lilacinus
Penicillium brevicompactum
Penicillium glabrum
Penicillium sp.
1.8
Penicillium spinulosum
Peziza violacea
Phaeosphaeria nodorum
Phoma foveata
Phoma plurivora
Pichia guilliermondii
Pleosporaceae sp.
8.4
Pongo abelii
Pueraria montana
Pyrenophora tritici-repentis
Rhizopogon sp.
Saccharomyces bayanus
Saccharomyces cerevisiae
Saccharomyces ellipsoideus
Saccharomycetales sp.
Schizophyllum commune
Schizosaccharomyces japonicus
20.0
Schizosaccharomyces pombe
Sebacina incrustans
1.8
Sordariomycete sp.
1.7
Stachybotrys chartarum
Stemphylium solani
Subulispora britannica
Teratosphaeria sp.
Torulaspora delbrueckii
Tremellales sp.
Trichaptum abietinum
Trichocomaceae sp.
Trichosporon loubieri
Non-Cultivable ascomycete
4.1 2.1
Non-Cultivable basidiomycete
Non-Cultivable ectomycorrhizal
Non-Cultivable endophytic
1.1 2.5
Non-Cultivable eukaryote
2.4
Non-Cultivable fungus
5.1
Non-Cultivable glomeromycete
Non-Cultivable Glomus
Non-Cultivable Leptosphaeriaceae
9.6
Non-Cultivable soil
1.4 11.7
Non-Cultivable Unknown
4.4 1.5
Verticillium sp.
Wallemia sebi
Xylariales sp.
7.7
Zygosaccharomyces pseudorouxii
Zygosaccharomyces rouxii
Count*
19 21

H3

H4

H5

H6

H7

H8

H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20
4.4

1.1

2.2
1.0
1.2

48.4
7.6
40.0
1.3

2.1
1.6
1.8
11.1
1.6
3.7
1.5
2.2
1.7
1.1
1.1
4.0
1.4
2.1
6.1
3.5
43.2
2.4

8.9
5.6 13.7 1.1 12.4 6.0
14.7

2.1
8.0

2.3
1.1 2.4 25.8
1.3
1.8 18.1 0.0 0.0 1.4
7.3 0.0
2.6
2.2

1.1
1.3
6.2

1.3

1.2
6.3
2.5
17.1 1.1 17.7
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Chapter 4

“SPR Detection of Bacteria Associated with the Cystic Fibrosis Lung”
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4.1 Abstract
Traditional bacterial identification systems use phenotypic and biochemical
analysis of the organism and/or antibody-based detection systems like ELISA. Antibodyantigen interactions can be observed on a nanoscale level using more sensitive techniques
such as surface plasmon resonance (SPR). This technique detects bacteria by indirectly
monitoring the oscillations of electrons that exist at the surface of an antibody-coated
gold sensor chip. As a result of antibodies capturing bacteria, electron oscillations will
change which is detectable by measuring the angle of light that is absorbed by the
electrons. This study proposed to detect the interactions of Pseudomonas aeruginosa and
Staphylococcus aureus with their cognate antibodies using SPR. The immunosensor
detected P. aeruginosa and S. aureus at concentrations of 107 to 108 colony forming units
per milliliter (cfu/mL). The sensitivity of the P. aeruginosa immunosensor was increased
by a factor of ten when bovine serum albumin (BSA) was not added to the sensor. The
immunosensor was specific showing only a minimum reaction to Escherichia coli at 108
cfu/mL. Optimization of the immunosensor assembly will increase the sensitivity and
accuracy of the biosensors.
Keywords: Surface plasmon resonance, Pseudomonas aeruginosa, Staphylococcus
aureus

Abbreviations: SPR, Surface Plasmon Resonance; SAM, Self-Assembled Monolayer,
BSA, Bovine Serum Albumin; cfu, colony forming units; cystic fibrosis (CF); phosphate
buffer saline (PBS); overnight (ON)
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4.2 Introduction
Per every million people, 2.4 people die in the United States as a result of a
bacterial infection (World Health Organization, 2008). Despite being an industrialized
nation, the US is ranked 4th (for bacterial associated death) out of the 47 countries that
give health statistics to the World Health Organization. Many bacterial infections are
treatable. If not treated, an infection can lead to sepsis and ultimately death. An accurate
and timely diagnosis is key in eliminating the bacterial infection and preventing the
spread of the organisms to uninfected people.
Identification of the infecting organism is critical for successful treatment.
Culturing for phenotypical and biochemical assays is the mainstay in most clinical
laboratories. Using various media, the sample from the infected person is inoculated
onto plates or broth and then the organism is allowed to grow for a period of time
(Murray & Baron, 2007). Based on the phenotype of the organism and the media it is
grown on, an identification of the bacteria is made.
biochemical tests are performed.

Besides visual phenotypes,

Currently, multiple biochemical tests can be

performed simultaneously using diagnostic kits such as the BioMérieux API system or
the VITEK 2 by BioMérieux (Bosshard et al., 2006). These products identify bacteria
within two to 24 hours.

Both of these assays are not error-proof leading to

misidentifications (Bosshard et al., 2006). The accuracy of the VITEK2 ID-GNB card
(BioMérieux, Marcy l'Etoile, France) has been examined (Bosshard et al., 2006; Brisse
et al., 2002; O'Hara & Miller, 2003). This system accurately identified 93.0 % of 414
clinically relevant enteric bacteria strains and 95.1 % of the 103 glucose-fermenting and
nonfermenting nonenteric strains (O'Hara & Miller, 2003). Another study compared the
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VITEK2 ID-GNB card (BioMérieux) and API 20 NE (BioMérieux) with sequencing
data from the same 107 isolates (Bosshard et al., 2006). The API system was able to
identify 54 % of the isolates to species level, 7 % to the genus level and failed to
identify 39 % of the isolates. Of the later, 26 % belonged to species that were not in the
API database (Bosshard et al., 2006). The VITEK 2 system had similar results whereas
53 % of the isolates were identified to species level, one percent to genus level, and 46
% (49 isolates) were unidentifiable. Of the 49 isolates, 39 belonged to a species not
represented in the VITEK 2 database (Bosshard et al., 2006). The VITEK has also been
compared with the BD Phoenix (BD Diagnostic System, Sparks, MD) to determine the
accuracy in identifying isolates of the B. cenocepacia complex, a known CF pathogen
(Brisse et al., 2002). The study determined an overall identification rate of 50 % for
both systems (Brisse et al., 2002). The accuracy of commercial systems varies greatly
but no system has a 100 % identification rate. Misidentification can lead to improper
treatment which can result in poor patient outcome and lead to a rise in antibiotic
resistance (Levy, 2000).
Pathogens can also be identified based on antibody – antigen interactions using an
enzyme-linked immunosorbent assay (ELISA). There are multiple ELISA protocols but
the original method begins by attaching capture antibodies to a polystyrene plate. Then,
the sample is placed into the system and if present the bacteria will bind to the antibody.
The antibody-antigen interaction is detected using either chromogenic or fluorogenic
methods (Engvall & Perlmann, 1971). The ELISA is not portable but still useful when
analyzing clinical samples.
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Rapid and portable diagnostic systems have been developed based on the concept
used in ELISA. One category of antibody-based detection systems are referred to as
immunochromatographic tests. One of the most well known examples of this type is the
at home pregnancy test (Vaiukaitis et al., 1972). The dipstick is coated with mouse
monoclonal antibodies that recognize the human chorionic gonadotrophin molecules that
are present in urine when pregnant (Vaiukaitis et al., 1972). The molecule binds to the
antibody and the complex moves down the strip where it is ensnared by polyclonal
antibodies which bind to the human chorionic gonadotropin. At the location of the
second reaction are dye molecules which undergo an enzymatic reaction to produce the
colored line (Vaiukaitis et al., 1972). Similar detection systems have been developed for
diphtheria (Engler et al., 2002), HIV (Esfandiari et al., 2004), Mycobacterium
tuberculosis (Esfandiari et al., 2004), vaginal Candida species (Matsui et al., 2009), and
Escherichia coli O157:H7 (Park et al., 2008). These systems can use various bodily
fluids such as urine and sera as well as cultured bacteria in liquid solutions.
The newest generation of immunochromatographic tests use nanotechnology.
The secondary capture antibody in these tests have been conjugated with colloidal gold
nanoparticles (Biagini et al., 2006; Chiao et al., 2008; Rong-Hwa et al., 2010; Shyu et
al., 2002). Using lateral flow, the analyte binds to the primary antibody and then moves
towards the labeled secondary antibody forming another complex.

The sandwich

complex flows to the capture pad on the test strip which will turn red when sufficient
nanoparticles accumulate. These tests have been developed to detect bacteria such as
Staphylococcus aureus and numerous toxins such as ricin, botulism, and staphylococcal
enterotoxin B (Biagini et al., 2006; Chiao et al., 2008; Rong-Hwa et al., 2010; Shyu et
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al., 2002). These tests may be the future of diagnostics as that they are rapid, portable,
user-friendly, cost-efficient, and have a long shelf-life (Rong-Hwa et al., 2010).
Antibody-antigen interactions can also be observed with instruments that use
surface plasmon resonance (SPR). The SPR effect is a phenomenon where electrons that
exist at the interface between any two materials oscillate and produce waves (Wood,
1902, 1912). This phenomenon can be used to determine if an antigen binds to an
antibody (Kretschmann & Raether, 1968; Otto, 1968). Using a SPR instrument, light is
passed through a glass chip thinly coated with gold (Figure 4.1). A specific frequency of
light passes into the gold creating an evanescent wave. The wave excites the plasmons
causing them to resonate and form a plasmon wave which travels along the gold film
interacting with the media in contact with the gold. The remaining frequencies of light
are reflected at a specific angle. The angle of the light reflection, which can be measured,
shifts as molecules adsorb onto the surface of the gold (Kretschmann & Raether, 1968;
Schasfoort & McWhirter, 2008).
One specific type of SPR biosensors is an immunosensor which detects
interactions between antibodies and other molecules such as bacteria (Geddes et al.,
1994; Mayo & Hallock, 1989). Essentially, SPR immunosensors detect antigens that
bind to antibodies on the gold sensor by measuring the angle of light reflection
(Kretschmann & Raether, 1968).

SPR immunosensors have been used to identify

Escherchia coli O157:H7 (Fratamico et al., 1998; Meeusen et al., 2005; Oh et al., 2003;
Su & Li, 2005; Subramanian et al., 2006a; Taylor et al., 2005), Vibrio cholera
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Figure 4.1: Surface plasmon resonance phenomenon. Incident light penetrates through a
gold coated glass chip and a specific frequency of light will create an evanescent wave.
This wave excites the plasmons and cause a plasmon wave to propagate along the surface
of the gold. The remaining light is reflected. Adapted from www.icxt.com.
(Jyoung et al., 2006), Salmonella enteritis (Bokken et al., 2003),

Salmonella

typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al., 2004b), Listeria
monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et al., 2005), Yersinia
enterocolitica (Oh et al., 2005), and Campylobacter jejuni (Taylor et al., 2006).
Immunosensors are designed using a layer-by-layer self-assembly method (Cui et
al., 2003). As that the design protocol can vary, the method used in this study is
explained in depth. The immunosensor self-assembly method starts with a glass chip that
is thinly coated with gold on one side. The chip is prepared by soaking it in 11mercaptoundecanoic acid (HSC10H20COOH) or similar alkanethiol solutions to allow a
self-assembled monolayer (SAM) formation. In this case, the gold molecule binds to the
thiol group in 11-mercaptoundecanoic acid. The carbon chain extends from the thiol and
is terminated with a carboxcyclic acid group (Figure 4.2) (Stettner et al., 2009).
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Figure 4.2: Self-assembled monolayer (SAM) formation on a gold coated chip. A gold
sensor chip is immersed in 11-mercaptoundecanoic acid. The thiols bind to the gold
leaving a chain of carbons ending with a carboxycyclic acid group (Chang & Liao,
2008).
After the formation of SAM, chip is placed onto the SPR instrument for layer-bylayer self assembly. The gold sensor is set onto the window of the instrument using a
matching liquid (refractive index = 1.515) to ensure that the refractive index of the sensor
is the same as the glass window (Biosensing Instrument, 2006). The instrument uses
microfluidics which allows a carrier solution to constantly run over the sensor. The
carrier is a reference buffer which establishes the baseline angle of light reflection.
Molecules such as antibodies are injected into a port and carried to the sensor by the
carrier buffer. After the injection is complete, the port closes and the carrier solution
washes away unbound injected molecules. Light is constantly beamed onto the sensor
and reflected as the carrier solution and injected chemicals are delivered to the sensor
(Figure 4.3) (Biosensing Instrument, 2006). The angle of reflection will change as
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Figure 4.3. Schematic diagram of SPR instrument. The carrier buffer and/or injected
chemicals flow into one port, across the gold sensor chip, and then the buffer with any
unbound chemicals exits via the out port.

As the buffer flows, a light source is

continuously
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through process
a prism on
andthe
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the sensor,
gold chip.
is reflected
To begin
the layering
the The
SAMlight
(COOH
groups)and
are
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angle ofusing
reflection
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of reflection is dependent
activated
N-hydroxysuccinimide
(NHS) The
and angle
N-(3-dimethylaminopropyl)-N’on
the molecules binding
to the gold
chip (Biosensing
2006).
ethylcarbodiimide
hydrochloride
(EDC).
The EDC Instrument,
catalyzes the
formation of amide
molecules adsorb onto the gold sensor. In between injections, the carrier/reference buffer
flows over the sensor and the angle will stay constant forming a baseline measurement.
bonds between carboxylic acids and amines. EDC converts the carboxylic acid into a
reactive intermediate (an ester) which can be attacked by amines. The NHS is used to
stabilize the intermediate for a longer period allowing an amide to be formed (Staros et
al., 1986). A solution of Protein G is then injected, and the nitrogen groups on the protein
attack the ester groups forming an amide bond between the carboxylic acid group on the
SAM and the amines on the Protein. Protein G molecules increase the layer of thickness
on the gold sensor which affects the surface plasmons, thereby changing the angle of
reflection. Protein G is added to ensure the antibodies bind in the proper orientation
(Figure 4.4) (Lee et al., 2007; Schmid et al., 2006).
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Figure 4.4. Antibody orientation. Panel A demonstrates antibodies binding to gold in
multiple orientations. Many antibodies bind in an orientation that compromises the
ability of the antibodies to bind to antigens. Panel B shows antibodies in the proper
orientation as a result of the Protein G molecules attached to the gold layer.
Any remaining unbound activated ester groups are deactivated by an
ethanolamine solution. The antibodies are injected and bind to the Protein G molecules
in the proper orientation leaving the antigen binding sites on the antibodies exposed
(Figure 4.3). Antibodies may not have bound to all Protein G molecules leaving Protein
G free to bind to non-selective antigens. To prevent a false-positive reaction, the Protein
G molecules are blocked by bovine serum albumin (BSA) which finishes the layer-bylayer self assembly of the immunosensor. Each addition increases the thickness of the
layer adsorbed to the gold which directly affects the reflection of light. The shifts in
angle of reflection can be measured in real-time (Figure 4.5).
To date, there are no SPR immunosensors for whole cell Staphylococcus aureus
and Pseudomonas aeruginosa, two common opportunistic pathogens that are feared in
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Figure 4.5: The SPR response. Panel A depicts a layer-by-layer self assembled gold
sensor chip on the SPR window. Incident light enters through a prism hitting the gold
sensor. The light is reflected. Panel B is a close up view of the reflected beam of light.
The incident light excited surface plasmons that were in contact with the layers above the
gold film. As a result of the electrons absorbing energy at a particular frequency of light,
the reflected beam has a dark line within it. The angle of the dark line within the beam is
the SPR response and it shifts depending on surface layers above the gold sensor chip.
Panel C is a sensograph. The time and angular shift are measured throughout a SPR
experiment.
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hospitals. S. aureus is a Gram-positive cocci that can be found in the skin flora of
healthy humans (Hartmann, 1978). The bacteria can also cause numerous infections due
to its ability produce virulence factors and toxins (Freer & Arbuthnott, 1982; Jakubicz,
1972; Kapral et al., 1965; Parker, 1924). S. aureus has been associated with a range of
infections from mild acne to life-threatening diseases such as pneumonia and septicemia
(Corner, 1940; Noble, 1998; Olansky & McCormick, 1958; Schneck, 1957).

The

bacteria can also cause respiratory infections in cystic fibrosis (CF) children and recent
research has shown that the bacteria are still present in the lungs of adult CF patients
(Beringer & Appleman, 2000; Kahl et al., 1998; Patient-registry, 2008). In addition, S.
aureus is one of the leading causes of nosocomial infections (Noskin et al., 2005;
Wertheim et al., 2005). These infectious could once be treated with penicillin, but now
the bacteria are resistant to it and other beta-lactam antibiotics (Ashley & Brindle, 1960;
Zetola et al., 2005). The emerging resistant strains of S. aureus make it more of a
challenge to treat a patient thus driving up the cost of treatment (Kim et al., 2001).
P. aeruginosa is a Gram-negative rod-shaped bacterium that is known for its
environmental versatility and ubiquity (lives in water, soil, and in animal tissues) (Ringen
& Drake, 1952; Winslow et al., 1920).

The organism is capable of surviving in

numerous environments due to its ability to metabolize a vast array of carbon sources
(Conrad et al., 1979; Haynes, 1951; Niel, 1943; Ringen & Drake, 1952). P. aeruginosa
produces numerous virulence factors and toxins which enable it to infect plants, animals,
and humans that are either immunocompromised, have burn wounds or have CF
(Caldwell et al., 2009; Doggett et al., 1964; Elrod & Braun, 1942; Finck-Barbançon et
al., 1997; Griffith et al., 1989; Lowbury & Fox, 1954; Niilo, 1959; Wretlind &
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Pavlovskis, 1981; Young, 1980). Up to 80 % of all CF adults have a P. aeruginosa lung
infection (Beringer & Appleman, 2000; Patient-registry, 2008). It is also one of the
leading pathogens in nosocomial infections (Aloush et al., 2006). P. aeruginosa is
intrinsically resistant to many antibiotics and is capable of acquire resistance to other
drugs over the course of the infection (Fullbrook et al., 1970; Li et al., 1994; Li et al.,
1998).
Both S. aureus and P. aeruginosa cause infections which can be difficult and
expensive to treat. Identifying the agents of infection is the first step in treatment. In this
study, SPR biosensors will be developed using Staphylococcus-specific and P.
aeruginosa-specific antibodies. The corresponding bacteria will be detected based on the
change of light refraction that is measured when the bacteria binds to the antibody that is
fixed on the gold sensor.

4.3 Materials and methods
4.3.1 Bacterial isolates. Escherichia coli DH5α (New England Biolabs, Ipswich,
MA), Pseudomonas aeruginosa PAO1 (Holloway & Morgan, 1986), and Staphylococcus
aureus ATCC 17672 were grown overnight (ON) at 37 °C in Luria Bertani (LB) broth
(10 g/L tryptone, 5g/L yeast extract, 5 g/L NaCL). One milliliter of the ON was placed
into 5 mL of fresh LB and grown until an optical density at 600 nm (OD600) was between
0.4 and 0.5. The cultures were pelleted by centrifugation at 16.6 X g for 10 minutes at 4
°C. The pellets were resuspended in 1X phosphate buffer saline (PBS) pH 7.0. The
samples were pelleted and washed two more times with 1X PBS. The pellets were
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resuspended in the PBS to achieve a final concentration of 108 colony forming units per
milliliter (cfu/mL).

4.3.2 Determination of bacterial concentration. For each isolate, the washed
pellet was resuspended in 10 mL of phosphate buffer saline (PBS). Serial dilutions were
made up till 106 dilution factor. One hundred microliters for the 104, 105, and 106
dilutions were plated on LB plates. The plates were grown ON at 37 °C. Colonies were
counted the next day to determine the colony forming units per milliliter (cfu/mL) for
each isolate at its particular OD600. Based on the cfu/mL determination, a specific
amount of 1X PBS was added to each pellet to make a 108 cfu/mL solution. Bacteria for
each experiment was then grown to the OD600 reading used in the cfu/mL calculation so
that fresh bacteria could be used in the SPR experiments.

4.3.3 Reagents and instrumentation. The Biosensing Instrument 3000 and the
associated Biosensing software and gold sensor chips (Biosensing Instrument, Tempe,
AZ) were used for all experiments. All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO) unless otherwise noted.

The antibody that was reactive with P.

aeruginosa was rabbit polyclonal IgG anti-P. aeruginosa whole cell (ABCAM ab68538;
Abcam, Cambridge, MA). Anti-Staphylococcus enterotoxin B, polyclonal was used to
detect S. aureus (Thermo Scientific PA17248; Thermo Fischer Scientific, Waltham,
MA).
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4.3.4 Preparation of gold sensor chip. Gold sensor chips were immersed in 50
mM 11-mercaptoudecanoic acid overnight at 4 °C to allow self-assembled monolayer
(SAM) formation. The chips were washed with deionized water and dried.

4.3.5 Immobilization of antibodies. The SAM modified gold sensor was placed
onto the window of the instrument using a matching liquid (refractive index = 1.515). To
allow for baseline stabilization, the reference solution which was 1X PBS (pH 7.0) was
allowed to flow through the system at a flow rate of 0.150 mL/min. The flow rate was
decreased to 0.050 mL/min once a baseline was established. The flow injection method
was used throughout all experiments. The SAM was activated by injecting 125 cc of a
1:1100 mM N-hydroxysuccinimide (NHS) and 400 mM N-(3-dimethylaminopropyl)-N’ethylcarbodiimide hydrochloride (EDC). The reference solution was allowed to run for
60 sec between injections to flush out the system. To increase the directional binding of
the antibody, Protein G was coupled to the activated SAM by injecting 125 cc of 10
µg/mL Protein G in 1X PBS (pH 7.0) into the instrument. Any remaining unbound
activated ester groups were deactivated by 125 cc 1 M aqueous ethanolamine solution
(pH 8.0).

Sixty seconds later, 125 cc of 1 mg/ml antibody was added. The Protein G

molecules that have no attached antibodies were blocked with 125 cc of 1 % BSA
(depending on the experiment). Excess BSA was removed from the sensor by running
the reference buffer for 60 seconds. All injection times were 10 µL/min except for the
antibodies and bacteria which were set at 5 µL/min.
The assembly process was monitored continuously by measuring the angle of
light reflection (SPR response) in mDegrees. The data was plotted on to a sensograph
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with time in seconds on the x-axis versus resonance in mDegrees on the y-axis. Peaks in
the sensograph indicated changes in SPR response caused by the injected chemicals
coming into contact with the functionalized gold surface. Unbound molecules were
washed away by carrier buffer causing the peak to decrease and a new baseline to form
(Figure 4.6).

The difference between post-injection and pre-injection baselines

(difference in angles) indicated the change in plasmon resonance caused by molecules
adsorbing onto the gold layer (Figure 4.6). The angle of light reflection shifted as each
compound was added to the sensor.

Figure 4.6: A representative sensograph. A theoretical SPR sensograph is depicted with
time in seconds on the x-axis and angle reflection on the y-axis. Baseline reflections are
stable in between injections. Injections cause a change in reflection. The reference
buffer washes away the excess injected chemical. The adsorption of the chemical on to
the gold layer is determined by subtracting the pre-injection baseline reference angle
from the post-injection baseline reference angle i.e. Baseline Reference Buffer 2 –
Baseline Reference Buffer 1.
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Throughout the experiment, the carrier buffer of PBS continuously flowed past
the sensor. The SPR response to the reference buffer forms a baseline measurement
which is recorded in a separate sensograph. The sensograph produced from the injected
compounds is subtracting from the reference sensograph, thereby removing background
noise. The resulting normalized data is plotted on another sensograph and analyzed using
the Biosensing Real Time Data Analysis software (Biosensing Instrument, Tempe, AZ).

4.3.6 Detection of S. aureus and P. aeruginosa. The prepared immunosensors
were tested using 125 cc of bacteria at difference concentrations. Bacterial concentrations
ranged from 106 to 108 cfu/mL for S. aureus and 105 to 108 cfu/mL for P. aeruginosa.
SPR was used to detect the interaction between S. aureus and anti-Staphylococcus
antibodies, and P. aeruginosa and anti-P. aeruginosa antibodies.

4.3.7 Determination of the sensitivity for the P. aeruginosa biosensor.
second immunosensor was developed for P. aeruginosa.

A

In the previous experiments,

BSA was used to decrease non-selective binding. However, BSA is a large molecule that
increases the thickness of the layers on top of the gold surface. SPR is less sensitive
when the layers above the gold surface becomes too thick. In addition, the instrument
cannot detect SPR when the distance between the bacteria and the gold becomes too
great. Thus to increase the sensitivity of the sensor, BSA was not added during the
assembly process. The immunosensor was tested using P. aeruginosa concentrations
from 105 to 108 cfu/mL.
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4.3.8

Determination of the specificity for the P. aeruginosa sensor.

To

determine if BSA was necessary to reduce non-selective binding, another P. aeruginosa
biosensor was developed without BSA. The sensor was first tested with 108 cfu/mL of E.
coli. After the reference buffer washed away any unbound bacteria, the sensor was tested
using 107 and 108 cfu/mL of P. aeruginosa.

4.4 Results
In order to detect the presence of bacteria in a solution, immunosensors were
manufactured using a layer-by-layer self assembly protocol. The immersion of the chip
in 50 mM 11-mercaptoudecanoic acid allowed self-assembled monolayer (SAM)
formation of thiols which were activated using a 1:1 ratio of NHS:EDC. The generated
reactive ester groups formed amide bonds with Protein G molecules. The antibodies
were then anchored to the chip via Protein G. Free Protein G molecules were blocked
with BSA to finish the assembly of the sensor. The SPR instrument monitored each
molecule absorbing on to the gold layer in real time. The molecules absorbed onto the
gold increased the thickness of the layer on top of the gold surface changing the plasmon
resonance which affected the angle of light reflection. After each chemical was injected
into the carrier solution, the change in SPR angle (mDegrees) was determined. The
baseline between peaks on the sensograph indicated the angle of incident for the
reference or carrier buffer flowing pass the sensor which is dependent on the thickness of
the layer above the gold chip. The peaks represented the chemical injected into the
carrier solution flowing over the sensor. The angles of reflection within the peak area do
not indicate molecules adsorbing onto the gold. Rather, adsorption of molecules onto the

175

gold sensor is determined by the difference in baseline measurements before and after
injection (Figure 4.6).

4.4.1 Self assembly of S. aureus immunosensor.

In the S. aureus

immunosensor, the reference buffer flowing past the sensor gave a baseline angle of light
incident at 37.02 mDeg (Figure 4.7). This angle shifts within a degree or two as the
buffer flows above the sensor due to the limitation of the SPR instrument. The injection
of NHS:EDC caused the reflection to change 41.9 mDeg in comparison to the initial
baseline (Figure 4.7). The reference buffer washed away unbound molecules. A solution
of Protein G was injected and the reflection changed 47.523 mDeg (Figure 4.7). The
reference buffer continued to run as the solution of the anti-Staphylococcus antibodies
was injected. The SPR response was an angle 100.63 mDeg of light reflection (Figure
4.7). Unbound 1 % BSA was injected to block free Protein G molecules. The angle of
incidence was changed to 187.29 mDeg (Figure 4.7).

4.4.2 Detection of S. aureus. The layer-by-layer self assembled immunosensor
was used to detect various concentration of S. aureus. The sensor was first tested with
106 cfu/mL of S. aureus in PBS (Figure 4.7). The peak in the sensogram after the
injection showed a 22.36 mDeg angle of reflection. Baseline measurements before and
after injection were not different; there was no change in light reflection (Figure 4.7).
There was a slight change in the angle of light reflection for 107 cfu/mL at 16.73 mDeg.
However, a more pronounced reflection was observed for 108 cfu/mL at 78.27 mDeg.
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Figure 4.7: Detection of S. aureus using an immunosensor. ∆y is the difference in angle of light reflection between post-injection
and pre-injection. The sensor was self assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM layer
on the gold chip. Ethanolamine deactivated any unbound ester groups. The anti-Staphylococcus antibodies were injected at 1800
seconds and a change in angle reflection was seen. Injected BSA was used to block free Protein G. Solutions of S. aureus at 106,
107, and 108 cfu/mL were injected into the SPR instrument. The angles of light reflection changed at 107 and 108 cfu/mL
injections.

4.4.3 Detection of P. aeruginosa. The 107 cfu/mL solution of P. aeruginosa
increased the angle of reflection 16.15 mDeg from the pre-injection (Figure 4.8). The
first injection of the 108 cfu/mL solution contained an air bubble which flowed over the
sensor changing the refractive index of the sensor interfering with the plasmon waves
(Figure 4.8). The next injection increased the angle by 36.34 mDeg as compared to the
pre-injection measurement. The same concentration was injected one more time showing
a reflection difference of 80.77 mDeg (Figure 4.8).

4.4.4 P. aeruginosa immunosensor used for sensitivity tests.

An

immunosensor was developed to determine if sensitivity of the SPR response could be
increased in the absence of BSA. The baseline of the thiol gold coated sensor was
established. The injection of NHS:EDC changed the angle of light reflection 150 mDeg
(Figure 4.9). Protein G injection caused a 131.70 mDeg change in angle (Figure 4.9).
The ethanolamine injection decreased the incident angle below the pre-injection baseline
by 131.46 mDeg (Figure 4.9). The injection of anti-P. aeruginosa antibodies changed the
light reflection 165.48 mDeg (Figure 4.9). The 105 cfu/mL of P. aeruginosa in PBS was
washed over the immunosensor causing a peak in the sensograph.

There was no

difference in angle between the pre and post-injection. Angles of reflection for 106, 107,
and 108 cfu/mL were 13.14, 30.64, and 127.62 mDeg, respectively (Figure 4.9).
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Figure 4.8: P. aeruginosa detection using an immunosensor. ∆y is the difference in angle of light reflection between postinjection and pre-injection. The sensor was self assembled by injecting NHS:EDC which allowed the Protein G to bind to the
SAM layer. Ethanolamine deactivated any unbound ester groups. The anti-P. aeruginosa antibodies were injected at 4300
seconds which shifted the angle of reflection. Injected BSA was used to block free Protein G. Solutions of P. aeruginosa at 106,
107, and 108 cfu/mL were injected into the SPR instrument. The first 108 cfu/mL injection contained an air bubble which caused
error in the SPR response. The solution was injected two more times. The 107 and both 108 cfu/mL solutions were detected.
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Sensitivity of the P. aeruginosa immunosensor. ∆y is the difference in angle of light reflection between post-

injection and pre-injection. The sensor was assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM
layer on the gold chip. Ethanolamine deactivated any unbound ester groups. The anti-P. aeruginosa antibodies were injected at
3300 seconds and a change in angle reflection was seen. The carrier solution contained air and the bubble passed over the sensor
at approximately 4100 seconds. The 105 cfu/mL P. aeruginosa solution did not change the angle of light reflection. Injections of
P. aeruginosa solutions 106, 107, and 108 cfu/mL were followed by changes in angles of reflection.

4.4.5 The effect of BSA on non-selective binding using the P. aeruginosa
immunosensor. BSA is added to immunosensors to block free Protein G molecules to
reduce non-selective binding (Dong et al., 2008; Jung et al., 2006; Jung et al., 2007; Lu
et al., 2001). The addition of BSA increases the thickness of the layers which can
decrease the sensitivity of the SPR response.

In addition, not all published

immunosensors use BSA (Fratamico et al., 1998; Waswa et al., 2006). Therefore, an
experiment was performed to determine if the P. aeruginosa immunosensor would give
false positive results if BSA was not excluded (Figure 4.10). An immunosensor was
designed as described earlier to include the anti-P. aeruginosa antibody but exclude BSA.
Briefly, the baseline of the thiol gold coated sensor was established at -10 mDeg. The
injection of NHS:EDC changed the angle of light reflection 139.01 mDeg (Figure 4.10).
Protein G injection did not affect the light reflection. The solution was injected again and
the reflection changed 18.58 mDeg (Figure 4.10). The ethanolamine injection decreased
the incident angle below the pre-injection baseline by 41.81 mDeg (Figure 4.10). The
anti-P. aeruginosa antibodies injection changed the light reflection 357.73 mDeg (Figure
4.10).

The reference buffer contained an air bubble which caused a spike in the

reflection. To test for non-selective binding, a solution of E. coli, which should not bind
to anti-P. aeruginosa antibodies, was used. A 108 cfu/mL solution of E. coli was injected
and changed the light reflection by 7.32 mDeg. The 107 and 108 cfu/mL P. aeruginosa
solutions produced an angle of reflection of 103.96 and 74.26 mDeg, respectively (Figure
4.10).
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Figure 4.10: Specificity of P. aeruginosa immunosensor. ∆y is the difference in angle of light reflection between post-injection
and pre-injection. The sensor was assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM layer on
the gold chip. Ethanolamine deactivated any unbound ester groups. The anti-P. aeruginosa antibodies changed the angle of
reflection. The carrier solution contained air and the bubble passed over the sensor at approximately 4800 seconds. Once the
baseline was stable, a 108cfu/mL E. coli solution was injected at 5700 seconds and no change in angle was seen. Angular shifts
occurred for 107, and 108 cfu/mL P. aeruginosa solutions.

4.5 Discussion
Bacteria

can

be

identified

using

antibody-antigen

interactions.

SPR

immunosensors have been shown to detect numerous bacteria based on antibody-antigen
interaction. This study attempted to develop two immunosensors to detect bacteria,
specifically S. aureus and P. aeruginosa. These bacteria cause infections in humans, are
responsible for the bullk of nosocomial infections, and can be difficult to treat due to
antibiotic resistance (Aloush et al., 2006; Ashley & Brindle, 1960; Fullbrook et al., 1970;
Li et al., 1994; Li et al., 1998; Noskin et al., 2005; Wertheim et al., 2005; Zetola et al.,
2005). The spread and the disease process of these organisms can be reduced by rapid
detection in patients.

SPR immunosensor detected S. aureus.

Using layer-by-layer self

assembled, a Staphylococcus immunosensor was made.

At the beginning of the

4.5.1

assembly, the sensor had layer of gold and a SAM of 11-mercaptoundecanoic acid
molecules (Figure 4.7). NHS:EDC chemically reacted with the 11-mercaptoumdecanoic
allowing Protein G to bind thereby shifting the angle of reflection (Figure 4.7). The antiStaphylococcus antibodies attached to the Protein G molecules fixed on the sensor
causing the 100.63 mDeg change in angle (Figure 4.7). Unbound 1 % BSA was injected
to block free Protein G molecules and the angle of reflection changed 187.29 mDeg
(Figure 4.7).
Upon the completion of the sensor, solutions of S. aureus were used to determine
if the sensor could detect bacteria. A change in light reflection was observed while the
106 cfu/mL solution flowed past the sensor as determined by the peak in the sensograph
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(Figure 4.7). Upon completion of the injection, the reference buffer carried away any
unbound molecules. The angle of reflection shifted and stabilized at the same angle of
reflection that was observed before the injection. Thus, no bacteria in the 106cfu/mL
solutions were captured by the antibodies on the sensor. Increasing the concentration of
bacteria (107 and 108 cfu/mL) increased the angle of reflection proportionally (Figure
4.7). As that angular shift of light reflection indicates a change in the layer adsorbed on
the gold sensor, it can be stated that the immunosensor assembled detected interactions
between anti-Staphylococcus antibodies and S. aureus.
The sensor was unable to detect cells less than 107 cfu/mL. Sensitivity is a crucial
characteristic of diagnostic assays. Immunosensors for other bacteria and toxins have
been developed with detection limits of 102 cfu/mL (Oh et al., 2004a; Oh et al., 2004b;
Oh et al., 2005). These sensors used SAM with various chemicals, Protein G/A, and no
BSA (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005). Optimization of the self
assembly protocol may increase the sensitivity of the sensor. In addition, the effect of
BSA on the sensitivity and specificity of the sensor should be examined.

4.5.2

P. aeruginosa immunosensor detected solutions containing P.

aeruginosa. A P. aeruginosa immunosensor was assembled in the same manner as the
Staphylococcus sensor (Figure 4.8). The NHS:EDC chemically changed the SAM layer
causing the angle of reflection to change by 41.07 mDeg (Figure 4.8). There was no
change in angle after the Protein G injection which indicted that no molecules were
adsorbed on to the SAM layer. To ensure that the sensor was properly designed, the
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Protein G solution was injected again and the reflection changed 17.60 mDeg suggesting
that molecules did bind to the ester group on the SAM layer (Figure 4.8).
The ethanolamine injection deactivated any remaining ester groups. The angle of
light reflection shifted resulting in an angle that was less than the pre-injection angle
(Figure 4.8). The angular shift would indicate the molecules that were adsorbed onto the
sensor before the ethanolamine injection were removed by the carrier solution containing
the ethanolamine. Removal of molecules decreased the thickness of the layer adsorbed
onto the gold sensor and decreasing the angle of reflection. This may be result of flow
rate. The carrier buffer ran for 60 seconds between each injection to ensure that any
unbound molecules were carried away from the sensor. This may have been too short of
a time to ensure that unbound Protein G was removed from the surface of the sensor.
Thus, the carrier buffer with ethanolamine continued to remove unbound Protein G
decreasing the thickness of the layer on the gold and shifting the angle of reflection. The
decreased angle of reflection may have also resulted from the activity of ethanolamine. If
a portion of the SAM layer was free of Protein G and still reactive then the ethanolamine
would deactivate the SAM layer, changing its shape and thus decreasing the thickness of
the SAM layer. The angle of reflection would decrease as more of the SAM layer was
deactivated. Both Protein G injections showed minimal changes in light reflection which
suggests very few molecules attached and much of the SAM layer was left reactive which
supports the ethanolamine explanation.
The angle of reflection after the ethanolamine injection is still greater than initial
baseline angle. Continuing the assembly of the sensor, the anti-P. aeruginosa antibodies
were injected. The angle of light reflection shifted by 205.38 mDeg (Figure 4.8). This
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significant shift indicated that many antibodies attached to the sensor by coupling to
Protein G molecules. The angular shift of 275.80 mDeg was observed upon the addition
of BSA indicating free Protein G was blocked by BSA (Figure 4.8).
The self assembled immunosensor was tested using 106, 107, and 108 cfu/mL of P.
aeruginosa (Figure 4.8).

There was no angular shift with the first injection which

showed the sensor did not detect the specific bacteria in the 106 cfu/mL solution. There
was an angular shift for the other concentrations (Figure 4.8). The change in angle was
proportional to the increase in cell concentrations. The second 108 injection caused the
greatest change in angle indicating that the sensor had not reached saturation with the
previous injections.
Despite the unexpected angular shifts observed during the assembly process, the
sensor clearly detected the presence of P. aeruginosa as shown by the angular shifts
observed with the 107 and 108 cfu/mL injections.

As with the Staphylococcus

immunosensor, the sensor should ideally be able to detect less concentrated solutions.

4.5.3

BSA decreases the sensitivity of the P. aeruginosa sensor.

An

immunosensor was developed to determine if sensitivity of the SPR response could be
increased if BSA was excluded.

The angular shifts for the NHS:EDC, Protein G,

ethanolamine, and anti-P. aeruginosa antibody injections were similar to the previous P.
aeruginosa sensor (Figure 4.9).

The assembled sensor was tested with various

concentrations of P. aeruginosa solutions.

The lowest limit of detection for an

immunosensor was 106 cfu/mL for the P. aeruginosa sensor assembled without BSA.
The presence of BSA lowered the threshold of detection to 107 cfu/mL for the other two
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chips.

This suggests that BSA does influence the sensitivity of the P. aeruginosa

biosensor. Even without the BSA, the sensitivity of the sensor is much lower than
published chips (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005).

4.5.4 Non-BSA chips shows selective binding of bacterial cells with cognate
antibodies. Accuracy and sensitivity are both important characteristics of a diagnostic
tool. Therefore, an experiment was performed to determine the selectivity of a sensor
(Figure 4.10). To test for non-selective binding, a solution of 108 cfu/mL E. coli was
injected into the instrument. The angle of light reflection shifted by 7.32 mDeg. The
shift indicated that high concentrations of E. coli non-specifically adsorbed to the sensor.
The 107 and 108 cfu/mL P. aeruginosa solutions produced an angle of reflection of
103.96 and 74.26 mDeg, respectively (Figure 4.10). These results proved that the sensor
was assembled correctly, functional, and specific. The SPR response for the E. coli was
insignificant in comparison to the response for the P. aeruginosa solution at the same
concentration. A similar insignificant angular shift was observed with E. coli on a
Salmonella specific sensor (Waswa et al., 2006).

Future experiments need to be

performed to determine if BSA is needed to prevent non-selective binding of other
bacteria.

4.5.5 Optimization of immunosensors. In order to use SPR immunosensors as
a diagnostic tool, the accuracy, specificity, and sensitivity of the sensors need to be
improved. SPR response can be affected by the instrumentation, environment and by the
choice in chemicals used in the layer-by-layer self assembly process.
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The instrument is very sensitive to the environment and should be placed in a
temperature controlled area (Dudak & Boyaci, 2009). Lack of temperature control causes
an increase in standard deviation between readings (Dutra et al., 2007; He et al., 2007;
Matsumoto et al., 2005; Naimushin et al., 2003). Additionally, the instrument uses
microfluidics to transfer chemicals to the gold sensor chip (Biosensing Instrument, 2006).
The flow rate of the reference buffer and the injections can be modified to increase the
adsorption of molecules to the sensor (Dudak & Boyaci, 2009). Ideally, the flow rate will
enable bacteria to bind to the antibodies before the reference buffer washes them away.
Though if the rate is too slow, the antigens will form aggregates and not be able to bind
to the antibodies. On the other hand if the rate is too fast, then the mass transfer
limitations will be minimized and antigens will flow past the antibodies unable to bind
(Dudak & Boyaci, 2009; Skottrup et al., 2008). The flow rate used in this study was an
intermediate rate (10 µL/min for reagents and 5 µL/min for antibodies and bacteria);
other published work used anywhere from 3 to 100 µL/min (Fratamico et al., 1998; Oh et
al., 2004a; Oh et al., 2004b; Oh et al., 2005; Subramanian & Irudayaraj, 2006; Waswa et
al., 2006). In addition, the reference buffer must run in between injections. Enough time
needs to be allowed to ensure that excess or unbound molecules are washed away from
the sensor. Sixty seconds was used in this study which may have not been enough time
to clean the sensor. This factor is rarely detailed in published material. Some of the
published studies do not use microfluidics for assembly; rather the chip is immersed in
Protein G or the antibody for hours to days and then rinsed off with a buffer (Oh et al.,
2004a; Oh et al., 2004b; Oh et al., 2005). Longer incubation times with more effective
rinses may increase the efficiency of the molecules binding to the sensor.
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Solutions used in the SPR sensor assembly also affect the SPR response. First,
the ionic solution and pH of the buffers may need to be optimized. SPR sensitivity is
affected by ionic strength as it directly affects the supramolecular interactions between
antibody and the antigen (Srilatha & Murthy, 2006). Besides PBS, HEPES buffer saline
has been used (Fratamico et al., 1998; Waswa et al., 2006). The composition of the PBS
may have not provided the optimum ionic strength that would lead to the appropriate
binding affinity constants. The pH of the PBS solution also needs to be optimized for
molecule interaction, especially the binding of antibodies to Protein G (Keeler et al.,
2007; Srilatha & Murthy, 2006; Waswa et al., 2006). One study has shown that more
antibodies bind to Protein G if a pH 5 is used while pH 7 is better for a sensor without
Protein G (Fratamico et al., 1998). In this work, pH 7 was used and that may have
affected the angular shift of light reflection in response to the antibody (Fratamico et al.,
1998).
The properties of the sensor can also be improved by using other methods to fix
the antibodies to the sensor, such as coating the sensor with streptavidin and labeling the
antibody with biotin (Dudak & Boyaci, 2007). This method has been used to detect E.
coli with a sensitivity of 102 cfu/mL (Dudak & Boyaci, 2007). This conjugation system
may increase the detection limit for the P. aeruginosa and Staphylococcus
immunosensors.
The assembly process can also be optimized by changing the chemical used to
form SAM. There are some studies that conclude mixed SAMs (using two different
alkanethiols) can increase the SPR response (Taylor et al., 2006; Tsai & Li, 2009).
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Once all these optimizations are determined, a sensor can be developed that is
accurate, reproducible, and sensitive. At this time, the SPR immunosensors developed in
this study lack the sensitivity to be used to detect S. aureus and P. aeruginosa in a
sample.
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Chapter 5

Summary and General Discussion
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5.1 Overview
Cystic fibrosis is a genetic disorder that affects approximately 30,000 children and
adults in the United States (Patient-registry, 2008). In addition, one out of 31 people are
have a mutation in one copy of the cftr gene encoding the cystic fibrosis transmembrane
conductance regulator protein (Patient-registry, 2008). If a person inherits two copies of
the gene each carrying a mutation then the individual can aspect to have difficulties with
their digestive, reproduction, and respiratory systems (Patient-registry, 2008). During the
1950’s few of these patients would live to attend elementary school.

Due to

advancements in science and medicine, the median age of survival has risen to 37.4 years
in 2008 (Patient-registry, 2008). The leading cause of morbidity and mortality in CF
patients is lung disease which stems from chronic microbial infection.
The CF lung contains a dehydrated layer of mucus which reduces the ability of
the cilia to beat the microorganisms out of the lungs (Andersen, 1938). The limited
mucosal clearance, the inability of the host immune system to eradicate the infection, and
development of antibiotic resistance leads to chronic infections that destroy the lungs
leaving the patient in need of a lung transplant (Patient-registry, 2008). In 2008, 158
people received a transplant to extend their lives (Patient-registry, 2008).

Lung

transplants are risky and the supply of lungs is limited (Adler et al., 2009). The most
likely way to increase CF life expectancy is to decrease bacterial and fungal lung load in
the lungs. In order to treat and reduce infections, one must identify the causative agent
and understand the role the organism plays in the lung.
This dissertation served to further understand the CF lung infection. First, the
composition of the bacterial community in the CF lung and its dynamics over time were
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determined using LH-PCR (Chapter 2). Second, the members of the community both
bacteria and fungi were identified using 454 sequencing (Chapter 3).

In addition,

correlations between the diseased and healthy bacterial communities were identified
(Chapter 3). Thirdly, a bacterial diagnostic tool targeted towards CF pathogens was
developed using SPR (Chapter 4).

5.2 Bacterial community profiling of the CF lung
Based on culturing methods, it was thought only a few bacteria including
Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa infected
the CF lung (Whittier, 2001). S. aureus, the predominant pathogen in children, is usually
succeeded by H. influenzae later in childhood and P. aeruginosa becomes the
predominant pathogen during adolescence, reaching a prevalence rate of 80% in adults
(Beringer & Appleman, 2000; Patient-registry, 2008). With the advent of molecular
tools, it became known that the CF lung community is larger and more diverse than
culturing results had show (Armougom et al., 2009; Bittar et al., 2008; Harris et al.,
2007; Rogers et al., 2003). One of the earliest studies analyzed CF patient sputa and
bronchoscopy samples with T-RFLP (Rogers et al., 2003). The common pathogens, P.
aeruginosa, Burkholderia cenocepacia, Staphylococcus aureus, and H. influenzae were
identified in the CF samples (Rogers et al., 2003).

In addition, Achromobacter

(Alcaligenes) xylosoxidans, Rhodotorula mucilaginosa, Abiotrophia spp, Bacteroides
gracilis, Eubacterium brachy, Mycobacterium mucilaginosus, Mycoplasma salivarium,
Porphyromonas salivae, Ralstonia spp, Staphylococcus hominis, Streptococcus
anginosus,

Treponema

vincentii,

Veillonella
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spp,

Burkholderia

gladioli,

Stenotrophomonas maltophilia and Pandoraea atypical were also shown to be members
of this polymicrobial infection (Rogers et al., 2003). Large scale Sanger sequencing
projects continued to resolve the bacterial community and revealed the presence of
organisms that were not previously associated with the CF lung. Moxaxella cattharalis,
Granulicatella

elegans,

Inquilinus

limosus,

Granulicatella

adiacens,

Rothia

mucilaginosa, Dialister pneumosintes, Dolosigranulum pigrum, Lysobacter, Coxiellaceae
were identified from either bronchoalveolar or sputum samples from CF patients (Bittar
et al., 2008; Harris et al., 2007; Rogers et al., 2003). These molecular studies indicate
that the total ecology of the CF lung niche remains an open question. This research
continued to identify the bacterial community in the CF lung by examining snap shots of
the overall bacterial community.
Though the composition of the lung niche is being teased apart, a larger question
still needs to be addressed. The interactions between these organisms, the host, and the
disease process are not well understood. There are some correlations with patient age
and infection. As noted earlier, S. aureus is most often identified in children and P.
aeruginosa is associated with adulthood (Beringer & Appleman, 2000; Patient-registry,
2008). Yet, the molecular studies have identified S. aureus in adults (Bittar et al., 2008).
Culturing results also vary throughout a patient’s life indicating that some bacteria are
transient while others are constantly present in the community regardless of antibiotic
therapy (Beringer & Appleman, 2000; Patient-registry, 2008; Rogers et al., 2010; Smith
et al., 2006). Therefore it can be hypothesized that the bacterial community in the CF
lung is dynamic. This study used LH-PCR to obtain a snap shot image of the bacterial
community in a CF sample at the time of collection. The presumptive identities of the
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organisms present in the sample were determined. The bacterial profiles were also used
in an attempt to understand how the community as a whole can be affected by the host
and other community members over a period of time.
In this study, 19 CF sputa samples from adult patients in Miami, FL were
analyzed for the presence of bacteria using LH-PCR (Chapter 2; (Doud et al., 2009)).
The profiles generated demonstrate the complexity and uniqueness of the bacterial CF
lung community (Chapter 2, Supplemental Figure 2.6 and 2.7). Each peak in a profile
represents at least one bacterium.

The V1_V2 profiles for 12 of the CF samples

contained multiple peaks and were different from one another. The most complex sample
contained eight amplicons (Chapter 2, Figure 2.1A). Seven of the samples had identical
V1_V2 profiles containing one peak at 342 bp (Chapter 2, Figure 2.1B). In contrast, all
V1 profiles contained multiple amplicons (10-30) and each profile was different
demonstrating that lung communities are unique to a patient (Chapter 2, Figure 2.7 and
Table 2.1). The profiles from the V1_V2 region were more similar than the V1 LH
profiles. Thus, the V1 region had a higher power of discrimination than the V1_V2
region. The LH profiles provided snap shot pictures of the bacterial communities further
highlighting the diversity and complexity of the CF lung infections.
The drawback to LH-PCR is the lack of species identification. It was first thought
that organisms within in one genus would have the same length for a particular variable
region. A bioinformatic analysis using the newly designed AmpliQué highlighted the
presence of extreme length variability in the V1_V2 region of the 16S rRNA gene
(Gonzalez et al., 2009). Not only do strains within a species vary in amplicon length,
multiple genera can produce the same amplicon length. Identification of bacteria in an
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LH profile based on one amplicon length is nearly impossible. Identification using LHPCR may be attainable if multiple regions of the 16S rRNA gene are used to profile the
same sample. Cloning and sequencing of the amplicons is the only way to identify an
organism.
Identification using other community profiling techniques can also be
challenging. T-RFLP has been used to analyze CF samples (Rogers et al., 2003; Rogers
et al., 2004; Rogers et al., 2006; Rogers et al., 2009; Rogers et al., 2010). This technique
produces the same variable length fragments as LH-PCR and then the amplicons are cut
with a restriction enzyme. This additional step increases the discriminatory power of the
technique (Rogers et al., 2003). Bacteria identification is still presumptive as that the
length of the amplicon generated from the restriction digestion can still be the same for
multiple organisms. Identification of bacteria is confirmed by cloning and sequencing
(Rogers et al., 2003; Rogers et al., 2004). Identity of bacteria in a community is not
easily determined with T-RFLP or LH-PCR but the techniques can easily provide an
estimate of bacterial diversity associated with the sample (Doud et al., 2009; Rogers et
al., 2003; Rogers et al., 2004). However, community profiling can provide information
on community dynamics.
Microbial community dynamics have traditionally been studied in the field of
ecology.

Many environmental factors such as nutrients, temperature, fertilization

practices, and metal pollutants have been found to have an effect on the bacterial
community in soil (Entry et al., 2008; Gunapala & Scow, 1998; Mills et al., 2003;
Moreno et al., 2006; Vinas et al., 2005) and in marine and fresh water (Boer et al., 2009;
Carrero-Colon et al., 2006; Crump et al., 2003; Simek et al., 2001).

196

LH-PCR and T-RFLP are quite commonly used in ecology to observe and
understand the relationship between members of the community and external factors.
The microbial ecology methodologies can be applied to microbial communities
associated with infections.
This study which used LH-PCR is the first to observe bacterial community
dynamics in the CF lung. One patient produced expectorated sputa multiple times in one
day and then again one year and two years later. Minor variations in the LH profile were
seen in the samples taken from one day at all time points (Chapter 2, Figure 2.5). In
contrast, the bacterial profiles generated from samples at different time points (M1, M3,
M16, and M17) were quite different from one another and from those samples given on
the same day in M22. Hence, there is a temporal variability in the CF lung bacterial
community indicating the community is not static but rather dynamic (Chapter 2, Figure
2.5).
Other human associated bacterial communities have been found to be constant
rather than dynamic. Pyrosequencing was used to determine the composition of bacteria
communities associated with various spots on the healthy human body (Costello et al.,
2009). Samples were collected on two consecutive days and then a month later for two
additional consecutive days. The researchers concluded that each habitat has its own
characteristic community and the communities were relatively stable over time (Costello
et al., 2009). The healthy human may contain a more stabilized microbiota because the
human is not influenced by pathogenic microbes and therapeutic drugs (Hilty et al.,
2010)
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The instability of the CF lung eubacteriome could be attributed to antimicrobial
therapy. To address this hypothesis, LH profiles were generated over a six month period
from two individuals undergoing antibiotic treatment (Chapter, Table 2.2). The variation
in profiles from the medicated patients was much more dramatic than the changes in the
communities from the stable patient. In addition, the most dramatic changes (drastic
changes in abundance and disappearance of peaks) correlated with changes in the
patient’s antibiotic treatment (Chapter 2; Table 2.2). Therefore, antibiotics are a potential
driver of the CF bacterial community. CF individuals from infancy are under periods of
antibiotic treatment. The continuous use of antibiotics has most likely disrupted the lung
flora.

Antibiotic treatment has already been established as a driver of bacterial

communities present in the mouse gastrointestinal track, the trachea of intubated people,
and chronic wounds (Antonopoulos et al., 2009; Flanagan et al., 2007; Price et al., 2009).
This study is the first to track the bacterial community in the CF lung over time.
Although the study used a small sample size over a relatively short period of time,
changes in the presence and abundance of amplicons in the LH profiles could be seen. To
accurately identify the drivers of the community, a more comprehensive long term study
needs to be performed. Armed with the patient’s antibiotic information and long term
sampling, it should be possible to determine the effectiveness of a drug against pathogens
in the CF lung. This could eventually lead to more effective treatments. In addition,
other drivers of the bacterial community need to be defined. The composition of the
bacterial community may be influenced by the patient’s age, ethnicity, cftr mutation or
daily environment.
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Future studies. To understand the community dynamics of the CF lung, the core
biome or baseline community of the healthy human mouth and nasopharyngeal regions
must be determined. Several recent studies have determined the microbiome in the oral
cavity and lungs from healthy individuals (Ghannoum et al., 2010; Hilty et al., 2010;
Keijser et al., 2008; Lazarevic et al., 2009; Zaura et al., 2009). This information should
be compared to CF data to discern the presence of unique organisms and their role in CF
pulmonary failure. Healthy samples, in addition to CF samples, can also be collected and
analyzed as controls during a long term study. It would be advantageous to use age,
gender, and race matched samples. Samples from healthy individuals that live with the
CF patient could also be used to look at the role the environment has on the community.
A much large sample size is needed to corroborate the preliminary results of this
study. Samples from CF patients from both genders, multiple races/ethnicities, different
ages, and cftr mutations are needed. In addition, the health of the patient (weight, lung
function, disease progression) should be recorded. Samples should be collected quite
often, at least monthly though more often would be preferred for a long period of time (a
year or more).
Ideally, the analysis of sputa or BAL samples using a community profiling
technique such as LH-PCR should be performed in conjunction with a sequencing
technique, such as 454 pyrosequencing. LH-PCR would provide bacterial profiles of the
samples. Sample profiles that show change from one time point to the next can then be
further analyzed using sequencing. The identity of the organisms and their relative
abundance from each community would be compared with other time periods. Using
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multivariate statistics, changes in community can be identified and correlated with patient
characteristics to identify the drivers of the CF community.

5.3 High throughput 454 sequencing identifies bacteria and fungi associated with
the CF lung
Community profiling and Sanger sequencing projects have been used to study the
polymicrobial nature of the CF lung (Armougom et al., 2009; Bittar et al., 2008; Harris et
al., 2007). These studies have shown that the bacterial communities are diverse and
unique to each patient. The list of bacteria associated with the CF lung as noted in the
previous section is getting longer with every study.
The CF lung can also be inhabited by fungi. Species-specific PCR and culturing
have identified a few fungi, such as Aspergillus and Candida (Bakare et al., 2003; Cimon
et al., 2001; Mearns et al., 1967).

There have been reports of Scedosporium

apiospermum, Exophilia sp., and Wangiella dermatitidis being cultured from CF sputa
(Defontaine et al., 2002; Dixon & Polak-Wyss, 1991; Hennequin et al., 1997; Horré et
al., 2004; Horré et al., 2009; Rogers et al., 2003; Williamson et al., 2001). Recent
statistics have shown that there is an increase in the prevalence of fungi being detected in
the CF patient which may be a consequence of aggressive antibacterial therapy (Nagano
et al., 2007).

Yet, the diversity of the fungal community has not been previously

analyzed with community profiling techniques or sequencing. A more comprehensive
study is needed to determine if the fungal community is as diverse and unique as the
bacterial community.
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To resolve the microbiome, high throughput 454 sequencing was used to analyze
the sputa from 19 south Floridian CF patients.

This study is the first to use this

technology to analyze the bacterial and fungal communities simultaneously in the same
samples. Multivariate statistics was used to identify similarities between the communities
and the relationship of the host’s gender and ethnicity with the microbial community.
The CF microbial communities were also compared to the communities sequenced from
healthy oral rinses.
The unique polymicrobial nature of the CF lung was shown by the data.
Sequencing results identified numerous bacteria in the CF lung, some of which were not
previously identified in other metagenomic studies (Armougom et al., 2009; Bittar et al.,
2008; Harris et al., 2007; Rogers et al., 2003; Tunney et al., 2008). Thirty-four taxa were
identified in the 18 samples.

All samples contained numerous organisms with the

average of 9.6±3.3 taxa present. Pseudomonas or Streptococcus were present in 16/18
samples. Chryseomonas was present in 15 samples and was the most abundant organism
in 14 samples.

Fourteen samples contained sequences from Micrococcineae and

Prevotella. Chryseomonas, Flavimonas, and Moryella may potentially be novel bacteria
in CF sputa.
Many genera that contain common CF pathogens were sequenced including
Pseudomonas, Haemophilus, Burkholderia, Staphylococcus, Achromobacter, and
Stenotrophomonas (Chapter 3, Table 3.2). In addition, many sequences corresponded to
organisms that are known to be present in the oral cavity. Some of these organisms are
commensal while others are known to cause infections. These oral sequences in the sputa
may be contributed by oral bacteria that come in contact with the sputa during sampling
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process or from bacteria that colonize the throat and lungs. The role of oral associated
organisms in the CF lung is unknown but it can be hypothesized that they play a role in
lung disease progression (Bittar et al., 2008; Rogers et al., 2006).
Some sequences were identified as organisms not cultured from CF samples but
identified through sequencing (Bittar et al., 2008; Harris et al., 2007). This analysis
identified sequences belonging to three genera that that have never been cultured or
sequenced from CF sputa or BAL (Chapter 3, Table 3.2).

Sequence hits for

Chryseomonas and Flavimonas were obtained for some MTPS reads. Both of these
genera have been reclassified as Pseudomonas. The species associated with those genera
can be pathogenic and have not been associated with the CF lung. Obtaining a full length
16S rRNA sequence is needed to verify the identity of these sequences. Sequences
identified as Moryella were present. Little is known about the anaerobe and this is the
first time it has been sequenced from CF samples. Overall, the 454 sequencing of the
south Florida CF patients showed a more diverse eubacteriome in the CF sputa than other
studies (Armougom et al., 2009; Bittar et al., 2008; Harris et al., 2007; Rogers et al.,
2003; Rogers et al., 2004; Rogers et al., 2006; Rogers et al., 2009; Rogers et al., 2010).
Many samples shared multiple taxa but statistically the communities were unique
to each patient (Chapter 3, Figure 3.2). Similarities between communities could not be
attributed to patient’s gender or ethnicity (Chapter 3, Figure 3.2). A much large sample
size is needed to determine if gender and ethnicity affect the composition of the bacterial
community.
The bacterial communities in the CF sputa were compared to communities from
healthy oral rinses. PCO clustered healthy bacterial communities closely together and
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separated from CF bacterial communities (Chapter 3, Figure 3.3).

Statistically, the

overall bacterial community in the CF lung was quite different than the healthy oral
samples. Twelve taxa were present in both datasets most of which were associated with
the oral cavity (Chapter 3, Table 3.4). Achromobacter was present in one healthy sample
which may indicate the person was not actually healthy. Burkholderia was present in
both groups; without the species, it cannot be determined if the pathogenic organism was
present in the healthy sample.

Many of the common CF pathogens including

Pseudomonas, Staphylococcus, and Stenotrophomonas were only sequenced in the CF
samples. The comparison of the communities indicated that some microbes sequenced in
the CF samples may originate from the mouth.
This study also used sequencing to identify the fungal taxa associated with the CF
lung. Previous to this research, the fungal community was thought to consist of a handful
of fungi, mainly species of Aspergillus and Candida (Bakare et al., 2003; Cimon et al.,
2001; Mearns et al., 1967). In contrast, 454 sequencing identified 33 taxa from 18 CF
samples (Chapter 3, Figure 3.4 and Table 3.5 and Supplemental Table 3.8). The samples
had an average of 26 ± 3 taxa. Ten genera including Aspergillus were present in all
samples. In regards to abundance, the most sequenced genus in 17 samples was Pichia
with sequences from P. anomala, P. membranaefaciens, and Pichia sp. The second most
abundant genera in all 17 samples was Rhizoctonia (Chapter 3, Table 3.5).
The opportunistic pathogen Candida albicans was present in eight samples. In
addition, the pathogens Aspergillus terreus, Aspergillus ustus, Cryptococcus neoformans,
Exophilia, and Wangiella dermatitidis were present in many samples (Chapter 3, Table
3.5 and Supplemental Table 3.8). None of these patients were being treated for a fungal
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infection yet the most abundant sequence in 17 samples was Pichia (P. sp., P.
membranefaciens, and P. anomala).

Attempts should be made to corroborate the

presence of the pathogenic fungi.
Of the 33 genera present, 26 genera were environmentally associated fungi. Their
associated low abundances indicated the fungi were not colonizing the lung but rather
transient members of the community originating from consumed food and inhaled air.
Comparisons of the mycobiome established that each patient had a unique fungal
community (Chapter 3, Table 3.5). PCO statistically showed that gender and/or ethnicity
did not contribute to the likelihood of organisms being shared between patients (Chapter
3, Figure 3.5). A correlation may be present when a larger sample size is analyzed.
The mycobiomes in the CF sputa were compared to the fungal communities
identified in healthy oral rinses (Chapter 3, Figure 3.6). Based on the presence of genera,
CF mycobiomes were clustered together and apart from healthy mycobiomes. The two
datasets shared 11 genera but at the species level only five organisms were in common.
Four organisms were associated with the environment. The remaining shared fungus was
Candida albicans, an opportunistic pathogen that is commonly found in the mouth. Both
groups of samples contained numerous fungi present in the environment. These fungi
varied between the datasets which may be a result of the individuals living in two very
different areas within the US.
The CF sputa eubacteriome was established to be diverse containing pathogens,
oral microbes, and environmental fungi. The role of the organism in the progression of
lung disease is unknown for the majority of the identified organisms. The core biome of
the oral cavity, nasal regions, throat, and bronchial tree should be determined to establish
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which microbes are transient, beneficial to the host, or truly associated with the CF lung
infection.

Deep sequencing may potentially determine the core biome but the

significance of the other organisms not associated with the healthy community cannot be
determined by sequencing alone.

Future studies. Patients who share the same cftr mutation can have different
predominant pathogens in their microbiomes.

In addition, patients with the same

pathogen can have completely different disease outcome.

These observations led

researchers to study the CF microbiome. In this study, the members of the microbiome
were identified using deep sequencing. These results have left more questions than
answers. First, is the assigned identity correct? Secondly, are the sequences from
metabolically active organisms? Thirdly, what role does the community member play in
the community? All future CF community studies should address these three questions.
To verify the identity of the organisms, the same CF samples can be sequenced
using multiple genetic markers. Using a bioinformatic program, the sequences can be
joined to make longer contigs which are then used for identification. Longer contigs will
be more specific and thus organisms are more accurately identified. If technology is
improved, longer read lengths of one marker will be possible and multiple markers will
not be necessary.
Culturing the sequenced organism from the sample will also confirm its presence.
For this method, it must be assumed that the identification obtained from a short
sequencing read is correct. Using selective media and growth conditions, the sequenced
organism may be cultured.

The identities of the pure isolates can be verified by
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sequencing the entire 16S rRNA gene for bacteria, 18S rRNA gene or the ITS regions
located between the rRNA genes for fungi.

If the organism is cultured then it is

obviously metabolically active in the lung. Using T-RFLP, and sequencing,
Streptococcus milleri group was detected and subsequently cultured from CF samples
(Sibley et al., 2008; Sibley et al., 2010). This species is not readily identified using
routine clinical culturing protocols (Sibley et al., 2010). Creating growth media to isolate
organisms identified by sequencing is laborious and will not always work for all
microbes.
A non-culturing molecular approach can also be used to determine if the sequence
bacteria is metabolically active. The active bacteria can be identified by analyzing the
meta-transcriptome (Leininger et al., 2006; Urich et al., 2008). In this method, the
metagenomic RNA is isolated from the CF samples.

The total RNA is reversely

transcribed into cDNA and then directly pyrosequenced. The resulting output is large
numbers of cDNA that are rRNA-tagged and mRNA-tagged sequences which provide the
sequence-based transcriptome of the community. Using bioinformatic programs like
MEGAN, the sequences can be binned, aligned and identified (Leininger et al., 2006;
Urich et al., 2008).

By analyzing the meta-transcriptome, the metabolically active

bacteria in the CF lung can be identified.
Determining the role of the organism in the community will be the most
challenging issue to address. Traditionally, Koch’s postulates must be fulfilled to state
that an organism causes a disease (Koch, 1884). Two requirements are that organism
causing disease be isolated and grown in culture and that the pure isolated organism
causes disease when introduced to a healthy person.
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First, it will be difficult to

impossible to culture all microbes in the CF lung (Staley & Konopka, 1985). In addition,
it is more likely that a combination of microbes increases lung disease in CF rather than
one specific organism. Furthermore, CF lung disease progression is also affected by the
host’s immune system (Makam et al., 2009). The complexity of these relationships
makes future studies on dynamics challenging.
Bacterial interactions can be studied by growing combinations of organisms
together in media or in artificial sputum (Sriramulu et al., 2005). Competition studies
can determine if bacteria can live in the same niche or if one bacteria flourishes in the
community.

In addition, the growth media can be analyzed for bacterial secreted

compounds that may be promote or decrease growth of another organism.

These

experiments should start with only two organisms and then other CF organisms should be
added in succession. However, the bacterial interactions monitored in these conditions
may not replicate the dynamics that occur in the complex CF lung.
Recreating the microbial community in a model system will provide information
on how the microbial community interacts with the host. A porcine and mouse lung
models have been developed that can be used to study lung infections (Hoffmann et al.,
2005; Rogers et al., 2008).

These animal models can be infected with various

combinations of microbes and the affect on the lung can be studied. In addition, BAL
samples from the lungs can be analyzed to determine the persistency of a microbe that
was colonized in the lung at the beginning of the infection. These studies will provide a
glimpse into the human CF lung.
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5.4 SPR as a bacterial detection tool
During a routine or a sick visit, a clinician will take a sputum sample from a CF
patient and send it to the lab for analysis. The sample is cultured on various media and
based on a phenotypic and biochemical assays, identification is made (Murray & Baron,
2007). Empirical treatment is initiated before microbial identification, based on the site
of infection and if the isolate is Gram positive or Gram negative. Within a day or two,
the clinician is notified of the laboratory result and adjusts treatment.

For limited

microbes, identifications can also be obtained using methods based on antibody-antigen
interactions, such as the ELISA (Engvall & Perlmann, 1971; Pedersen et al., 1987; Voller
et al., 1978). Molecular tools are favored for rapid detection of organisms. Many of
these methods were discussed in Chapter 1. Diagnostic tools for microbial identification
are constantly being upgraded or developed anew to achieve faster, cheaper, and more
accurate identifications. This study looked at the feasibility of using surface plasmon
resonance (SPR) as a bacterial diagnostic tool.
SPR is a phenomenon in which molecules between the interface of two media
vibrate (Wood, 1902, 1912). This phenomenon can be used to determine if an antigen
binds to an antibody (Kretschmann & Raether, 1968; Otto, 1968).

Using a SPR

instrument, light is passed through a glass chip thinly coated with gold (Chapter 4, Figure
4.1). A specific frequency of light passes into the gold creating an evanescent wave. The
wave excites the plasmons causing them to resonate and form a plasmon wave which
travels along the gold film interacting with the media in contact with the gold.

The

remaining frequencies of light are reflected at a specific angle. The angle of the light
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reflection, which can be measured, shifts as molecules adsorb onto the surface of the gold
(Kretschmann & Raether, 1968; Schasfoort & McWhirter, 2008).
SPR immunosensor detects interactions between antibodies and other molecules
such as bacteria (Geddes et al., 1994; Mayo & Hallock, 1989).

Essentially, SPR

immunosensors detect antigens that bind to antibodies on the gold sensor by measuring
the angle of light reflection (Kretschmann & Raether, 1968). SPR immunosensors have
been used to identify Escherchia coli O157:H7 (Fratamico et al., 1998; Meeusen et al.,
2005; Oh et al., 2003; Su & Li, 2005; Subramanian et al., 2006a; Taylor et al., 2005),
Vibrio cholera (Jyoung et al., 2006), Salmonella enteritis (Bokken et al., 2003),
Salmonella typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al., 2004b),
Listeria monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et al., 2005),
Yersinia enterocolitica (Oh et al., 2005), and Campylobacter jejuni (Taylor et al., 2006).
This research study developed SPR immunosensors to detect Staphylococccus and
Pseudomonas aeruginosa using the self assembled layer-by-layer approach. The gold
sensor chip was functionalized with SAM and then activated to allow binding of Protein
G molecules which enables either Pseudomonas aeruginosa or Staphylococcus antibodies
to bind to the sensor in the proper orientation (Chapter, 4, Figure 4.7). The sensitivity
and specificity of the sensors were determined using various bacterial solutions.
The Staphylococcus sensor was able to detect 107 and 108 cfu/mL of
Staphylococcus aureus (Chapter 4, Figure 4.7). A P. aeruginosa immunosensor detected
107 and 108 cfu/mL of P. aeruginosa (Chapter 4, Figure 4.8).
SPR immunosensors have been capable of detecting bacteria down to the 102
cfu/mL (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005). Attempts were made to

209

improve the sensitivity of the P. aeruginosa sensor by excluding BSA in the assembly
process (Chapter 4, Figure 4.9). This modification enabled the sensor to detect 106
cfu/mL. Therefore, the sensor without BSA was more sensitive. BSA has been shown to
decrease the sensitivity of other immunosensors (Dong et al., 2008; Jung et al., 2006;
Jung et al., 2007; Lu et al., 2001).
The absence of BSA may increase false positives for the sensor. Therefore, an
experiment was performed to determine the selectivity of a P. aeruginosa sensor made
without BSA (Chapter 4, Figure 4.10). The sensor detected a minimal angular shift for a
108 cfu/mL E. coli solution demonstrating the specificity of the sensor.
In summary, four immunosensors were successful assembled. These sensors
could detect either Staphylococcus or P. aeruginosa cells in a solution. The sensitivity
and specificity of the sensors were not ideal and not as good as other published sensors.
Optimization of the self assembling process may lead to sensors that could be used for
bacterial detection in a clinical setting.

Future studies. The qualifications for any detection system are reproducibility
and accuracy. In addition, for marketing reasons, systems should be sensitive, cost
efficient, easy to use, portable, and provide diagnosis in a short period of time. At this
time, SPR immunosensors lack the vast majority of these characteristics.
The immunosensors developed in this work do not meet many of the criteria
needed for clinical use. The assembly and detection protocols need to be optimized. A
detailed description of potential optimization steps was discussed in Chapter 4 (Chapter
4.5.5). Briefly, all future work should be performed in a temperature control setting
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(Dudak & Boyaci, 2009; Dutra et al., 2007; He et al., 2007; Matsumoto et al., 2005;
Naimushin et al., 2003). Flow rates of both the reference buffer and the injections should
be determined so that enough time is allowed for molecules to interact on the gold
surface without causing unbound molecule aggregates to form on the surface (Dudak &
Boyaci, 2009; Skottrup et al., 2008). Different methods can be used to ensure proper
orientation of the antibodies onto the sensor without decreasing the sensitivity of the
sensor (Dudak & Boyaci, 2007). In addition, the ionic composition and pH of buffers
should be adjusted to maximize the detection limit (Srilatha & Murthy, 2006). Choice of
antibodies also plays a role in adjusting the sensitivity and accuracy of the detection
system.
In general, SPR immunosensors are more cost efficient then using sequencing for
bacterial detection but more expensive than the commonly used phenotypic detection
systems (Dalvie et al., 2005; Rantakokko-Jalava et al., 2006). The largest part of the
SPR cost is the gold chip that costs around $30. It is possible to reuse the chip after the
first detection experiment by injecting a harsh chemical that removes all material
adsorbed onto the gold (Waswa et al., 2006). This method does affect the gold on the
glass chip which will decrease the sensitivity of the next detection experiment.
Validation studies would have to be performed to determine how significant the decrease
is. The loss of sensitivity may outweigh the need to reduce cost. Low labor costs also
makes the system more cost efficient. No additional training would be required for the
technician to use SPR. The instrument is relatively easy to use with the only labor being
manual injections into the instrument.
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The time required for results is on par with ELISA and commercial identification
systems (Funke & Funke-Kissling, 2005; Janyapoon et al., 2000; Rantakokko-Jalava et
al., 2006). The lengthiest part of the analysis for all these methods is isolating and
culturing a bacterium from a sample. Once the sensor has been assembled and the
bacteria have grown, the antibody-antigen interaction can be observed within three to ten
minutes depending on the injection flow rate. Changes in SPR response are observed in
real time and no additional wait is needed for the results. With optimization of buffers,
chips, antibodies, and assembly protocols it may be possible to create an immunosensor
that can use human fluids and is faster and cheaper than current identification tools.
Currently developed SPR immunosensors could only be marketed to test for one
type of bacteria in a pure culture or with samples containing two or three isolates that do
not cross react with the antibodies on the sensor chip. As discussed earlier, a CF sputum
sample contains a multitude of bacteria. A multiplex SPR immunosensor could be
developed to analyze complex samples like CF sputa. This sensor must be made with
multiple species-specific polyclonal antibodies affixed to the chip. In addition, the SPR
response for each type of antibody on the chip would have to be distinguishable from
each other. Advances in nanotechnology may allow SPR instruments to detect multiple
antibody – antigen detections at faster rates and better detection limits.

5.5 Conclusions
This work further proved the CF lung contains numerous bacteria and fungi and
the lung community is dynamic affected by multiple drivers. By understanding the
members in the community, one can begin to learn the role of the organisms within the
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community and how they affect the host. These relationships are the key to decreasing
lung damage and increasing the median age of survival for the patient, which is 37.7
years of age (Patient-registry, 2008). In the future, antibiotics may be prescribed to shift
the community dynamic to a healthier state instead of killing one bacterium which leaves
the door open for other pathogens.
The research projects in this study used two groups of CF patients, with 18-19
participants. These patients were all adults and mostly Caucasians. Future studies should
use a larger population size that includes various races, ethnicity, ages, and cftr
mutations. These factors as well as diet, health, and antibiotic use should be used to
statistically determine if there is a correlation between the factors and the microbiome. In
addition, healthy samples need to be analyzed to determine the organisms associated with
the normal oral/lung core biome. Through the use of 454 sequencing and LH-PCR, the
organisms in the lung can be identified, tracked and then related to host factors. Then, it
can be determined if the presence of some organisms are necessary for good lung
function. Contrary to common belief, the bronchial tree of the healthy person is not
sterile and these microbes may play a role in maintaining lung health (Hilty et al., 2010).
Certain personal factors may also increase the likelihood of a particular microbe
colonizing the lung. Determining how a microbial community causes pathogenicity is
the next step to understanding the CF lung biome.
The studies addressed in this work can also be implemented with infants and
children.

By using LH profiling and 454 sequencing, the transition from a sterile

newborn lower lung to the complex adult lung infection can be observed. Determining
the organism that first cultures the lung and how the infection progresses throughout
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childhood may change how the United States treats CF children. In Europe, CF patients
are treated early and aggressively with antibiotics with the goal being eradication
(Hansen et al., 2008). In the US, treatment is only post infection (Flume et al., 2009).
Understanding the community in the neonate may lend one course of treatment better
than the other and perhaps extend the life span considerably.
CF lung infections will need to be diagnosed, understood, and treated until cftr
mutations are no longer being passed on to new generations. Continuing this research
using 454 sequencing and community profiling with a large population of CF and healthy
individuals may provide the knowledge needed to stabilize the lung community and
reduce the pathogens that cause lung deterioration which ultimately kills the CF
individual.
The advances of sequencing technology has made it cheaper, faster, and easier to
identify microbial DNA in a CF sample. The name of the organism is but the first step in
understanding the microscopic community living in the CF lung. Understanding how
bacteria interact with each other and with the host is the next step in the puzzle.
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